EOS Med Chem Impurity Stock 20201029-39

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Bisphenol Z-d6, CAS: /, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₆O₂.

Bisphenol A (2,3-dihydroxypropyl) Glycidyl Ether, CAS: 76002-91-0, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₅.

(αS)-α-[[(1S)-1-Carboxyethyl]amino]benzenebutanoic Acid, CAS: 84023-58-5, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

(αS)-α-[[(1S)-1-Carboxyethyl]amino]benzenebutanoic Acid 1-Methyl Ester, CAS: 1356354-32-9, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

Bisphenol A (3-chloro-2-hydroxypropyl) Glycidyl Ether, CAS: 13836-48-1, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₄.

Bisphenol A bis(3-chloro-2-hydroxypropyl) Ether, CAS: 4809-35-2, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆Cl₂O₄.

(αS,2S)-2-Carboxy-α-[[(1,1-dimethylethoxy)carbonyl]amino]-1-azetidinebutanoic Acid, CAS: 90599-96-5, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₂O₆.

(βS)-β-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-(trifluoromethyl)benzenebutanoic Acid, CAS: 270065-75-3, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂F₃NO₃.

Epon 828, Technical Grade, CAS: 25068-38-6, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  xC₁₈H₂₁ClO₃.

o-Hydroxy-α,α-dimethylbenzyl Alcohol, CAS: 3045-32-7, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₂.

(γR)-γ-Aminobenzenebutanoic Acid Hydrochloride, CAS: 1010129-08-4, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.

Tetrabromobisphenol A, CAS: 79-94-7, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂Br₄O₂.

Tetrabromobisphenol A Allyl Ether, CAS: 25327-89-3, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Br₄O₂.

(γR)-γ-Aminobenzenebutanoic Acid-d5 Hydrochloride, CAS: /, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₅ClNO₂.

(R)-(+)-2-Methylsuccinic Acid 4-Methyl Ester, CAS: 81025-83-4, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

Tetrabromobisphenol A Diglycidyl Ether, CAS: 3072-84-2, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Br₄O₄.

Tetrabromobisphenol A Diglycidyl Ether-d10, CAS: /, stock: 1.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₀D₁₀Br₄O₄.

(R)-(+)-Verapamilic Acid, CAS: 38175-99-4, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₄.

(R)-(-)-2-Hydroxy-2-methylbutyric Acid, CAS: 37505-02-5, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

Tetrabromobisphenol A Dimethyl Ether, CAS: 37853-61-5, stock: 9.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆Br₄O₂.

Tetrabromobisphenol A-13C12, CAS: 132876-39-1, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₁₂H₁₂Br₄O₂.

(R)-(-)-2-Phenylbutyric Acid, CAS: 938-79-4, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

Tetrabromobisphenol A-D6, CAS: /, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₆D₆Br₄O₂.

Tetracresyl bisphenol A bisphosphate, CAS: 93981-32-9, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₇H₅₀O₈P₂.

(R)-(-)-3-Hydroxybutyric Acid  Sodium Salt, CAS: 13613-65-5, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₃.

(R)-(-)-3-Hydroxybutyric Acid-d4  Sodium Salt, CAS: 344298-82-4, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₄NaO₃.

Tetramethyl Bisphenol A, CAS: 5613-46-7, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₂.

Tetramethyl Bisphenol A-d6, CAS: 203578-30-7, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₆O₂.

(R)-(-)-Methyl-2-hydroxy-2-methylbutanoate, CAS: 55568-78-0, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

(R)-2,3-Dimethylbutyric Acid, CAS: 27855-05-6, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylbutanoic Acid, CAS: 1231709-22-0, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

(R)-2-((Methoxycarbonyl)amino)-3-methylbutanoic Acid, CAS: 171567-86-5, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄.

(R)-2-((tert-Butoxycarbonyl)(methyl)amino)-3-methylbutanoic Acid, CAS: 89536-85-6, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

(R)-2-((tert-Butoxycarbonyl)amino)-4-(tritylthio)butanoic Acid, CAS: 1301706-43-3, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁NO₄S.

(R)-2-(Fmoc-Amino)-4-(1h-Tetrazol-5-Yl)Butanoic Acid, CAS: 1464137-16-3, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉N₅O₄.

(R)-2-Amino-2-methylbutanoic Acid, CAS: 3059-97-0, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

(R)-2-Aminobutanoic Acid Methyl Ester Hydrochloride, CAS: 85774-09-0, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.

(R)-2-Aminobutyric Acid, CAS: 2623-91-8, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

(R)-2-Benzyl-4-(tert-butoxy)-4-oxobutanoic Acid, CAS: 122225-33-6, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₄.

(R)-2-Bromobutyric Acid, CAS: 2681-94-9, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₂.

(R)-2-Methylbutyric Acid, CAS: 32231-50-8, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

(R)-2-Methylbutyric Acid-d3, CAS: 1346617-08-0, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₂.

(R)-3-(((Benzyloxy)carbonyl)amino)-4-methoxy-4-oxobutanoic Acid, CAS: 47087-37-6, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₆.

(R)-3-((tert-Butoxycarbonyl)amino)-4,4,4-trifluorobutanoic Acid, CAS: 1310680-29-5, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄NO₄F₃.

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid, CAS: 486460-00-8, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈F₃NO₄.

(R)-3-(tert-Butoxycarbonylamino)butanoic Acid, CAS: 159991-23-8, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

(R)-3-Amino-4,4-diphenyl-butyric acid, hydrochloride, CAS: 332062-03-0, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈ClNO₂.

(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride, CAS: 1204818-19-8, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClF₃NO₂.

(R)-3-Amino-4-(2-bromo-phenyl)-butyric acid hydrochloride, CAS: 401915-60-4, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrClNO₂.

(R)-3-Amino-4-(2-naphthyl)butanoic acid, hydrochloride, CAS: 331847-02-0, stock: 5.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆ClNO₂.

(R)-3-Amino-4-(3-chloro-phenyl)-butyric acid hydrochloride, CAS: 331763-55-4, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₂.

(R)-3-Amino-4-(3-fluorophenyl)butanoic acid, hydrochloride, CAS: 331763-65-6, stock: 7.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClFNO₂.

(R)-3-Amino-4-(4-chloro-phenyl)-butyric acid hydrochloride, CAS: 331763-59-8, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₂.

(R)-3-Amino-4-(4-nitro-phenyl)-butyric acid hydrochloride, CAS: 331763-78-1, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂O₄.

(R)-3-Aminobutanoic Acid, CAS: 3775-73-3, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

(R)-3-Aminobutanoic acid hydrochloride, CAS: 58610-42-7, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂ • HCl.

(R)-3-Methyl-4-morpholino-2,2-diphenylbutanoic Acid, CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₃.

(R)-4,4,4-Trifluoro-3-hydroxybutanoic Acid, CAS: 108211-36-5, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅O₃F₃.

(R)-4-((1-(3-(2-Cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)amino)-4-oxobutanoic Acid, CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄FN₅O₅.

(R)-4-(Boc-amino)-3-hydroxybutanoic Acid, CAS: 120021-39-8, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₅.

(R)-4-Chlorokynurenine, CAS: 175777-22-7, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂O₃.

(R)-4-Oxo-4-(1-phenylethylamino)butanoic Acid, CAS: 21752-33-0, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

(R)-4-tert-Butoxy-4-oxo-2-phenylbutanoic Acid, CAS: 1229381-08-1, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

(R)-Ethyl 4-Chloro-3-hydroxybutanoate (~90%), CAS: 90866-33-4, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₃.

(R)-α-Hydroxycyclohexanebutanoic Acid Ethyl Ester, CAS: 95500-39-3, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₃.

(E)-3-(4-((2-Isopropoxyethoxy)methyl)phenoxy)prop-2-en-1-ol, CAS: /, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₄.

(E)-Methyl 3-(4-((2-isopropoxyethoxy)methyl)phenoxy)acrylate, CAS: /, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₅.

(R)-α-[[(4-Nitrophenyl)sulfonyl]oxy]cyclohexanebutanoic Acid Ethyl Ester, CAS: 112110-45-9, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₇S.

1,1’-[Methylenebis(4,1-phenyleneoxy)]bis[3-(1-ethylamino)-2-propanol], CAS: 1797132-90-1, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄N₂O₄.

1,1’-[Methylenebis(4,1-phenyleneoxy)]bis[3-(1-ethylamino)-2-propanol]-d10, CAS: /, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₁₀N₂O₄.

(R)-N-Fmoc-3-amino-4-(phenylthio)butanoic acid, CAS: 1244724-97-7, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉FN₂O.

(R)-Pantoic Acid Sodium Salt, CAS: 60979-68-2, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NaO₄.

1,1’-[Methylenebis(4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]-2-propanol, CAS: 1225195-70-9, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈N₂O₄.

1,1’-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]-2-propanol Fumarate (Bisoprolol Fumarate Impurity), CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄N₂O₉.

(R)-Phenylephrine-L-tartaramide (>90%), CAS: /, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₇.

(R)​-​Methyl 3-​aminobutanoate, CAS: 103189-63-5, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

1,1’-[Oxybis(methylene-4,1-phenyleneoxy)]bis[3-[(1-methylethyl)amino]-2-propanol Fumarate-d14 (Bisoprolol Fumarate Impurity), CAS: /, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀D₁₄N₂O₉.

1-Isopropylamino-3-(p-tolyloxy)-2-propanol, CAS: 5790-46-5, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO₂.

(R,S)-3-[(Tert-butyldimethylsilyl)oxy]-2-methyl-butanoic Acid Methyl Ester, CAS: 155897-72-6, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₆O₃Si.

(RS)-Pantoic Acid Sodium Salt, CAS: 08/01/1902, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NaC₆H₁₁O₄.

1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-2-[(1-methylethyl)amino]-1-methylethanol Hemifumarate (Bisoprolol Hemifumarate Impurity), CAS: /, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₆N₂O₁₂.

1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-2-[(1-methylethyl)amino]-1-methylethanol-d5 Fumarate (Bisoprolol Fumarate Impurity), CAS: /, stock: 3.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀D₅NO₈.

(S)-(+)-2-Methylbutyric Acid, CAS: 1730-91-2, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

(S)-(+)-2-Methylbutyric Acid-d3, CAS: 175779-05-2, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₂.

2,2’-((((Oxybis(methylene))bis(4,1-phenylene))bis(oxy))bis(methylene))bis(oxirane), CAS: /, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₅.

2-((4-(((4-(Allyloxy)benzyl)oxy)methyl)phenoxy)methyl)oxirane, CAS: /, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄.

(S)-(+)-N-Carboxybenzoyl-4-Amino-2-hydroxybutyric Acid, CAS: 40371-50-4, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅.

2-((4-((2-Isopropoxyethoxy)methyl)phenoxy)methyl)-1-isopropylaziridine, CAS: /, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₃.

2-((4-((2-Propoxyethoxy)methyl)phenoxy)methyl)oxirane, CAS: /, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₄.

(S)-(-)-Verapamilic Acid, CAS: 36622-24-9, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₄.

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3,3-dimethylbutanoic Acid, CAS: 1172579-62-2, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₄.

2-(4-((2-Isopropoxyethoxy)methyl)phenoxy)maloic Acid Diethyl Ester, CAS: /, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈O₇.

2-(4-((2-Isopropoxyethoxy)methyl)phenoxy)propane-1,3-diol, CAS: /, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

(S)-2-(((Benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoic Acid, CAS: 49855-91-6, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₆.

2-(4-((2-Isopropoxyethoxy)methyl)phenoxy)propane-1,3-diol-d5, CAS: /, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₅O₅.

2-(4-((2-Isopropoxyethoxy)methyl)phenoxy)propane-1,3-diyl Bis(4-methylbenzenesulfonate), CAS: /, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₆O₉S₂.

(S)-2-(((Benzyloxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoic Acid Hydrate, CAS: 229957-50-0, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆ • H ₂O.

(S)-2-(((Benzyloxy)carbonyl)amino)butanoic Acid, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.

2-(4-((2-Isopropoxyethoxy)methyl)phenoxy)propane-1,3-diyl-d5 Bis(4-methylbenzenesulfonate), CAS: /, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁D₅O₉S₂.

(S)-2-((Isopropoxycarbonyl)amino)-3-methylbutanoic Acid, CAS: 140923-27-9, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

(S)-2-((Methoxycarbonyl)amino)-4-methylbutanoic Acid, CAS: 74761-42-5, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄.

2-Hydroxyethyl 4-(Oxiran-2-ylmethoxy)benzoate, CAS: /, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₅.

(S)-2-(2-(2-Aminoacetamido)acetamido)-4-methylbutanoic Acid, CAS: 20274-89-9, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N₃O₄.

(S)-2-(3-((2-(2-Hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic Acid, CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃N₃O₄S.

2-Isopropoxyethyl 4-(2,3-Epoxypropoxy)benzoate, CAS: 1346603-05-1, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₅.

2-Isopropoxyethyl 4-Hydroxybenzoate, CAS: 1346600-95-0, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

(S)-2-(3-((2-(2-Hydroxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic Acid Methyl Ester, CAS: /, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅N₃O₄S.

(S)-2-(3-(1-(tert-Butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoic Acid, CAS: 1208245-85-5, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₂O₅S.

3,3’-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol), CAS: /, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₃NO₈.

3-[4-[2-Isopropoxyethoxy)methyl]phenoxy]-1,2-propanediol, CAS: 1797024-50-0, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O₅.

(S)-2-(Boc-amino)butanoic Acid, CAS: 34306-42-8, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

(S)-2-(tert-Butoxycarbonyl)-4-(methylsulfonyl)butanoic Acid, CAS: 60280-45-7, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₆S.

3-[4-[2-Isopropoxyethoxy)methyl]phenoxy]-1,2-propanediol-d5, CAS: /, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₅O₅.

4,4’-(Oxybis(methylene))bis((allyloxy)benzene), CAS: /, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₃.

(S)-2-Amino-4-(((R)-1-carboxy-2-(1H-imidazol-5-yl)ethyl)amino)butanoic Acid, CAS: /, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₄O₄.

(S)-2-Amino-4-((tert-butoxycarbonyl)amino)butanoic Acid, CAS: 10270-94-7, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₄.

(S)-2-Amino-4-[(3-aminopropyl)amino]-butanoic Acid, CAS: 131333-20-5, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇N₃O₂.

(S)-2-Aminobutanoic Acid Hydrochloride, CAS: 5959-29-5, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClNO₂.

(S)-2-Benzoylthiobutyric Acid, CAS: 1217740-06-1, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃S.

(S)-2-Bromobutyric Acid, CAS: 32659-49-7, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₂.

4-Hydroxybenzyl Alcohol, CAS: 623-05-2, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈O₂.

(S)-2-Di(tert-butyloxycarbonyl)amino-4-cyano-13C-butanoic Acid tert-Butyl Ester, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₃₂N₂O₆.

(S)-2-Di(tert-butyloxycarbonyl)amino-4-iodo-butanoic Acid tert-Butyl Ester, CAS: 1798902-92-7, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂INO₆.

4-[(2-Isopropoxyethoxy)methyl]phenol, CAS: 177034-57-0, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₃.

5-[[4-(Hydroxymethyl)phenoxy]methyl]-3-(1-methylethyl)-2-oxazolidinone, CAS: 1071765-44-0, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

(S)-2-Hydroxybutanoic Acid, CAS: 3347-90-8, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₃.

Bisoprolol Hemifumarate, CAS: 104344-23-2, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₄ •1/2[C₄H₄O₄].

(S)-2-Methyl-d3-butanoyl Chloride, CAS: 1217722-29-6, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆D₃ClO.

(S)-2-Phenylbutanoic Acid, CAS: 4286-15-1, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

Bisoprolol Hydroxyethyl Ester Hemifumarate Impurity, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀N₂O₁₄.

Bisoprolol-d5, CAS: 1189881-87-5, stock: 9.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆D₅NO₄.

(S)-3-((Tert-Butoxycarbonyl)Amino)-4,4,4-Trifluorobutanoic Acid, CAS: 1310680-43-3, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄NO₄F₃.

(S)-3-(4-(2-Chloro-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzyl)phenoxy)-4-hydroxybutanoic Acid, CAS: 1938057-70-5, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClO₉.

Bisoprolol-d7 Hemifumarate, CAS: 1310012-16-8, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆D₇NO₆.

Des(isopropoxyethyl) Bisoprolol, CAS: 62572-93-4, stock: 6.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO₃.

(S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic Acid Hydrochloride, CAS: 1217809-78-3, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀F₃NO2  • HCi.

(S)-3-Amino-4-(2-trifluoromethylphenyl)butanoic Acid Hydrochloride, CAS: 332061-77-5, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClF₃NO₂.

Des(isopropoxyethyl) Bisoprolol-d7, CAS: /, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₇NO₃.

(S)-3-Amino-4-(3,4-dichlorophenyl)butanoic acid, hydrochloride, CAS: 332061-65-1, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂Cl₃NO₂.

(S)-3-Amino-4-(4-bromophenyl)butanoic acid, hydrochloride, CAS: 331763-71-4, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃BrClNO₂.

Keto Bisoprolol Hydrochloride, CAS: /, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₄ • (HCl).

(S)-3-Amino-4-(4-iodophenyl)butanoic acid, hydrochloride, CAS: 332061-75-3, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClINO₂.

(S)-3-Amino-4-(4-methylphenyl)butanoic acid, hydrochloride, CAS: 331846-95-8, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO₂.

N-Acetyl Bisoprolol, CAS: 66722-65-4, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃NO₅.

N-Boc Bisoprolol, CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₉NO₆.

(S)-3-Amino-4-(4-nitrophenyl)butanoic acid, hydrochloride, CAS: 331763-77-0, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂O₄.

(S)-3-Amino-4-hydroxybutanoic Acid, CAS: 16504-57-7, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

N-Boc Keto Bisoprolol, CAS: /, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₇NO₆.

N-Desisopropyl-N-formyl Bisoprolol, CAS: 1346602-59-2, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₅.

(S)-3-Aminobutanoic Acid, CAS: 3775-72-2, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

(S)-3-methyl-2-phenylbutanoic acid, CAS: 13490-69-2, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₂.

N-Formyl Bisoprolol, CAS: 1447715-45-8, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁NO₅.

O-Desisopropyl O-Propyl Bisoprolol (Bisoprolol EP Impurity B), CAS: 1447715-44-7, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁NO₄.

(S)-3-Phenylbutyric Acid, CAS: 772-15-6, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

(S)-3’’-Hydroxy Pravastatin Lactone, CAS: /, stock: 2.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₇.

O-Desisopropyl-O-ethyl Bisoprolol Hemifumarate, CAS: 1346601-75-9, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉NO₄ •1/2C₄H₄O₄.

O-Desisopropyl-O-ethyl Bisoprolol-d7 Hemifumarate, CAS: 1346600-13-2, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂D₇NO₄ •1/2C₄H₄O₄.

(S)-4-(Tert-Butoxy)-2-Isopropyl-4-oxobutanoic Acid, CAS: 134807-43-5, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₄.

(S)-4-Chlorokynurenine, CAS: 153152-32-0, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂O₃.

O-Desisopropyl-O-methyl Bisoprolol Hemifumarate, CAS: 1346604-00-9, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NO₄ •1/2C₄H₄O₄.

O-Desisopropyl-O-methyl Bisoprolol-d7 Hemifumarate, CAS: 1346600-98-3, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀D₇NO₄ •1/2C₄H₄O₄.

(S)-4-Oxo-homophenylalanine Hydrochloride, CAS: 168154-76-5, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO₃.

(S)-5-Amino-4-(4-amino-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid, CAS: 874760-72-2, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₄.

p-(2,3-Epoxypropoxy)benzyl Alcohol, CAS: 4204-78-8, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

R-(+)-Bisoprolol Fumarate, CAS: 216309-92-1, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅NO₈.

rac Des(isopropoxyethyl)-2-isopropoxyethoxymethyl Bisoprolol, CAS: 1215342-36-1, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃NO₅.

S-(-)-Bisoprolol Fumarate, CAS: 216309-94-3, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅NO₈.

(S)-Duloxetine Succinamide, CAS: 199191-66-7, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₄S.

[[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]methyl]oxirane, CAS: 66722-57-4, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₄.

[[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]methyl]oxirane-d5, CAS: 1215808-65-3, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₅O₄.

(S)-Duloxetine-d7 Succinamide, CAS: /, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆D₇NO₄S.

(S)-Ethyl 2-(((S)-1-(Benzyloxy)-1-oxopropan-2-yl-d3)amino)-4-oxo-4-phenylbutanoate, CAS: /, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₃NO₅.

(S)-α-Acetolactic Acid Potassium Salt, CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇KO₄.

(S)-N-Boc-L-homoserine Dicyclohexylammonium Salt, CAS: 63491-82-7, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₀N₂O₅.

(S)-N-Boc-L-homoserine Triethylammonium Salt, CAS: 796072-25-8, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂N₂O₅.

(S)-N-Fmoc-[2-(4-pyridyl)ethyl]glycine, CAS: 273222-04-1, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂N₂O₄.

(S)-Oxiranylmethyl Butyrate, CAS: 65031-96-1, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

(S)-tert-Butyl 2-Hydroxy-3-methylbutanoate, CAS: 3519-30-0, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₃.

(S,S)-3-Hydroxy Lovastatin, CAS: 127910-58-1, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₆.

(S,Z)-2-((S)-1-Aminoethyl)-5-(2-aminothiazol-4-yl)-8,8,11,11-tetramethyl-4,9-dioxo-7,10-dioxa-3,6-diazadodec-5-en-1-oic Acid, CAS: /, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₅O₆S.

(Z)-2-(Methoxyimino)-3-oxo-butanoic Acid Ethyl Ester, CAS: 66340-86-1, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₄.

(Z)-2-(Methoxyimino)-3-oxobutanoic Acid Methyl Ester, CAS: 80350-55-6, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₄.

(Z)-2-(Methoxyimino)-3-oxobutanoic Acid-d3 Methyl Ester, CAS: 1331636-65-7, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₃NO₄.

(Z)-Ethyl 2-(2,3-Dichlorobenzylidene)-3-oxobutanoate, CAS: 68064-63-1, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂Cl₂O₃.

(Z)-Methyl 2-(3-Nitrobenzylidene)-3-oxobutanoate, CAS: 119128-13-1, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

1,1-Dioxide-α-​(1-methylethyl)​-​4-thiomorpholineacetic Acid, CAS: 477858-29-0, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄S.

1,1’-[(2-Ethyl-1,3-propanediyl)bis(oxymethylene)]bisbenzene, CAS: 33498-90-7, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₂.

1,3-Dimethylbutyl butanoate, CAS: 5332-88-7, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

1-(3-Carboxypropyl)-3,7-dimethyl Xanthine-d6, CAS: 1246816-64-7, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₆N₄O₄.

1-(3-Carboxypropyl)-3,7-dimethylxanthine, CAS: 08/07/6493, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₄.

1-(3-Pyridyl)-1-butanol-4-carboxylic Acid Na+/NH4+ Salt, CAS: /, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₃⁻ • Na ⁺/NH₄⁺.

1-(3-Pyridyl)-1-butanol-4-carboxylic Acid-13C6 Ammonium Salt, CAS: /, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₄N₂O₃.

1-(3-Pyridyl)-1-butanone-4-carboxylic Acid-d4, CAS: 1623019-52-2, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅D₄NO₃.

1-(Ethyl-3-carboxypropyl)-3,7-dimethylxanthine, CAS: 83636-88-8, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₄O₄.

1-​Methyl-​5-​nitro-1H-​benzimidazole-​2-​propanol, CAS: 895093-87-5, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃.

1-Methyl-5-amino-1H-benzimidazole-2-butanoic Acid Ethyl Ester, CAS: 3543-73-5, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₂.

1-Methyl-5-amino-1H-benzimidazole-2-butanoic Acid Ethyl Ester-d3, CAS: 1246819-70-4, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₃N₃O₂.

1-Methyl-5-amino-1H-benzimidazole-2-propanol-4-thiolate Potassium, CAS: /, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄KN₃OS.

1-Methyl-5-nitro-1H-benzimidazole-2-butanoic Acid Ethyl Ester, CAS: 3543-72-4, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₂.

1-Methyl-5-nitro-1H-benzimidazole-2-butanoic Acid Ethyl Ester-d3, CAS: 1286893-94-4, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄N₁₄D₃N₃O₄.

1-Methyl-5-nitro-1H-benzimidazole-2-propanoic Acid, CAS: 33138-03-3, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₄.

1-Pyrenebutyric Acid, CAS: 3443-45-6, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₂.

1-Pyrenebutyric Acid-13C4, CAS: /, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₆O₂.

1-Pyrenebutyric hydrazide, CAS: 55486-13-0, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂O.

1-Pyrrolidinebutyric Acid Hydrochloride, CAS: 49637-21-0, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆ClNO₂.

2(R,S)-Hydroxy-4[[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxo-butanoic Acid, CAS: 1217525-08-0, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆.

2(S)-Amino-4-azido-butanoic Acid, CAS: 120042-14-0, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₄O₂.

2,2-Bis(hydroxymethyl)butanoic Acid, CAS: 10097-02-6, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₄.

2,2-Dibromo-4,4,4-trifluorobutanoic Acid, CAS: 1210691-01-2, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃O₂F₃Br₂.

2,2-Dimethyl-5-[2-(4-octylphenyl)ethyl]-1,3-dioxan-5-amine, CAS: 1313876-85-5, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇NO₂.

2,2-Dimethylacetoacetic Acid Ethyl Ester, CAS: 597-04-6, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

2-Chloronicotinoyl Chloride, CAS: 49609-84-9, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO.

2,2-Dimethylbutanedioic Acid 1-(1,1-Dimethylethyl) Ester, CAS: 660423-00-7, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₄.

2,2-Dimethylbutanoic Acid, CAS: 595-37-9, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2,2-Dimethylbutanoic Acid-d6, CAS: 101419-75-4, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₆O₂.

2,2’-(Ethanediyldiimino)bis-butanoic Acid(Mixture of Diastereomers), CAS: 498-17-9, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀N₂O₄.

2,3,4,4-Tetrachloro-3-(dichloromethyl)butanoic Acid Methyl Ester, CAS: 97055-35-1, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆Cl₆O₂.

2,3-dihydroxy-2-methylbutanoic acid, CAS: 14868-24-7, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄.

2,3-Dimethylbutanoic Acid, CAS: 14287-61-7, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose-O-(L-threonine), CAS: /, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NO₈.

2,4-Dihydroxy-2-hydromethylbutanoic Acid-1,4-lactone, CAS: 19444-86-1, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₄.

2,4-Dihydroxybutanoic Acid Lithium Salt, CAS: 170033-68-8, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇LiO₄.

2,4-Dioxo-4-phenylbutanoic acid, CAS: 5817-92-5, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄.

2,5-Dihydro-2,5-dioxo-β-sulfo-1H-pyrrole-1-butanoic Acid 1-(2,5-Dioxo-1-pyrrolidinyl) Ester, CAS: 1193111-53-3, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₉S.

2-(((R)-1-(Benzyloxy)-1-oxopropan-2-yl)amino)-4-phenylbutanoic Acid (R)-Methyl Ester, CAS: /, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₄.

2-(((S)-1-(Benzyloxy)-1-oxopropan-2-yl)amino)-4-phenylbutanoic Acid (S)-Methyl Ester, CAS: 1356011-63-6, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₄.

2-((3S,10bR)-3-Methyl-1,4-dioxodecahydropyrazino[2,1-a]isoindol-2(6H)-yl)-4-phenylbutanoic Acid (2S)-Methyl Ester, CAS: /, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀N₂O₄.

2-(1,1-Dioxo-1,2-thiazolidin-2-yl)-3-methylbutanoic Acid, CAS: 1016729-63-7, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄S.

2-(1,3-Dioxo-octahydro-1H-isoindol-2-yl)-4-(methylsulfanyl)butanoic Acid, CAS: 1008946-61-9, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₄S.

2-(1-Piperazinyl)butanoic Acid Dihydrochloride, CAS: 1051369-22-2, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₂ • 2HCl.

2-(2,1,3-benzothiadiazole-4-sulfonamido)-3-methylbutanoic acid, CAS: 1396964-23-0, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₄S₂.

2-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-3-methylbutanoic acid, CAS: 1396965-93-7, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆S.

2-(2,3-dihydro-1,4-benzodioxine-6-sulfonamido)-4-(methylsulfanyl)butanoic acid, CAS: 1396963-71-5, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆S₂.

2-(2,4-Difluorophenoxy)-3-methylbutanoic Acid, CAS: 1016734-04-5, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃F₂.

2-(2,4-Dinitrophenyl)butanoic Acid, CAS: 1418117-86-8, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₆.

2-(2,5-Dichlorobenzenesulfonamido)-4-(methylsulfanyl)butanoic Acid, CAS: 1008243-41-1, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄S₂Cl₂.

2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-methylbutanoic acid, CAS: 148991-43-9, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄.

2-(2,6-Dimethylmorpholin-4-yl)-3-methylbutanoic Acid Hydrochloride, CAS: 1214108-42-5, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₃ • HCl.

2-(2-Cyanophenoxy)-3-methylbutanoic Acid, CAS: 1016502-71-8, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

2-(2-Fluorobenzenesulfonamido)-4-(methylsulfanyl)butanoic Acid, CAS: 1008243-60-4, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₄FS₂.

2-(2-Fluorophenyl)-3-methylbutanoic Acid, CAS: 1181574-74-2, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

2-(2-Nitrobenzylidene)-3-oxobutanoic Acid, 2-Acetoxy-2-methylpropyl Ester, CAS: 106685-67-0, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₇.

2-(2-Nitrobenzylidene)-3-oxobutanoic Acid, 2-Acetoxy-2-methylpropyl Ester-d6, CAS: 1185235-10-2, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₆NO₇.

2-(2-Nitrobenzylidene)-3-oxobutanoic Acid, Methyl Ester, CAS: 39562-27-1, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

2-(2-Propyl-1H-benzimidazol-1-yl)butanoic Acid Hydrochloride, CAS: 1349708-62-8, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₂ • HCl.

2-(3,4-Dichlorobenzenesulfonamido)-3-hydroxybutanoic Acid, CAS: 1009233-17-3, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₅SCl₂.

2-(3,4-Dichlorophenyl)-2-ethylbutanoic Acid, CAS: 1178279-26-9, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₂Cl₂.

2-(3,4-Dimethoxyphenyl)-2-ethylbutanoic Acid, CAS: 1184828-98-5, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₄.

2-(3,4-Dimethoxyphenyl)butanoic Acid, CAS: 138505-15-4, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

2-(3,4-Dimethylbenzenesulfonamido)-3-hydroxybutanoic Acid, CAS: 1008068-91-4, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₅S.

2-(3-Chloro-4-fluorobenzenesulfonamido)-4-(methylsulfanyl)butanoic Acid, CAS: 1009235-46-4, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄FS₂Cl.

2-(3-Chlorophenoxy)-3-methylbutanoic Acid, CAS: 1019372-32-7, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₃Cl.

2-(3-chlorophenyl)-2-hydroxybutanoic acid, CAS: 1249633-28-0, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃Cl.

2-(3-Hydroxypropyl)-3-methyl-6,8-dihydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-7(3H)-one, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₂S.

2-(3-Methyl-1H-pyrazol-1-yl)butanoic Acid, CAS: 1006459-57-9, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₂.

2-(3-Methylphenoxy)butanoic Acid, CAS: 113104-27-1, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2-(3-tert-Butylphenoxy)butanoic Acid, CAS: 1157985-51-7, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₃.

2-(4-((t-Butyldimethylsilyl)oxy)butyl)-1-methyl-1H-benzo[d]imidazol-5-amine, CAS: /, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁N₃OSi.

2-(4-Aminophenyl)butanoic acid, CAS: 29644-97-1, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

2-(4-bromo-1H-pyrazol-1-yl)-3-methylbutanoic acid, CAS: 1179883-30-7, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₂O₂Br.

2-(4-bromophenoxy)butanoic acid, CAS: 143094-65-9, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃Br.

2-(4-chlorobenzenesulfonamido)-3-hydroxybutanoic acid, CAS: 1396962-58-5, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₅SCl.

2-(4-Chlorobenzenesulfonamido)-4-methanesulfonylbutanoic Acid, CAS: 1025058-88-1, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₆S₂Cl.

2-(4-Chlorophenoxy)butanoic Acid, CAS: 10310-19-7, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃Cl.

2-(4-Chlorophenyl)-3-methylbutanoic Acid, CAS: 2012-74-0, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClO₂.

2-(4-Fluorophenyl)-5,5-dimethyl-1,3-dioxane-2-butanoic Acid, CAS: 953805-21-5, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁FO₄.

2-(4-methylcyclohexyl)butanoic acid, CAS: 1461707-45-8, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

2-(4-methylphenoxy)butanoic acid, CAS: 143094-64-8, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2-(5,6-Difluoro-1H-1,3-benzodiazol-1-yl)-3-methylbutanoic Acid Hydrochloride, CAS: 1251922-62-9, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O₂F₂.HCl.

2-(Acetylamino)-3-mercapto-3-methylbutanoic Acid, CAS: 59-53-0, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃S.

2-(Acetylamino)butanoic Acid-d5, CAS: /, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₅NO₃.

2-(Aminomethyl)-2-ethylbutanoic Acid Hydrochloride, CAS: 1086265-11-3, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • HCl.

2-(azaniumylmethyl)-2-methylbutanoic acid chloride, CAS: 1485425-33-9, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄NO₂+.Cl-.

2-(Benzylamino)-3-hydroxy-3-methylbutanoic Acid, CAS: 14598-96-0, stock: 4.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₃.

2-(benzylamino)-3-methylbutanoic acid hydrochloride, CAS: 1396964-70-7, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.HCl.

2-(Benzylsulfanyl)-3-methylbutanoic Acid, CAS: 1016686-85-3, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂S.

2-(Cyclohexanesulfonyl)-3-methylbutanoic Acid, CAS: 1178202-86-2, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₄S.

2-(Cyclohexylmethyl)butanoic Acid, CAS: 110604-57-4, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

2-(cyclopentylmethyl)-3-methylbutanoic acid, CAS: 1251251-50-9, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₂.

2-(cyclopentylmethyl)butanoic acid, CAS: 14276-86-9, stock: 8.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

2-(Cyclopentyloxy)butanoic Acid, CAS: 1157982-27-8, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₃.

2-(diethylamino)butanoic acid hydrochloride, CAS: 1315365-38-8, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.HCl.

2-(Dimethyl-1,2-oxazol-4-yl)butanoic Acid, CAS: 1240528-03-3, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₃.

2-(Dimethylamino)-4-(2-pyridinyldithio)butanoic Acid 2,5-Dioxo-1-pyrrolidinyl Ester, CAS: 1193111-73-7, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₄S₂.

2-(dimethylamino)butanoic acid hydrochloride, CAS: 1394040-12-0, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.HCl.

4,6-Dichloro-5-(2-methoxyphenoxy)-2,2’-bipyrimidine, CAS: 150728-13-5, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀Cl₂N₄O₂.

2-(ethylamino)-3-methylbutanoic acid hydrochloride, CAS: 1396964-36-5, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.HCl.

2-(Ethylamino)butanoic Acid Ethyl Ester, CAS: 874525-99-2, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

4-(1,1-dimethylethyl)-N-[5-hydroxy-6-[2-(2-hydroxyethoxy)ethoxy][2,2’-bipyrimidin]-4-yl]-Benzenesulfonamide, CAS: 1257099-41-4, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₆S.

2-(Ethylsulfanyl)-3-methylbutanoic Acid, CAS: 1019538-92-1, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂S.

4-(1,1-dimethylethyl)-N-[6-(ethenyloxy)-5-(2-methoxyphenoxy)[2,2’-bipyrimidin]-4-yl]-Benzenesulfonamide, CAS: 1257099-44-7, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇N₅O₅S.

4-(1,1-dimethylethyl)-N-[6-(ethenyloxy)-5-hydroxy[2,2’-bipyrimidin]-4-yl]-Benzenesulfonamide, CAS: 1257099-42-5, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₅O₄S.

2-(Hydroxymethyl)butanoic-d5 Acid, CAS: /, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₅O₃.

2-(Methoxyimino)-3-oxo-butanoic Acid Ethyl Ester (E/Z-Mixture), CAS: 60846-14-2, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₄.

4-(tert-butyl)-N-(6-(2-(2-hydroxyethoxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2’-bipyrimidin]-4-yl)benzenesulfonamide, CAS: /, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₃N₅O₇S.

4-Chloro-6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)-2,2’-bipyrimidine, CAS: 1177447-87-8, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClN₄O₄.

2-(Methylamino)butanoic Acid Hydrochloride, CAS: 1214138-93-8, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ •  HCl.

2-(N-Propylbut-2-enamido)butanoic Acid (E)-Ethyl Ester, CAS: /, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₃.

4-Chloro-6-[2-(1,1-dimethylethoxy)ethoxy]-5-(2-methoxyphenoxy)-2,2’-bipyrimidine-D4, CAS: /, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₄ClN₄O₄.

4-tert-Butylbenzenesulfonamide, CAS: 6292-59-7, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₂S.

Bosentan, CAS: 147536-97-8, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₅O₆S.

2-({[(4-fluorophenyl)methyl]carbamoyl}amino)-3-methylbutanoic acid, CAS: 1396964-39-8, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₂O₃F.

2-({[(tert-butoxy)carbonyl]amino}methyl)-2-methylbutanoic acid, CAS: 1423031-71-3, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

Bosentan Acetate, CAS: 1160515-46-7, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇ClN₄O₅.

Bosentan Hydrate, CAS: 157212-55-0, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁N₅O₇S.

2-Acetamido-3,3-dimethylbutanoic Acid, CAS: 22146-58-3, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

2-AcetamidobutanoicAcid, CAS: 7211-57-6, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃.

Bosentan-13C2, d4, CAS: /, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅¹³C₂H₂₅D₄N₅O₆S.

Bosentan-d4, CAS: 1065472-77-6, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅D₄N₅O₆S.

2-Amino-2,3-dimethylbutanoic Acid, CAS: 26287-62-7, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

2-Amino-2-(4-fluorophenyl)butanoic acid, CAS: 2248-61-5, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂FNO₂.

Desmethyl Bosentan, CAS: 253688-61-8, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₆S.

Desmethyl Bosentan-d4, CAS: 253688-61-8, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃D₄N₅O₆S.

2-amino-2-(trifluoromethyl)butanoic acid hydrochloride, CAS: 1427379-54-1, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈NO₂F₃.HCl.

2-Amino-2-ethylbutanoic acid hydrochloride, CAS: 92398-53-3, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂ •HCl.

Hydroxy Bosentan, CAS: 253688-60-7, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉N₅O₇S.

Hydroxy Bosentan-d4, CAS: 1065472-91-4, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅D₄N₅O₇S.

2-amino-2-methyl-4-phenylbutanoic acid hydrochloride, CAS: 132539-65-2, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.HCl.

2-Amino-3,3-dimethylbutanoic Acid Hydrobromide, CAS: 1028362-22-2, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂ • HBr.

Hydroxy Bosentan-d6, CAS: 1246817-57-1, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃D₆N₅O₇S.

Hydroxy Desmethyl Bosentan, CAS: 253688-62-9, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇N₅O₇S.

2-Amino-3-fluorobutyric acid, CAS: 50885-01-3, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈FNO₂.

2-Amino-4,4,4-trifluorobutanoic Acid Hydrochloride, CAS: 262296-39-9, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NO₂F₃ • HCl.

Hydroxy Desmethyl Bosentan-d4, CAS: /, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃D₄N₅O₇S.

N,N’-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2’-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide, CAS: 1097263-60-9, stock: 4.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₅₂N₁₀O₁₀S₂.

2-Amino-4,4-difluorobutanoic Acid, CAS: 107910-31-6, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₂F₂.

2-Amino-4-(S-methylsulfonimidoyl)butanoic Acid, CAS: 1982-67-8, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₃S.

N,N’-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2’-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)-benzenesulfonamide-d4, CAS: /, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₈D₄N₁₀O₁₀S₂.

N,N’-[5-(2-Methoxyphenoxy)[2,2’-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide], CAS: 1218951-81-5, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈N₆O₆S₂.

2-amino-4-hydroxy-4-phenylbutanoic acid hydrochloride, CAS: 1432677-71-8, stock: 2.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.HCl.

2-amino-4-methoxy-4-oxobutanoic acid hydrochloride, CAS: 1835-52-5, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄ • HCl.

N-[6-Chloro-5-(2-methoxyphenoxy)-(2,2-bipyrimidine)4-4-yl]-(1,1-dimethylethyl)-benzenesulfonamide, CAS: 150727-06-3, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄ClN₅O₄S.

O-Deshydroxyethyl Bosentan, CAS: 174227-14-6, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅N₅O₅S.

2-amino-4-oxo-4-(thiophen-2-yl)butanoic acid hydrochloride, CAS: 1423029-16-6, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃S.HCl.

2-Amino-4-phenoxybutanoic Acid, CAS: 52161-80-5, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

Tezosentan, CAS: 180384-57-0, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₇N₉O₆S.

Tezosentan-d4, CAS: 1794707-10-0, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃D₄N₉O₆S.

2-Amino-4-[4-(trifluoromethyl)phenyl]butanoic Acid, CAS: 1214098-81-3, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂NO₂F₃.

2-Aminoisobutanoic Acid Methyl Ester Hydrochloride, CAS: 15028-41-8, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.

2-Aminoisobutyric Acid (2-Methylalanine), CAS: 62-57-7, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

2-​Hydroxy-​4-​(methylsulfanyl)​butanoic Acid-d3, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₃S.

2-Benzamido-2-methyl-4-(2-nitrophenyl)-4-oxobutanoic Acid Methyl Ester, CAS: /, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₆.

2-Bromo-2-ethylbutanoic acid, CAS: 5456-23-5, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

2-Bromo-3-fluoro-3-methylbutyric Acid, CAS: 50884-94-1, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂FBr.

2-Bromo-4-chloro-4-oxo-butanoic Acid Ethyl Ester, CAS: 1027400-76-5, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈BrClO₃.

2-Chlorobutyric Acid (~90%), CAS: 4170-24-5, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClO₂.

2-Cyanoethyl Acetoacetate, CAS: 65193-87-5, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₃.

2-Ethanesulfonamido-4-(methylsulfanyl)butanoic Acid, CAS: 1009529-97-8, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₄S₂.

2-Ethyl-2,3,3-trimethylbutyric Acid, CAS: 38541-67-2, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

2-Ethyl-2,3,3-trimethylbutyric Acid-d3, CAS: 38541-67-2, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃O₂.

2-Ethyl-2-phenylglycine Ethyl Ester, CAS: 6480-87-1, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

2-Ethylbutyric Acid, CAS: 88-09-5, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2-Ethylhexanoic Acid, CAS: 149-57-5, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

2-Hydroxy-2-methyl-3-oxo-butanoic Acid Sodium Salt, CAS: 67761-53-9, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NaO₄.

2-hydroxy-2-methyl-3-phenylbutanoic acid, CAS: 1375473-28-1, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2-Hydroxy-2-methylbutyric Acid, CAS: 3739-30-8, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

2-hydroxy-3-(4-methylphenyl)butanoic acid, CAS: 1354961-66-2, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2-Hydroxy-3-methyl-2-phenylbutanoic acid, CAS: 15879-60-4, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

2-Hydroxy-3-methylbutyric Acid, CAS: 4026-18-0, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

2-Hydroxy-4-(hydroxymethylphosphoryl) Butanoic acid, CAS: 80902-10-9, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁O₅P.

2-Hydroxy-4-(hydroxymethylphosphoryl) Butanoic acid-d3, CAS: /, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃O₅P.

2-Hydroxy-4-amino Butanoic Acid, CAS: 13477-53-7, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

2-Hydroxybutanoic Acid, CAS: 600-15-7, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₃.

2-Hydroxyisobutyric Acid, CAS: 594-61-6, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₃.

2-Imidazo[2,1-b][1,3]thiazol-6-ylbutanoic Acid Hydrochloride, CAS: 1332530-25-2, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂S.HCl.

2-Indol-3-yl-4-oxo-4-phenylbutanoic Acid, CAS: 6266-66-6, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NO₃.

2-Isopropyl-2,3-dimethylbutanoic Acid, CAS: 23119-04-2, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈O₂.

2-Isopropyl-2,3-dimethylbutanoic Acid-d3, CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅D₃O₂.

2-Keto-3-(methyl-d3)-butyric Acid-4-13C Sodium Salt, CAS: 1189985-32-7, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₄D₃NaO₃.

2-Methoxyethyl 2-(3-Nitrobenzylidene)acetoacetate, CAS: 39562-22-6, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₆.

2-Methyl Simvastatin (Mixture Of Diasteroisomers), CAS: 774611-54-0, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

2-Methyl-3-(3’-carboxybutyl)-1,4-naphthoquinone, CAS: 34927-45-2, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₄.

2-Methyl-3-(3’-carboxybutyl)-1,4-naphthoquinone-5,6,7,8-D4, CAS: /, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₄O₄.

2-Methyl-4-oxo-4-phenylbutyric Acid, CAS: 1771-65-9, stock: 5.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

2-Naphthalenebutanoic Acid, CAS: 782-28-5, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₂.

2-Oxo-1-benzimidazolinebutyric Acid, CAS: 3273-68-5, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₃.

2-Oxo-4-phenylbutanoic Acid, CAS: 710-11-2, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

2-Oxobutanoic Acid Methyl Ester, CAS: 3952-66-7, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

2-Oxobutanoic Acid-13C,d5 Sodium Salt, CAS: /, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CD₅NaO₃.

2-Phenoxybutanoic Acid, CAS: 13794-14-4, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

2-Phenylbutyric Acid, CAS: 90-27-7, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

2-Phenylbutyric Acid-d5, CAS: 1189708-92-6, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₅O₂.

2-Phenylbutyric Acid-d5 Methyl Ester, CAS: 1794940-35-4, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₅O₂.

2-Phosphono-3-(methylbutyric Acid) Triethyl Ester, CAS: 35051-50-4, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₃O₅P.

2-Phosphono-3-(methylbutyric Acid) Triethyl Ester-d7, CAS: /, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆D₇O₅P.

2-Pyrrolidinone, CAS: 616-45-5, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO.

2-Thiophenebutanoic Acid, CAS: 06/11/4653, stock: 2.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₂S.

2-[(1,1-dioxo-1,2-benzothiazol-3-yl)amino]-3-methylbutanoic acid, CAS: 1396968-55-0, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₄S.

2-[(1-Phenyl-1H-1,2,3,4-tetrazol-5-yl)amino]butanoic Acid, CAS: 1218314-52-3, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₅O₂.

2-[(2,6-difluorophenyl)formamido]-3-methylbutanoic acid, CAS: 1396972-19-2, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃F₂.

2-[(2-bromophenyl)formamido]-3-methylbutanoic acid, CAS: 1397007-38-3, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₃Br.

2-[(2-Bromophenyl)formamido]-4-methanesulfonylbutanoic Acid, CAS: 1032039-60-3, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₅SBr.

2-[(2-chloro-4-nitrophenyl)formamido]-3-methylbutanoic acid, CAS: 1397003-81-4, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₅Cl.

2-[(2-chloro-5-nitrophenyl)formamido]-3-methylbutanoic acid, CAS: 1396968-84-5, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₅Cl.

2-[(2-Chlorophenyl)formamido]-4-methanesulfonylbutanoic Acid, CAS: 1025058-89-2, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₅SCl.

2-[(2-fluorophenyl)formamido]-3-methylbutanoic acid, CAS: 1396999-93-1, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₃F.

2-[(2-methoxyphenyl)formamido]-3-methylbutanoic acid, CAS: 1396968-87-8, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

2-[(3,5-dimethoxyphenyl)formamido]-3-methylbutanoic acid, CAS: 1397000-89-3, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₅.

2-[(3-Bromophenyl)methyl]-4-methanesulfonylbutanoic Acid, CAS: 1183099-58-2, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅O₄SBr.

2-[(3-Bromophenyl)methyl]-4-methoxybutanoic Acid, CAS: 1182757-92-1, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅O₃Br.

2-[(3-Bromophenyl)methyl]butanoic Acid, CAS: 1183114-86-4, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂Br.

2-[(3-Methylcyclohexyl)oxy]butanoic Acid, CAS: 1218052-49-3, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₃.

2-[(3-Nitrophenyl)methylene]-3-oxo-butanoic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Ester, CAS: 210579-45-6, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₅.

2-[(3-Nitrophenyl)methylene]-3-oxo-butanoic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Ester Hydrochloride, CAS: 929212-20-4, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₅•HCl.

2-[(3-Nitrophenyl)methylene]-3-oxo-butanoic Acid Propyl Ester, CAS: 77888-04-1, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₅.

2-[(4-Aminophenyl)methyl]butanoic Acid, CAS: 103893-69-2, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

2-[(4-bromophenyl)formamido]-3-methylbutanoic acid, CAS: 1396964-71-8, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₃Br.

2-[(4-Butoxyphenyl)formamido]-3-hydroxybutanoic Acid, CAS: 1396963-93-1, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₅.

2-[(4-chloro-3-nitrophenyl)formamido]-3-methylbutanoic acid, CAS: 1397006-89-1, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₅Cl.

2-[(4-Chlorophenyl)formamido]-4-methanesulfonylbutanoic Acid, CAS: 1103964-06-2, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NO₅SCl.

2-[(4-Chloropyridin-2-yl)formamido]-4-(methylsulfanyl)butanoic Acid, CAS: 1008946-60-8, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂O₃SCl.

2-[(4-Methyl-1,3-thiazol-2-yl)amino]butanoic Acid, CAS: 1218535-97-7, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₂S.

2-[(4-nitrophenyl)methyl]butanoic acid, CAS: 1248983-13-2, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

2-[(4-tert-butylphenyl)formamido]-3-methylbutanoic acid, CAS: 1396965-62-0, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₃.

2-[(4-tert-Butylphenyl)formamido]-4-methanesulfonylbutanoic Acid, CAS: 1032040-46-2, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₅S.

2-[(5-chloro-1H-1,3-benzodiazol-2-yl)methyl]-2-ethylbutanoic acid hydrochloride, CAS: 1251925-10-6, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₂O₂Cl.HCl.

2-[(5-chloro-2-fluorophenyl)formamido]-3-hydroxybutanoic acid, CAS: 1396969-18-8, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₄FCl.

2-[(Benzylcarbamoyl)amino]-3-methylbutanoic Acid, CAS: 1009681-22-4, stock: 4.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₃.

2-[(Ethoxycarbonyl)amino]-3-methylbutanoic Acid, CAS: 111421-95-5, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

2-[(Methoxycarbonyl)amino]-3-methylbutanoic Acid, CAS: 111398-44-8, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄.

2-[(Phenylmethoxy)methyl]-1-butanol, CAS: 14058-59-4, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

2-[(Phenylmethoxy)methyl]butanoic Acid, CAS: 1598357-06-2, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

2-[(tert-Butoxycarbonyl)amino]butanoic Acid, CAS: 77284-64-1, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

2-[2-Chloro-5-(trifluoromethyl)benzenesulfonamido]-4-(methylsulfanyl)butanoic Acid, CAS: 1008945-26-3, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₄F₃S₂Cl.

2-[3-(trifluoromethyl)phenyl]butanoic acid, CAS: 129140-97-2, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₂F₃.

2-[4-Amino-3-(trifluoromethyl)-1H-pyrazol-1-yl]butanoic Acid, CAS: 1171203-11-4, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₃O₂F₃.

2-[5-Cyclopropyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]butanoic Acid, CAS: 1006348-77-1, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂O₂F₃.

2-[Ethyl(methyl)amino]butanoic Acid, CAS: 1214699-59-8, stock: 2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

2-[Methyl(phenylmethyl)amino]ethyl 3-Oxo-butanoic Acid, CAS: 54527-65-0, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-butanoic Acid Methyl Ester, CAS: /, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄O₃Si.

2-{[(2-chlorophenyl)methyl]amino}-3-methylbutanoic acid hydrochloride, CAS: 1396967-35-3, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₂Cl.HCl.

2-{[(3-chlorophenyl)methyl]amino}-3-methylbutanoic acid hydrochloride, CAS: 1396962-45-0, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₂Cl.HCl.

2-{[(3-fluorophenyl)methyl]amino}-3-methylbutanoic acid hydrochloride, CAS: 1396964-92-3, stock: 2.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₂F.HCl.

2-{[(4-Chlorophenyl)methyl]amino}-3-methylbutanoic Acid Hydrochloride, CAS: 1396965-14-2, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NO₂Cl.HCl.

2-{[(tert-butoxy)carbonyl]amino}-4-(diethylamino)butanoic acid, CAS: 1404688-53-4, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₄.

2-{[(tert-butoxy)carbonyl]amino}-4-(dimethylamino)butanoic acid, CAS: 1404828-76-7, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₄.

2-{[(tert-Butoxy)carbonyl]amino}-4-methanesulfonylbutanoic Acid, CAS: 1163303-84-1, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₆S.

2-{[2-(Trifluoromethyl)quinazolin-4-yl]amino}butanoic Acid, CAS: 1094029-20-5, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₃O₂F₃.

2-{[2-chloro-5-(dimethylsulfamoyl)phenyl]formamido}-3-methylbutanoic acid, CAS: 1396980-30-5, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₂O₅SCl.

2-{[3-(diethylsulfamoyl)phenyl]formamido}-3-methylbutanoic acid, CAS: 1396997-83-3, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₅S.

2-{[4-(trifluoromethyl)phenyl]methyl}butanoic acid, CAS: 1269529-72-7, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃O₂F₃.

20-Oxo-20-deoxyphorbol 12,13-dibutyrate, CAS: 100930-03-8, stock: 7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈O₈.

2a-Phenyl-1,2(2a)-Homo[5,6]fullerene-C60-Ih-2a-butanoic Acid Stereoisomer, CAS: 161196-25-4, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₁H₁₂O₂.

2’-(Methylamino)-5’-nitro-succinanilic Acid, CAS: 91332-91-1, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₅.

2’-Deoxymugineic Acid, CAS: 74235-24-8, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₇.

2R,3S-Dihydroxy-4-oxo-butanoic Acid (>80%), CAS: 1106851-69-7, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₅.

2S-[(1-Carboxyethyl)amino]-benzenebutanoic Acid Methyl Benzyl Ester Maleate, CAS: 1356011-64-7, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₈.

2S-[(1-Carboxyethyl)amino]-benzenebutanoic Acid Methyl Ester, CAS: 1356354-32-9, stock: 4.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

3(R)-Ramiprilat Diketopiperazine, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O₄.

3,3-Difluoro-2-hydroxybutanoic Acid Ethyl Ester, CAS: 165544-31-0, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀F₂O₃.

3,3-Dimethylbutyric Acid, CAS: 1070-83-3, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

3,4-Diaminobutanoic Acid Dihydrochloride, CAS: 109754-82-7, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₂O₂ • 2HCl.

3,4-Difluoro-benzenebutanoic acid, CAS: 136295-00-6, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂F₂.

3,4-Dihydroxybutanoic Acid Sodium Salt, CAS: 40951-20-0, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₄.

3,4-Epoxy-6-keto-4a,5-ene Simvastatin, CAS: 1795790-98-5, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₇.

3,​3-​Dimethyl-​2-​oxobutyric Acid, CAS: 815-17-8, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃.

3-(((Benzyloxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid, CAS: /, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆F₃NO₄.

3-((4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-4-(dimethylamino)butanoic Acid, CAS: /, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇ClFN₅O₄.

3-((tert-Butoxycarbonyl)amino)-3-methylbutanoic Acid, CAS: 129765-95-3, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

3-(1,2,3,4-Tetrahydroquinolin-1-yl)butanoic Acid, CAS: 1153828-45-5, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

3-(1,3-Benzoxazol-2-yl)-4,4,4-trifluoro-3-hydroxybutanoic Acid, CAS: 1197669-20-7, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈NO₄F₃.

3-(1-Azepanyl)butanoic Acid, CAS: 856627-47-9, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₂.

3-(1-Benzyl-1H-imidazol-2-yl)-4,4,4-trifluoro-3-hydroxybutanoic Acid, CAS: 1197579-69-3, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₂O₃F₃.

3-(1-Piperidinyl)butanoic Acid, CAS: 764633-91-2, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.

3-(1H-Imidazol-1-yl)butanoic Acid, CAS: 98009-60-0, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂.

3-(1H-pyrazol-1-yl)butanoic Acid, CAS: 890092-84-9, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂.

3-(2,3-Dichlorobenzoyl)-propionic Acid, CAS: 32003-41-1, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈Cl₂O₃.

3-(2,4-Dichlorobenzoyl)propionic Acid, CAS: 58457-57-1, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈Cl₂O₃.

3-(2,4-Difluorophenyl)butanoic Acid, CAS: 1042815-69-9, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂F₂.

3-(2-(Trifluoromethyl)phenyl)butanoic Acid, CAS: 1042815-75-7, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₂F₃.

3-(2-Amino-6-methyl-6H-imidazo[4’,5’:3,4]benzo[1,2-d]thiazol-7-yl)propan-1-ol, CAS: /, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄OS.

3-(2-Chlorophenyl)-2,2-difluoro-3-hydroxybutanoic Acid(Mixture of Diastereomers), CAS: 1247356-07-5, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClF₂O₃.

3-(2-Chlorophenyl)-2-fluoro-3-hydroxybutanoic Acid (Mixture of Diastereomers), CAS: 1539613-67-6, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀ClFO₃.

3-(2-chloropyridine-3-sulfonamido)butanoic acid, CAS: 1156804-12-4, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₂O₄SCl.

3-(2-Fluorophenyl)-3-methylbutanoic Acid, CAS: 1226160-51-5, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

3-(2-Fluorophenyl)butanoic Acid, CAS: 1042815-30-4, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂F.

3-(2-Methoxyphenyl)butanoic Acid, CAS: 104216-85-5, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

3-(2-Naphthoyl)propionic Acid, CAS: 1590-22-3, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

3-(2-Oxopiperidin-1-yl)butanoic Acid, CAS: 1094630-83-7, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

3-(3-Chlorophenyl)butanoic Acid, CAS: 1226163-60-5, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂Cl.

3-(3-Fluorophenyl)butanoic Acid, CAS: 1042815-12-2, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂F.

3-(3-Methyl-3,6,7,8-tetrahydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-2-yl)propan-1-ol, CAS: /, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃OS.

3-(4-Chlorophenyl)-1,2,4-oxadiazole-5-butanoic Acid, CAS: 439108-15-3, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁ClN₂O₃.

3-(4-Fluorobenzenesulfonyl)butanoic Acid, CAS: 1017197-73-7, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₄FS.

3-(4-Methoxy-benzylsulfanyl)-3-methyl-butyric Acid, CAS: 268219-99-4, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₃S.

3-(4’-Chlorobenzenesulfonyl)butyric Acid, CAS: 175205-43-3, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClO₄S.

3-(acetylamino)butanoic acid, CAS: 136781-39-0, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₃.

3-(Benzylamino)-3-methylbutanoic Acid, CAS: 113479-11-1, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

3-(Benzyloxy)butyric Acid, CAS: 1135-38-2, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

3-(Cyclohexylformamido)butanoic Acid, CAS: 1094766-18-3, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₃.

3-(Cyclopentylformamido)butanoic Acid, CAS: 1099132-22-5, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃.

3-(Ethylthio)-butanoic Acid, CAS: 89534-40-7, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂S.

3-(Furan-2-yl)-4-phenylbutanoic Acid, CAS: 92190-42-6, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

3-(p-Aminobenzoyl)butyric Acid, CAS: 42075-29-6, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

3-(Phenyl((S)-1-phenylethyl)amino)butanoic Acid (R)-tert-Butyl Ester, CAS: /, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₂.

3-(piperidin-3-yl)butanoic acid, CAS: 1334486-36-0, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂.

3-(S)-(4-(S)-Isopropyl-2-oxo-oxazolidine-3-carbonyl)-octanoic Acid tert-Butyl Ester, CAS: 147961-55-5, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃NO₅.

3-(Trifluoromethyl)-benzenebutanoic acid, CAS: 145485-43-4, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₂F₃.

3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine, CAS: 486460-20-2, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃F₃N₄.

3-amino-3-(4-nitrophenyl)butanoic acid, CAS: 1270410-82-6, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.

3-amino-3-cyclopropylbutanoic acid, CAS: 1270536-24-7, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₂.

3-Amino-3-methylbutanoic Acid, 90%, CAS: 625-05-8, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

3-Amino-4-phenylbutanoic Acid, CAS: 15099-85-1, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

3-Amino-butanoic Acid Ethyl Ester Hydrochloride, CAS: 102014-64-2, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂ • HCl.

3-Aminopentane-3-carboxylic acid, CAS: 2566-29-2, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

3-​Methyl-butanoic Acid Anhydride With Ethyl Hydrogen Carbonate, CAS: 85877-55-0, stock: 3.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

3-​[[(4-​Methylphenyl)​sulfonyl]​oxy]​-butanoic Acid Ethyl Ester, CAS: 316148-56-8, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₅S.

3-Benzoylpropanoic Acid, CAS: 2051-95-8, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

3-Benzoylpropanoic Acid-13C6, CAS: 1346600-75-6, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₀O₃.

3-Benzyl-3-(p-methoxyphenyl)propionic Acid, CAS: 118806-78-3, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₃.

3-Benzyloxybutyric Acid Ethyl Ester, CAS: 92156-52-0, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₃.

3-Bromo-2-methylpropionic Acid, CAS: 56970-78-6, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₂.

3-Bromo-2-oxobutanoic Acid Methyl Ester, CAS: 34329-73-2, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇BrO₃.

3-Bromo-4-(4-chlorophenyl)-4-oxobutanoic Acid, CAS: 35158-39-5, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrClO₃.

3-Bromo-benzenebutanoic Acid, CAS: 899350-32-4, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO₂.

3-Butyramido-2-oxobutanoic Acid Methyl Ester, CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₄.

3-Carbomethoxy-3-methylbutanoic Acid, CAS: 32980-26-0, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₄.

3-Carboxypropyl Methanethiosulfonate, CAS: 92953-15-6, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄S₂.

3-Cyclopropyl-3-methylbutanoic Acid, CAS: 1021939-05-8, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

3-Formyl-1H-pyrrole-1-butanoic Acid, CAS: 400715-66-4, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

3-Hydroxy-2,2-dimethylbutyric Acid Ethyl Ester, CAS: 69737-23-1, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₃.

3-Hydroxy-2-(4-methoxybenzenesulfonamido)butanoic Acid, CAS: 113793-31-0, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₆S.

3-Hydroxy-2-(naphthalene-2-sulfonamido)butanoic Acid, CAS: 1008972-08-4, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₅S.

3-Hydroxy-2-methylbutanoic Acid, CAS: 473-86-9, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

3-Hydroxy-2-methylbutanoic Acid Ethyl Ester(Mixture of Diastereomers), CAS: 27372-03-8, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₃.

3-Hydroxy-2-[(quinazolin-4-yl)amino]butanoic Acid, CAS: 1008675-44-2, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃O₃.

3-Hydroxy-4-[[(2R)-2-hydroxy-2-(3-hydroxyphenyl)ethyl]methylamino]-4-oxo-butanoic Acid, CAS: 830346-80-0, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆.

3-Hydroxy-4-[[(2R)-2-hydroxy-2-[3-(phenylmethoxy)phenyl]ethyl]methylamino]-4-oxobutanoic Acid Phenylmethyl Ester, CAS: 1049703-03-8, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉NO₆.

3-Hydroxy-DL-kynurenine, CAS: 484-78-6, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.

3-Hydroxybutanoic Acid + 3-(3-Hydroxybutyryloxy)butyric Acid (CAS:7565-79-9) (50:50 Mixture), CAS: 300-85-6, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₃ •  C₈H₁₄O₅.

3-Hydroxybutyric Acid Magnesium Salt, CAS: 163452-00-4, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄MgO₆.

3-Hydroxykynurenine-O-β-glucoside (Mixture of Diastereomers), CAS: 23224-46-6, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₉.

3-Isopropenyl-2-oxo-1-benzimidazolinebutyric Acid, CAS: 52099-78-2, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₃.

3-Isopropenyl-2-oxo-1-benzimidazolinebutyric Acid Ethyl Ester, CAS: 116199-87-2, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₃.

3-Mercapto-3-methylbutanoic Acid Ethyl Ester, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂S.

3-Mercaptophenylbutyric Acid; Technical Grade (85-90%; Remainder Possibly Dimer), CAS: 359436-80-9, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂S.

3-methanesulfonyl-2-methylbutanoic acid, CAS: 1496436-89-5, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₄S.

3-Methoxybutanoic Acid, CAS: 10024-70-1, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

3-Methyl-2-(1,2,3,4-tetrahydroisoquinolin-2-yl)butanoic Acid Hydrochloride, CAS: 1214122-46-9, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂ • HCl.

3-Methyl-2-(1-oxo-1,3-dihydro-2h-isoindol-2-yl)butanoic Acid, CAS: 101004-93-7, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₃.

3-Methyl-2-(1h-1,2,4-triazol-1-yl)butanoic Acid, CAS: 1016503-66-4, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃O₂.

3-Methyl-2-(2-methyl-1H-1,3-benzodiazol-1-yl)butanoic Acid, CAS: 1016703-24-4, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₂.

3-Methyl-2-(2-oxopyrrolidin-1-yl)butanoic Acid, CAS: 1094652-93-3, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

3-Methyl-2-(4-methylpiperidin-1-yl)butanoic Acid Hydrochloride, CAS: 1214119-76-2, stock: 7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₂ • HCl.

3-Methyl-2-(5-phenyl-2H-1,2,3,4-tetrazol-2-yl)butanoic Acid, CAS: 1019459-07-4, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄O₂.

3-Methyl-2-(naphthalene-2-sulfonamido)butanoic Acid, CAS: 115239-41-3, stock: 9.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₄S.

3-Methyl-2-(oxolan-2-ylmethoxy)butanoic Acid, CAS: 1016785-00-4, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₄.

3-Methyl-2-(piperidin-1-yl)butanoic Acid Hydrochloride, CAS: 1214690-59-1, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₂ •  HCl.

3-methyl-2-(pyridin-4-ylformamido)butanoic acid, CAS: 147218-37-9, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

3-Methyl-2-(pyrrolidin-1-yl)butanoic Acid Hydrochloride, CAS: 1214838-86-4, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₂ • HCl.

3-methyl-2-phenoxybutanoic acid, CAS: 13794-02-0, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

3-Methyl-2-phenylbutanoic Acid, CAS: 3508-94-9, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₂.

3-methyl-2-sulfanylbutanoic acid, CAS: 138619-81-5, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂S.

3-methyl-2-[(2-methylphenyl)formamido]butanoic acid, CAS: 1396968-32-3, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

3-methyl-2-[(3-methylphenyl)formamido]butanoic acid, CAS: 1396967-48-8, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

3-methyl-2-[(propan-2-yl)amino]butanoic acid hydrochloride, CAS: 1396964-87-6, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.HCl.

3-methyl-2-[(pyridin-2-ylmethyl)amino]butanoic acid dihydrochloride, CAS: 1396965-89-1, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.₂[HCl].

3-methyl-2-[(pyridin-3-ylmethyl)amino]butanoic acid dihydrochloride, CAS: 1396967-33-1, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.₂[HCl].

3-methyl-2-[(pyridin-4-ylmethyl)amino]butanoic acid dihydrochloride, CAS: 1396965-31-3, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.₂[HCl].

3-methyl-2-[2-(naphthalen-2-yl)acetamido]butanoic acid, CAS: 1396968-66-3, stock: 10g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₃.

3-Methyl-2-{1,8,8-trimethyl-2,4-dioxo-3-azabicyclo[3.2.1]octan-3-yl}butanoic Acid, CAS: 1009549-80-7, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₄.

3-methyl-2-{[(2-methyl-1,3-thiazol-4-yl)methyl]amino}butanoic acid dihydrochloride, CAS: 1396967-32-0, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₂S.₂[HCl].

3-methyl-2-{[(3-methylphenyl)methyl]amino}butanoic acid hydrochloride, CAS: 1396964-02-5, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.HCl.

3-Methyl-3,6,7,8-tetrahydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanenitrile, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄S.

3-Methyl-3-(methylamino)butanoic Acid Methyl Ester, CAS: /, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

3-Methyl-3-(phenylmethoxy)butanoic Acid, CAS: 96556-32-0, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

3-Methyl-3-methyloxy-4-benzyloxy-butanoic Acid Methyl Ester, CAS: 1797024-70-4, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₄.

3-Methyl-3-phenylbutanoic Acid, CAS: 1010-48-6, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₂.

3-Oxo-butanoic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Ester, CAS: /, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁NO₃.

3-Oxobutanoic Acid 2-Acetoxy-2-methylpropyl Ester, CAS: 106685-66-9, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₅.

3-Oxobutanoic Acid 2-Acetoxy-2-methylpropyl Ester-d6, CAS: 1185147-99-2, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₆O₅.

3-Oxobutyric Acid Methyl-d3 Ester, CAS: 107694-22-4, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃O₃.

3-Phenylpropyl Acetoacetate, CAS: 113778-34-0, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₃.

3-Thiophenebutyric Acid, CAS: 1505-47-1, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₂S.

3-[(1,1-Dioxo-1,2-benzothiazol-3-yl)amino]butanoic Acid, CAS: 1094565-75-9, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₄S.

3-[4-(Trifluoromethyl)phenyl]butanoic Acid, CAS: 1042815-82-6, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₂F₃.

3-[Ethyl(methyl)amino]butanoic Acid Hydrochloride, CAS: 1609399-82-7, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ •  HCl.

3-{1-[(tert-butoxy)carbonyl]piperidin-3-yl}butanoic acid, CAS: 1334493-47-8, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.

3-{1-[(tert-butoxy)carbonyl]piperidin-4-yl}butanoic acid, CAS: 1334495-20-3, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅NO₄.

3-{[(tert-butoxy)carbonyl]amino}-2,2,3-trimethylbutanoic acid, CAS: 1375471-46-7, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₄.

3’(S)-Hydroxy Simvastatin, CAS: 133645-46-2, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₆.

3’,5’-Dihydrodiol Simvastatin(Mixture of Diastereomers), CAS: 198818-02-9, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀O₇.

3’,5’-Dihydrodiol Simvastatin-d6(Mixture of Diastereomers), CAS: /, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄D₆O₇.

3”-Hydroxy Simvastatin, CAS: 126313-98-2, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₆.

3”-O-tert-Butyl-2’-deoxymugineic Acid tert-Butyl Diethyl Ester, CAS: 958350-41-9, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₄N₂O₇.

3α-Hydroxy Pravastatin Lactone, CAS: 85798-96-5, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₆.

3α-Hydroxy Pravastatin Lactone-d3, CAS: 1329809-35-9, stock: 1.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁D₃O₆.

3β-Hydroxy Pravastatin Lactone, CAS: 87984-67-6, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₆.

4,4,4-Trifluoro-2-(aminomethylphenyl)methylene-3-oxo-butanoic Acid Ethyl Ester, CAS: 1798421-25-6, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄F₃NO₃.

4,4,4-trifluoro-3-(1H-pyrazol-1-yl)butanoic acid, CAS: 1343742-50-6, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂O₂F₃.

4,4,4-Trifluoro-3-(trifluoromethyl)butanoic Acid, CAS: 17327-33-2, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄F₆O₂.

4,4,4-trifluoro-3-(trimethyl-1H-pyrazol-4-yl)butanoic acid, CAS: 1375473-90-7, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₂O₂F₃.

4,4,4-Trifluoro-3-hydroxy-3-(1H-imidazol-2-yl)butanoic Acid, CAS: 1211096-65-9, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N₂O₃F₃.

4,4,4-Trifluoro-3-hydroxy-3-(4-methyl-1,3-thiazol-2-yl)butanoic Acid, CAS: 1197469-61-6, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₃F₃S.

4,4,4-Trifluoro-3-hydroxybutanoic Acid, CAS: 86884-21-1, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅O₃F₃.

4,4,4-trifluoro-3-methoxybutanoic acid, CAS: 1343115-14-9, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇O₃F₃.

4,4,4-Trifluoro-3-oxobutanoic Acid Ethyl Ester, CAS: 372-31-6, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇F₃O₃.

4,4,4-trifluoro-3-phenylbutanoic acid, CAS: 149680-95-5, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₂F₃.

4,4,4-Trifluoro-3-{4-oxo-3H,4H-thieno[2,3-d]pyrimidin-3-yl}butanoic Acid, CAS: 1114823-92-5, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇N₂O₃F₃S.

4,4,4-Trifluorobutanoic acid- d4, CAS: /, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₄F₃O₂.

4,4,4-Trifluorobutanoic acid-13C3, CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₃H₅F₃O₂.

4,4,4-Trimethoxybutanoic Acid Methyl Ester, CAS: 71235-00-2, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₅.

4,4-Difluoro-2-methylbutanoic Acid, CAS: 1010422-68-0, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂F₂.

4,4-Dimethoxybutanoic Acid Methyl Ester, CAS: 4220-66-0, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₄.

4,4’-Dithiobisphenylbutyric Acid, CAS: 72007-92-2, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄S₂.

4,4’-[(4-Acetyl-2-propyl-1,3-phenylene)bis(oxy)]bisbutanoic Acid 1,1’-Diethyl Ester, CAS: /, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₇.

4-(((5-Chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl)amino)butanoic Acid, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN₃O₄.

4-((2,4-Dinitrophenyl)amino)butanoic Acid, CAS: 10466-75-8, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃O₆.

4-((tert-Butoxycarbonyl)(methyl)amino)butanoic Acid, CAS: 94994-39-5, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

4-(1,3-Dioxo-1,3-dihydro-2h-isoindol-2-yl)butanoic acid, CAS: 3130-75-4, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₄.

4-(1,4-Dioxa-8-azaspiro[4.5]dec-8-yl)-4-oxobutanoic Acid, CAS: 883550-05-8, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₅.

4-(1-Azepanyl)-4-oxobutanoic Acid, CAS: 154740-93-9, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃.

4-(1-Methyl-1H-pyrazol-4-yl)-4-oxobutanoic Acid, CAS: 1152553-14-4, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₃.

4-(1-Methyl-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic Acid, CAS: 1228552-02-0, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₃.

4-(1-Methyl-d3-5-morpholino-1H-benzo[d]imidazol-2-yl)butanoic Acid, CAS: /, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₃N₃O₃.

4-(1H-1,2,3-triazol-1-yl)butanoic acid, CAS: 1369016-84-1, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

4-(1H-1,2,4-Triazol-1-yl)butanoic Acid, CAS: 158147-52-5, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂.

4-(1H-1,2,4-Triazol-1-yl)butanoic Acid Hydrochloride, CAS: 1255718-20-7, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉N₃O₂ • HCl.

4-(1H-Benzimidazol-2-yl)butanoic Acid, CAS: 50365-32-7, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂.

4-(1H-Pyrazol-1-yl)butanoic Acid, CAS: 110525-56-9, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂.

4-(2,3-Dihydro-1,4-benzodioxin-6-yl)butanoic Acid, CAS: 14939-93-6, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

4-(2,3-Dihydro-1H-indol-1-yl)-4-oxobutanoic Acid, CAS: 105105-00-8, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

4-(2,3-Dihydro-1H-indol-1-yl)butanoic Acid Hydrochloride, CAS: 1059626-21-9, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂ •  HCl.

4-(2,3-Dihydroxyphenyl)butyric Acid, CAS: 79638-23-6, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

4-(2,3-Dimethoxyphenyl)butanoic Acid, CAS: 64400-76-6, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

4-(2,4-Dichlorophenoxy)butanoic Acid, CAS: 94-82-6, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀Cl₂O₃.

4-(2,4-Dichlorophenoxy)butanoic Acid-13C6, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₀Cl₂O₃.

4-(2,4-difluorophenoxy)butanoic acid, CAS: 127556-94-9, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃F₂.

4-(2,4-Difluorophenyl)-4-oxobutanoic Acid, CAS: 110931-77-6, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈F₂O₃.

4-(2,4-dimethoxyphenyl)-4-oxobutanoic acid, CAS: 14617-06-2, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₅.

4-(2,4-Dimethylphenyl)-4-oxobutanoic Acid, CAS: 15880-03-2, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

4-(2,4-Dinitrophenyl)butanoic Acid, CAS: 52120-49-7, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₆.

4-(2,5-Dimethoxyphenyl)-4-oxobutanoic Acid, CAS: 1084-74-8, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₅.

4-(2,5-Dimethoxyphenyl)butanoic Acid, CAS: 1083-11-0, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

4-(2,5-Dimethylphenoxy)butanoic Acid, CAS: 105401-49-8, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

4-(2,5-Dimethylphenyl)-4-oxobutanoic Acid, CAS: 5394-59-2, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

4-(2,5-Dimethylphenyl)butanoic Acid, CAS: 1453-06-1, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

4-(2-(Acryloyloxy)ethoxy)-4-oxobutanoic Acid, CAS: 50940-49-3, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₆.

4-(2-Amino-6-methyl-6H-imidazo[4’,5’:3,4]benzo[1,2-d]thiazol-7-yl)butan-1-ol, CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄OS.

4-(2-Aminophenyl)-2-benzamido-2-methyl-4-oxobutanoic Acid, CAS: /, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₄.

4-(2-Aminophenyl)butyric Acid, Hydrochloride, CAS: 56182-28-6, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.

4-(2-bromophenoxy)butanoic acid, CAS: 132902-25-1, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃Br.

4-(2-Chlorophenyl)-4-oxobutanoic Acid, CAS: 106263-50-7, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₃Cl.

4-(2-Fluorophenyl)-2-methyl-4-oxobutanoic Acid, CAS: 1225922-26-8, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₃F.

4-(2-Fluorophenyl)-2-methylbutanoic Acid, CAS: 1225852-32-3, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

4-(2-fluorophenyl)butanoic acid, CAS: 143654-62-0, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂F.

4-(2-Methyl-1H-benzimidazol-1-yl)butanoic Acid, CAS: 115444-73-0, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

4-(2-Methyl-1H-imidazol-1-yl)butanoic Acid, CAS: 110525-54-7, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₂.

4-(2-oxo-1,3-benzoxazol-3(2H)-yl)butanoic acid, CAS: 13610-66-7, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₄.

4-(2-Oxo-2,3-dihydro-1H-indol-5-yl)butanoic Acid, CAS: 1042520-06-8, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

4-(2-Oxopyrrolidin-1-yl)butanoic Acid, CAS: 6739-80-6, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

4-(2-Phenyl-1H-imidazol-1-yl)butanoic Acid Hydrochloride, CAS: 1059626-15-1, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₂ • HCl.

4-(2H-1,3-benzodioxol-5-yloxy)butanoic acid, CAS: 127556-98-3, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅.

4-(3,4-Dichlorophenyl)-4-phenylbutanoic Acid, CAS: 79560-18-2, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄Cl₂O₂.

4-(3,4-Dihydro-2H-1,5-benzodioxepin-7-yl)-4-oxobutanoic Acid, CAS: 175136-33-1, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₅.

4-(3,4-Dihydroxyphenyl)butyric Acid, CAS: 70217-89-9, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

4-(3,4-Dimethoxyphenyl)butanoic Acid, CAS: 13575-74-1, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

4-(3,4-Dimethoxyphenyl)butanoic Acid-d6, CAS: /, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀D₆O₄.

4-(3-Aminophenyl)butyric Acid, Hydrochloride, CAS: 91843-18-4, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.

4-(3-bromobenzenesulfonyl)butanoic acid, CAS: 1338988-44-5, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₄SBr.

4-(3-Bromophenyl)-2-methyl-4-oxobutanoic Acid, CAS: 1225964-83-9, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₃Br.

4-(3-Cyclopropyl-1,2,4-oxadiazol-5-yl)butanoic Acid, CAS: 1038375-57-3, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₃.

4-(3-fluorophenyl)-2-methylbutanoic acid, CAS: 1354950-70-1, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

4-(3-fluorophenyl)-3-methyl-4-oxobutanoic acid, CAS: 1247512-15-7, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₃F.

4-(3-fluorophenyl)-3-methylbutanoic acid, CAS: 1354953-18-6, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃O₂F.

4-(3-Propyl-1,2,4-oxadiazol-5-yl)butanoic Acid, CAS: 1153313-94-0, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₃.

4-(4-((2-((Bis(2-chloroethoxy)phosphoryl)oxy)ethyl)(2-chloroethyl)amino)phenyl)butanoic Acid, CAS: /, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇Cl₃NO₆P.

4-(4-Acetyl-2-methoxy-5-nitrophenoxy)-butanoic Acid Ethyl Ester, CAS: 1031702-80-3, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₇.

4-(4-Acetyl-2-methoxyphenoxy)-butanoic Acid Ethyl Ester, CAS: 174884-21-0, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₅.

4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butanoic Acid Ethyl Ester, CAS: 88420-31-9, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₅.

4-(4-Amino-3-nitrophenyl)-2-(tert-butoxycarbonylamino)butanoic Acid, CAS: 1214179-85-7, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₃O₆.

4-(4-Aminophenoxy)butanoic Acid, CAS: 851757-04-5, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

4-(4-Aminophenyl)-3-methyl-4-oxobutanoic Acid Hydrochloride, CAS: 120757-13-3, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃ • HCl.

4-(4-Aminophenyl)butyric Acid, CAS: 15118-60-2, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

4-(4-aminopiperidin-1-yl)butanoic acid dihydrochloride, CAS: 1461707-77-6, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₂.₂[HCl].

4-(4-Bromo-2,5-Dimethylphenyl)-4-Oxobutanoic Acid, CAS: 30098-34-1, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃BrO₃.

4-(4-Bromo-3-Fluorophenoxy)Butanoic Acid, CAS: 1451085-00-9, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃FBr.

4-(4-Bromo-3-methyl-1H-pyrazol-1-yl)butanoic Acid, CAS: 1006495-34-6, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₂O₂Br.

4-(4-bromobenzenesulfinyl)butanoic acid, CAS: 1248054-79-6, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₃SBr.

4-(4-Bromobenzenesulfonyl)butanoic Acid, CAS: 1018522-96-7, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₄SBr.

4-(4-Bromophenyl)butanoic acid, CAS: 35656-89-4, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO₂.

4-(4-Butoxypheny)-4-oxobutanoic Acid, CAS: 63471-88-5, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

4-(4-Chloro-1H-pyrazol-1-yl)butanoic Acid, CAS: 1006319-31-8, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₂O₂Cl.

4-(4-Chlorophenoxy)butanoic Acid, CAS: 07/07/3547, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClO₃.

4-(4-Chlorophenyl)-3,3-dimethylbutanoic Acid, CAS: 1089303-25-2, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅O₂Cl.

4-(4-Ethoxy-3-methylphenyl)butanoic Acid, CAS: 878431-90-4, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₃.

4-(4-Ethoxyphenyl)-4-oxobutanoic Acid, CAS: 53623-37-3, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₄.

4-(4-Fluorophenyl)-4-oxobutanoic Acid, CAS: 366-77-8, stock: 4.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₃F.

4-(4-Fluorophenyl)butanoic Acid, CAS: 589-06-0, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂F.

4-(4-Formyl-3-methoxyphenoxy)butanoic Acid, CAS: 309964-23-6, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₅.

4-(4-Hydroxyphenyl)butanoic Acid, CAS: 06/11/7021, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

4-(4-Methanesulfonylphenoxy)butanoic Acid, CAS: 1157776-47-0, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₅S.

4-(4-Methoxyphenoxy)butyric Acid, CAS: 55579-99-2, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄.

4-(4-Methoxyphenyl)butyric Acid, CAS: 4521-28-2, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

4-(4-methyl-2,5-dioxoimidazolidin-4-yl)butanoic acid, CAS: 1423029-75-7, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₄.

4-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-4-oxobutanoic acid, CAS: 126802-55-9, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₅.

4-(4-Methylphenyl)-4-oxobutanoic Acid, CAS: 4619-20-9, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

4-(4-Morpholinyl)-4-oxobutanoic Acid, CAS: 67900-19-0, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₄.

4-(4-Oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoic Acid, CAS: 18623-60-4, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₃S₂.

4-(4-phenylpiperazin-1-yl)butanoic acid dihydrochloride, CAS: 1258725-11-9, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.₂[HCl].

4-(4-tert-Butyl-2-methylphenoxy)butanoic Acid, CAS: 1099046-07-7, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂O₃.

4-(4-{[(tert-butoxy)carbonyl]amino}piperidin-1-yl)butanoic acid, CAS: 1461714-30-6, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₂O₄.

4-(5,6,7,8-tetrahydronaphthalen-2-yloxy)butanoic acid, CAS: 1304269-07-5, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₃.

4-(5-((2-Chloroethyl)(2-((2,3-dihydroxypropyl)thio)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid, CAS: /, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈ClN₃O₄S.

4-(5-((2-Chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid Ethyl Ester, CAS: /, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClN₃O₂.

4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid, CAS: /, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₅N₃O₄.

4-(5-(Bis(2-(benzyloxy)ethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic Acid tert-Butyl Ester, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₃N₃O₄.

4-(5-Bromo-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)butanoic Acid, CAS: 299964-12-8, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀NO₄Br.

4-(5-Chloro-2-((4-fluorobenzyl)thio)pyrimidine-4-carboxamido)butanoic Acid, CAS: 1225162-49-1, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClFN₃O₃S.

4-(5-phenyl-1,3-oxazol-2-yl)butanoic acid, CAS: 133602-40-1, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₃.

4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanenitrile, CAS: /, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClN₄S.

4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid Hydrochloride, CAS: /, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClN₃O₂S  •  HCl.

4-(Acetyloxy)-2-methylbutanoic Acid 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl Ester, CAS: 109828-33-3, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₇.

4-(benzyloxy)-3-hydroxybutanoic acid, CAS: 1495397-04-0, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄.

4-(Benzyloxy)butanoic Acid, CAS: 10385-30-5, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

4-(Boc-4-aminophenyl)butanoic Acid, CAS: 105300-90-1, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₄.

4-(Cycloheptylamino)-4-oxobutanoic Acid, CAS: 545349-11-9, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₃.

4-(Cyclohex-3-en-1-ylformamido)butanoic Acid, CAS: 1016804-29-7, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₃.

4-(Cyclooctylamino)-4-oxobutanoic Acid, CAS: 392714-61-3, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₃.

4-(Cyclopentylamino)-4-oxobutanoic Acid, CAS: 541537-57-9, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

4-(decylamino)butanoic acid hydrochloride, CAS: 1376391-99-9, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₉NO₂.HCl.

4-(Dibenzylamino)butanoic Acid, CAS: 106518-44-9, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₂.

(±)-Bifonazole, CAS: 60628-96-8, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₂.

4-(dimethyl-4H-1,2,4-triazol-3-yl)butanoic acid, CAS: 1249819-92-8, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃O₂.

4-(Dimethylamino)-3-hydroxybutanoic Acid, CAS: 542-06-3, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

4-(Methoxymethylamino)-4-oxobutanoic Acid, CAS: 1156151-44-8, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

4-(Methylamino)-4-(3-pyridyl)butyric Acid, CAS: 15569-99-0, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

1-Chloro-2-(α-chlorophenylmethyl)benzene, CAS: 56961-47-8, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀Cl₂.

4-(Methylamino)butanoic Acid Hydrochloride, CAS: 6976-17-6, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ • HCl.

4-(Methylnitrosamino)-4-(3-pyridyl)butyric Acid, CAS: 123743-84-0, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₃.

1-Chloro-2-(α-chlorophenylmethyl)benzene-d5, CAS: /, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₅D₅Cl₂.

2-Chlorobenzhydrol, CAS: 6954-45-6, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁ClO.

4-(Methylnitrosamino)-4-(3-pyridyl)butyric Acid Methyl Ester, CAS: 1246820-63-2, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₃.

4-(Methylnitrosamino)-4-(3-pyridyl)butyric Acid-d4, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₄N₃O₃.

2-Chlorobenzhydrol-d5, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆D₅ClO.

4-(Methylnitrosamino-d3)-4-(3-pyridyl)butyric Acid, CAS: 1330277-38-7, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₃N₃O₃.

4-(Methylsulfanyl)-2-(2-phenylethenesulfonamido)butanoic Acid, CAS: 1008200-40-5, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄S₂.

4-(Methylsulfanyl)-2-[(5-nitrofuran-2-yl)formamido]butanoic Acid, CAS: 1008068-92-5, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₆S.

4-(N-Methylacetamido)butanoic Acid, CAS: 117704-99-1, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

4-(p-Iodophenyl)butyric Acid, CAS: 27913-58-2, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁IO₂.

4-(Phenylamino)butanoic Acid Hydrochloride, CAS: 113407-64-0, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂ • HCl.

4-(Pyridin-2-yl)butanoic Acid, CAS: 102879-51-6, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

4-(pyridin-3-yloxy)butanoic acid, CAS: 1250546-24-7, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

4-(Pyrrolidine-1-sulfonyl)butanoic Acid, CAS: 1018283-85-6, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄S.

4-({1-Benzyl-2-[(4-nitrophenyl)amino]-2-oxoethyl}amino)-4-oxobutanoic Acid, CAS: 2440-62-2, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₆.

4-amino-2-(2-aminoethyl)butanoic acid dihydrochloride, CAS: 1384651-82-4, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O₂.₂[HCl].

4-amino-3,3-difluorobutanoic acid, CAS: 1258651-00-1, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₂F₂.

4-Amino-3-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-2-methyl-4-oxobutanoic Acid, CAS: /, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉FN₄O₄.

4-amino-3-(difluoromethyl)butanoic acid hydrochloride, CAS: 1378736-74-3, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₂F₂.HCl.

4-Amino-3-hydroxy Butanoic Acid Methyl Ester Hydrochloride, CAS: 170726-96-2, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₃.

4-Amino-3-hydroxy Butanoic Acid Methyl Ester Hydrochloride-d3, CAS: /, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉D₃ClNO₃.

4-Amino-3-hydroxy-butanoic Acid Methyl Ester, CAS: 88550-64-5, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  133.07.

4-Amino-3-Hydroxybutanoic Acid, CAS: 924-49-2, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

4-Amino-3-methylbutyric Acid Heminaphthalene-1,5-disulfonate, CAS: 1216629-00-3, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2C₅H₁₁NO₂•C₁₀H₈O₆S₂.

4-Amino-3-phenylbutanoic Acid, CAS: 1078-21-3, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

(+)-Biotin (+)-Sulfoxide, CAS: 10406-89-0, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₄S.

4-amino-4-(3,4-dichlorophenyl)butanoic acid hydrochloride, CAS: 1251923-47-3, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂Cl₂.HCl.

4-amino-4-(4-methoxyphenyl)butanoic acid hydrochloride, CAS: 1423029-69-9, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃.HCl.

(+)-Biotin Methyl Ester, CAS: 608-16-2, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₃S.

4-Amino-4-cyanobutanoic Acid, CAS: 14046-56-1, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₂O₂.

4-Anilino-4-oxobutanoic Acid, CAS: 102-14-7, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

(+)-Biotin-PEG3 Acid, CAS: 252881-76-8, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃N₃O₇S.

(+)-Biotin-PFP-ester, CAS: 120550-35-8, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅F₅N₂O₃S.

4-Anilino-4-oxobutanoic Acid-d5, CAS: 840529-98-8, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₅NO₃.

4-​(Dimethyloxidoamino)​butanoic Acid Hydrochloride, CAS: /, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₃.

(+)-Biotinyl 3,6,9-Trioxaundecanediamine, CAS: 359860-27-8, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₄O₅S.

(+)-Trimethaphan Camphorsulfonate, CAS: 87335-42-0, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁N₂O₅S₂⁺.

4-​(Dimethyloxidoamino)​butanoic Acid-d6 Hydrochloride, CAS: /, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈D₆ClNO₃.

4-​(Phenylmethoxy)​-​benzenebutanoic Acid Methyl Ester, CAS: 1166181-77-6, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₃.

(-)-Biotin Sulfoxide, CAS: 3376-83-8, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₄S.

(-)-Trimethaphan Camphorsulfonate, CAS: 99297-10-6, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁N₂O₅S₂⁺.

4-​Hydroxy-​benzenebutanoic Acid Methyl Ester, CAS: 22320-10-1, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

4-​[[5-​[[(1,​1-​Dimethylethoxy)​carbonyl]​amino]​pentyl]​(phenylmethoxy)​amino]​-​4-​oxo-butanoic Acid, CAS: 153492-12-7, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂N₂O₆.

(2aR,7aS,7bS)-Hexahydro-2H-1-thia-3,4a-diazacyclopent[cd]inden-4(3H)-one, CAS: 1160173-32-9, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂OS.

(3-(5-(4-Acetamidophenylsulfonamido)-6-methoxypyrazin-2-yl)propyl)carbamate tert-Butyl Ester, CAS: 1621083-39-3, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₅O₆S.

4-Bromo-2,2-diphenylbutyric Acid, CAS: 37742-98-6, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅BrO₂.

4-Bromobutyric Acid, CAS: 2623-87-2, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₂.

(3-(5-Amino-6-methoxypyrazin-2-yl)propyl)carbamate tert-Butyl Ester, CAS: 1621083-38-2, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₄O₃.

(S)-5-Oxo-3-thiomorpholinecarboxylic Acid Methyl Ester, CAS: 118903-82-5, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₃S.

1,17-Bisbiotinylamino-3,6,9,12,15-pentaoxaheptadecane (>90%), CAS: 440680-87-5, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₆N₆O₉S₂.

4-carbamoyl-2-(4-methoxybenzenesulfonamido)butanoic acid, CAS: 1396963-05-5, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₆S.

4-carbamoyl-2-[(4-chlorophenyl)formamido]butanoic acid, CAS: 1396963-68-0, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₄Cl.

1,2-Dipalmityl-sn-glycero-3-Phosphoethanolamine-N-(cap biotinyl) Sodium Salt, CAS: 384835-52-3, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₉₈N₄NaO₁₁PS.

1,3-Dibenzyldihydro-1H-furo[3,4-d]-imidazole-2,4-(3H, 3aH)dione, CAS: 56688-82-5, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₃.

4-carbamoyl-2-[(4-fluorophenyl)formamido]butanoic acid, CAS: 1396962-29-0, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₄F.

4-Carbamoyl-2-[3-(trifluoromethyl)benzenesulfonamido]butanoic Acid, CAS: 1008582-71-5, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₂O₅F₃S.

1,6-Anhydro-2,3,4-tri-O-benzyl-β-D-glucopyranose, CAS: 10548-46-6, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈O₅.

1,6-Anhydro-β-D-glucopyranose, CAS: 498-07-7, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

4-Chloro Kynurenine, CAS: 75802-84-5, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₂O₃.

4-Chloro Kynurenine-13C2,15N, CAS: 1391051-72-1, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₁ClN¹⁵NO₃.

1,6-Anhydro-β-D-glucopyranose 2,3,4-Triacetate, CAS: 13242-55-2, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₈.

1,6-Anhydro-β-D-glucopyranose-13C6, CAS: 478518-93-3, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₀O₅.

4-Chlorobutanoic acid methyl ester, CAS: 3153-37-5, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉ClO₂.

4-Chlorobutyroyl Chloride, CAS: 4635-59-0, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆Cl₂O.

1,6-Anhydro-β-D-glucopyranose-d1, CAS: /, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉DO₅.

1-Biotinylamino-3,6,9-trioxaundecane-11-bromide, CAS: 1041766-91-9, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂BrN₃O₅S.

4-cyano-3-phenylbutanoic acid, CAS: 131906-15-5, stock: 3.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

4-Cyanobutanoic Acid, CAS: 39201-33-7, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NO₂.

1-Biotinylamino-3,6,9-trioxaundecane-11-ol, CAS: 1322625-82-0, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₃N₃O₆S.

1-Biotinylamino-3,6,9-trioxaundecane-11-yl-methanethiosulfonate, CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅N₃O₇S₃.

4-Dimethylamino 3-[3-(tert-Butyldimethylsilyloxy) (Hexadec-9(Z)-enoyloxy)]butanoic Acid Benzhydryl Ester, CAS: /, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₅NO₅Si.

4-Dimethylaminobutyric Acid Hydrochloride, CAS: 69954-66-1, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂ •  HCl.

1-O-(4,4’-Dimethoxytrityl)-3-O-(N-biotinyl-3-aminopropyl)glycerol, CAS: 131622-83-8, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₇N₃O₇S.

1-O-(4,4’-Dimethoxytrityl)-3-O-(N-biotinyl-3-aminopropyl)glycerol-d5, CAS: /, stock: 5.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂D₅N₃O₇S.

4-Dimethylaminobutyric Acid Hydrochloride-d6, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₆NO₂•HCl.

4-Dimethylaminobutyric Acid N-Oxide-d12, CAS: /, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₁₂NO₃.

1-[[[(N-Biotinylaminohexyl)carbamoyl]oxy]nonyl] Citrate, CAS: 1795789-44-4, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₄N₄O₁₁S.

10-Benzyloxyethoxyphosphinyl-N-biotinamidopentyldecanamide, CAS: 1246814-51-6, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₇N₄O₆PS.

4-Ethoxy-2-methylidene-4-oxobutanoic Acid, CAS: 57718-07-7, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₄.

4-Ethoxy-4-oxobutanoic Acid, CAS: 1070-34-4, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

10-Ethoxyphosphinyl-N-biotinamidopentyldecanamide, CAS: /, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₁N₄O₆PS.

13-Amino-4,7,10-trioxatridecanyl-2,2’,3,3’,11,11’,12,12’-d8)-N-methyl-N-biotinylglycinamide, CAS: 1217717-09-3, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅D₈N₅O₆S.

4-Ethoxybutanoic Acid, CAS: 10374-37-5, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

4-Ethyl-γ-oxobenzenebutanoic Acid, CAS: 49594-75-4, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

15-Biotinamino-4,7,10,13-tetraoxa-pentadecanoic Acid Succinimidyl Ester, CAS: 459426-22-3, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀N₄SO₁₀.

1’N-(4,4’-Dimethoxytrityl) Biotin, CAS: 144095-63-6, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₅S.

4-Guanidinobutanoic acid, CAS: 463-00-3, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N₃O₂.

4-Hydroxyamino-2-sulfosuccinic Acid Sodium Salt and 4-Hydroxyamino-3-sulfosuccinic Acid Sodium Salt, CAS: /, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆NNaO₇S.

1’N-(4,4’-Dimethoxytrityl) Biotin Benzyl Ester, CAS: /, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₀N₂O₅S.

1’N-(4,4’-Dimethoxytrityl)-2’N-Benzyl Biotin Benzyl Ester, CAS: /, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₄₆N₂O₅S.

4-Hydroxybutyric Acid Benzyl Ester, CAS: 91970-62-6, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

4-Hydroxybutyric Acid Methyl Ester, CAS: 925-57-5, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

1’N-Benzyl Biotin, CAS: 76335-62-1, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₃S.

2-[(2-Biotinylamidoethyl)dithiopropionylamino]-N-11-[4-benzoyl-1,3-bis-(1,6-anhydro-2,3-isopropylidine-ß-D-manopyrano-4-yloxy)-2-propylamino-3,6,9,12-tetraoxododecanyl]-N’-[2-hydroxylcarbonylethylamino]malonic Acid Diamide, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₈₅N₇O₂₂S₃.

2-[(2-Biotinylamidoethyl)dithiopropionylamino]-N-11-[4-benzoyl-1,3-bis-(D-manos-4-yloxy)-2-propylamino-3,6,9,12-tetraoxododecanyl]-N’-(2-hydroxylcarbonylethylamino)malonic Acid Diamide, CAS: /, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₁H₈₁N₇O₂₄S₃.

2-[(2-Nitrophenyl)thio]acetic Acid Hydrazide, CAS: 4871-40-3, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₃S.

4-Imino-4-methoxybutanoic Acid Methyl Ester Hydrochloride, CAS: 52070-12-9, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO₃.

4-Iodobutyric Acid, CAS: 7425-27-6, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇IO₂.

4-Maleimidobutyric Acid, CAS: 57078-98-5, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₄.

4-Maleimidobutyric Acid Hydrazide Trifluoroacetic Acid Salt, CAS: 1239587-68-8, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂F₃N₃O₅.

2-[N2-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-N6-(6 -biotinamidocaproyl)-L-lysinyl]ethyl 2-Carboxyethyl Disulfide, CAS: 1356841-73-0, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₇F₄N₉O₇S₃.

2-[N2-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-N6-(6 -biotinamidocaproyl)-L-lysinyl]ethyl 2’- (N-sulfosuccinimidylcarboxy)ethyl Disulfide, Sodium Salt, CAS: /, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₉F₄N₁₀NaO₁₂S₄.

4-Methanesulfonyl-2-(2-phenylethenesulfonamido)butanoic Acid, CAS: 1025448-55-8, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆S₂.

4-Methanesulfonyl-2-(phenylformamido)butanoic Acid, CAS: 1163291-88-0, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅S.

2-[N2-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-N6-(6-biotinamidocaproyl)-L-lysinyl]ethyl Methanethiosulfonate, CAS: 1356383-18-0, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅F₄N₉O₇S₃.

2-[N2-(6-Aminocaproyl)-N6-(6-biotinamidocaproyl)-L -lysinylamido] Ethyl Methanethiosulfonate Trifluoroacetic Acid Salt, CAS: /, stock: 1.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈F₃N₇O₉S₃.

4-methanesulfonyl-2-phenylbutanoic acid, CAS: 1484901-75-8, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₄S.

4-Methanesulfonyl-2-[(2-methoxyphenyl)formamido]butanoic Acid, CAS: 1032039-85-2, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₆S.

2-[N2-(N6-t-Boc-6-aminocaproyl)-N6-(6-biotinamidocaproy)-L -lysinylamido]ethyl Methanethiosulfonate, CAS: /, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₅N₇O₉S₃.

2-[Nα-Benzoylbenzoicamido-N6-(6-biotinamidocaproyl)-L-lysinylamido]ethyl Methanethiosulfonate, CAS: 910036-44-1, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₄N₆O₈S₃.

4-Methanesulfonyl-2-[(3-methylphenyl)formamido]butanoic Acid, CAS: 1025058-90-5, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₅S.

4-methanesulfonylbutanoic acid, CAS: 148928-08-9, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₄S.

2-{N2-[N6-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-6 -aminocaproyl]-N6-(6-biotinamidocaproyl)-L -lysinylamido}] Ethyl 2-Carboxyethyl Disulfide, CAS: 1217773-33-5, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₈F₄N₁₀O₈S₃.

2-{N2-[N6-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-6 -aminocaproyl]-N6-(6-biotinamidocaproyl)-L-lysinylamido}] Ethyl 2-(N-Sulfosuccinimydylcarboxy)ethyl Disulfide, Sodium Salt, CAS: /, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₀F₄N₁₁NaO₁₃S₄.

4-methoxy-2,2-dimethylbutanoic acid, CAS: 1338986-76-7, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₃.

4-Methoxy-2,4-Dioxobutanoic acid, CAS: 13192-05-7, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₅.

2-{N2-[N6-(4-Azido-2,3,5,6-tetrafluorobenzoyl)-6- aminocaproyl]-N6-(6-biotinamidocaproyl)-L -lysinylamido}ethyl Methanethiosulfonate, CAS: 1356841-34-3, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₆F₄N₁₀O₈S₃.

2-{N2-[Nα-Benzoylbenzoicamido-N6-6-biotinamidocaproyl]lysinylamido}ethyl-2’-(N-sulfosuccinimidylcarboxy)ethyl Disulfide Sodium Salt, CAS: /, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₈N₇NaO₁₃S₄.

4-Methoxy-3-methylbutanoic Acid, CAS: 100862-21-3, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

4-Methoxybutanoic acid, CAS: 29006-02-8, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

2-{N2-[Nα-Benzoylbenzoicamido-N6-6-biotinamidocaproyl]lysinylamido}ethyl-2’-carboxylethyl Disulfide, CAS: /, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₆N₆O₈S₃.

25-Hydroxy Vitamin D3 3,3’-Biotinylaminopropyl Ether, CAS: 193278-59-0, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₅N₃O₄S.

4-Methylvaleric Acid, CAS: 646-07-1, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

4-Methylvaleric Acid-d7, CAS: /, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₇O₂.

3,4-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]benzeneethanamine, CAS: 165749-18-8, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₉NO₂Si₂.

3,4-Diamino-2-thiophenepentanoic Acid Potassium Salt, CAS: /, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃KN₂O₂S.

4-Nitrobutyric Acid Methyl Ester, CAS: 13013-02-0, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO₄.

4-O-tert-Butyldimethylsilyl Epi Lovastatin, CAS: 82978-03-8, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O₅Si.

3-(25-Hydroxy Vitamin D3)propylamino-PEG12-Biotin, CAS: /, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₇H₁₁₈N₄O₁₇S.

3-(25-Hydroxy Vitamin D3)propylamino-PEG6-Maleimide, CAS: /, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₈₅N₃O₁₂.

4-octanamidobutanoic acid, CAS: 140846-94-2, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₃.

4-Oxo-4-(1,3,4-thiadiazol-2-ylamino)butanoic Acid, CAS: 26861-97-2, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₃S.

3-(25-Hydroxy Vitamin D3)propylamino-PEG6-MTS, CAS: /, stock: 6.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₈₆N₂O₁₂S₂.

3-(4-(N-Biotinoyl-6-aminocaproyloxy)phenyl)propionic Acid, CAS: 83592-10-3, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅N₃O₆S.

4-Oxo-4-(4-propoxyphenyl)butanoic Acid, CAS: 39496-82-7, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₄.

4-Oxo-4-(4-propylphenyl)butanoic Acid, CAS: 57821-78-0, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₃.

3-(4-(N-Biotinoyl-6-aminocaproyloxy)phenyl)propionic Acid, N-Hydroxysuccinimide Ester, CAS: 1322623-44-8, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆N₄O₈S.

3-(N-Maleimidylpropionyl)biocytin, CAS: 102849-12-7, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₅O₇S.

4-Oxo-4-piperidin-1-ylbutanoic Acid, CAS: 4672-17-7, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅NO₃.

4-Oxo-4-pyrrolidin-1-ylbutanoic Acid, CAS: 69338-35-8, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

3-[2-N-(Biotinyl)aminoethyldithio]propanoic Acid, CAS: 104582-29-8, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅N₃O₄S₃.

3-[[2-(Biotinamido)ethyl]dithio]propionic Acid 4’-(Hydroxymethyl)DMPO Ester, CAS: 1255087-87-6, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₆N₄O₅S₃.

4-Oxo-4-[(2-oxo-1,2-diphenylethyl)amino]-butanoic Acid, CAS: 55217-13-5, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.

4-Oxo-4-[3-(1-pyrrolidinylcarbonyl)anilino]butanoic Acid, CAS: 1003683-04-2, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂O₄.

3’N-Benzyl Biotin, CAS: 57229-92-2, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₃S.

3’N-Benzyl Biotin Benzyl Ester, CAS: /, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃S.

4-Phenoxybutanoic Acid, CAS: 6303-58-8, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

4-Phenyl-2-(S)-trifluoromethanesulfonyloxy-butyric Acid, Ethyl Ester, CAS: 138333-09-2, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅F₃O₅S.

4-(Cyanophenyl)boronic Acid Pinacol Ester, CAS: 171364-82-2, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆BNO₂.

4-(Hydroxymethyl)-5-(1,6-dihydroxyhexyl)-1,3-dibenzyl-2-imidazolidinone Benzyl Ether, CAS: 1796891-36-5, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₄.

4-Phenylbutyric Acid, CAS: 1821-12-1, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

4-Phenylbutyric Acid-13C6, CAS: 1346602-38-7, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₂O₂.

4-(tert-Butyldimethylsilyloxymethyl)-5-(1,6-dihydroxyhexyl)-1,3-dibenzyl-2-imidazolidinone Benzyl Ether, CAS: 1796891-25-2, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₂N₂O₄Si.

4-(tert-Butyldimethylsilyloxymethyl)-5-(6-O-triethylsilyl-1,6-dihydroxyhexyl)-1,3-dibenzyl-2-imidazolidinone, CAS: 1796891-26-3, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀N₂O₄Si₂.

4-Phospho D-Erythronate, CAS: 57229-25-1, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉O₈P.

4-Pyridoxolactone, CAS: 4753-19-9, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₃.

4-(tert-Butyldimethylsilyloxymethyl)-5-(6-O-triethylsilyl-1,6-dihydroxyhexyl)-1,3-dibenzyl-2-imidazolidinone Benzyl Ether, CAS: 1796929-74-2, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₆N₂O₄Si₂.

4-[1-[(2,6-Dichlorophenyl)methyl]-2-methyl-1H-imidazol-4-yl]-2-pyrimidinamine, CAS: 477852-69-0, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃Cl₂N₅.

4-tert-Butyldimethylsilyl-4a’-hydroxy Simvastatin, CAS: 125142-16-7, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₄O₆Si.

4-tert-Butyldimethylsilyl-5’-chloro-4a’-hydroxy Simvastatin, CAS: 123852-10-8, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₃ClO₆Si.

4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1-butanamine, CAS: 245660-15-5, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₅NOSi.

4-tert-Butyldimethylsilyl-5’-chloro-4a’-hydroxy-6’-(hydroxyimino)methyl Simvastatin, CAS: 123852-22-2, stock: 1.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₂ClNO₇Si.

4-tert-Butyldimethylsilyl-5’-chloro-6’-oxo Simvastatin, CAS: 134395-20-3, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₁ClO₆Si.

5,8,11,14,17,20,23-Heptaoxa-2-azahexacosanedioic Acid 1-(1,1-Dimethylethyl) Ester, CAS: 2055044-68-1, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₃NO₁₁.

5-(Biotinamido)pentylamine, CAS: 115416-38-1, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈N₄O₂S.

4-tert-Butyldimethylsilyl-6’-carboxy-5’-chloro-4a’-hydroxy Simvastatin γ-Lactol, CAS: /, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₁ClO₇Si.

4-tert-Butyldimethylsilyl-6’-carboxy-5’-chloro-4a’-hydroxy Simvastatin γ-Lactone, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₉ClO₇Si.

5-(Biotinamido)pentylazide, CAS: 1349190-76-6, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆N₆O₂S.

5-(tert-Butyldimethylsilyloxymethyl)-1,3-dibenzyl-2-oxo-4-imidazolidine-(6-triethylsilyloxy-hexanoic Acid) Benzyl Ester, CAS: 1796889-76-3, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₄N₂O₅Si₂.

4-[(1,1-Dioxo-1,2-benzothiazol-3-yl)(methyl)amino]butanoic Acid, CAS: 1094316-25-2, stock: 3.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₄S.

4-[(1,3-Benzothiazol-2-yl)amino]butanoic Acid, CAS: 104344-78-7, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂S.

5-​tert-​Butyl-​2-​methylbenzenethiol, CAS: 7340-90-1, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆S.

5-Oxohexyl Biotin, CAS: 1160188-05-5, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₂S.

4-[(1-Methyl-1H-pyrazol-4-yl)amino]-4-oxobutanoic Acid, CAS: 1006470-52-5, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₃O₃.

4-[(1-{[1,2,4]Triazolo[4,3-a]pyridin-3-yl}ethyl)carbamoyl]butanoic Acid, CAS: 1184188-37-1, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₃.

5-[2-Biotinylamidoethyl]-dithiopropionamido]-3,7-diaza-4,6-diketononanoic Acid Bis-N-sulfosuccinimidyl Ester Disodium Salt, CAS: /, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₈Na₂O₁₉S₅.

5-[2-Biotinylamidoethyl]-dithiopropionamido]-3,7-diaza-4,6-diketononanoic Acid Bis-N-sulfosuccinimidyl Ester-d4 Disodium Salt, CAS: /, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₄D₄N₈Na₂O₁₉S₅.

4-[(2-Methoxy-5-methylphenyl)amino]butanoic Acid, CAS: 1016735-33-3, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₃.

4-[(2-Phenoxyethyl)amino]butanoic Acid Hydrochloride, CAS: 1193390-32-7, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₃ •  HCl.

6-(Biotinylamino)thiocaproic Acid S-Ethyl Ester, CAS: 353754-94-6, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁N₃O₃S₂.

6-N-Biotinylaminohexanol, CAS: 106451-92-7, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉N₃O₃S.

4-[(2-tert-BButylphenyl)amino]-4-oxobutanoic Acid, CAS: 904807-77-8, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

4-[(3-Chloro-2-methylphenyl)amino]-4-oxobutanoic Acid, CAS: 196934-77-7, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂NO₃Cl.

6-N-Biotinylaminohexyl Hydrogenphosphate, CAS: 566945-94-6, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀N₃O₆PS.

6-N-Biotinylaminohexyl Hydrogenphosphonate, CAS: 224583-35-1, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀N₃O₅PS.

4-[(3-Hydroxyphenyl)amino]-4-oxobutanoic Acid, CAS: 16141-43-8, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.

4-[(3-Methoxyphenyl)amino]butanoic Acid, CAS: 103565-46-4, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃.

6-N-Biotinylaminohexyl Isopropyl Hydrogenphosphonate, CAS: 224583-37-3, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₆N₃O₅PS.

6-N-Biotinylaminohexyl Isopropyl Phosphorofluoridate, Hemihydrate, CAS: 353754-93-5, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅FN₃O₅PS •1/2 H ₂O.

4-[(3-methylbutyl)amino]butanoic acid hydrochloride, CAS: 1423031-44-0, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO₂.HCl.

4-[(4-Iodophenyl)amino]butanoic Acid, CAS: 1039879-15-6, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NO₂I.

6-N-Biotinylaminohexyl Isopropyl-d7 Phosphorofluoridate, Hemihydrate, CAS: 1246812-28-1, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈D₇FN₃O₅PS •1/2 H ₂O.

6-[2-Biotinylamidoethyl]-dithiopropionamido]-4,8-diaza-5,7-diketoundecanoic Acid Bis-N-sulfosuccinimidyl Ester Disodium Salt, CAS: 1044220-56-5, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₈Na₂O₁₉S₅.

4-[(4-Methoxyphenyl)amino]-butanoic Acid Methyl Ester, CAS: 51814-74-5, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₃.

4-[(4-Propylphenyl)amino]butanoic Acid Hydrochloride, CAS: 1172524-44-5, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂ • HCl.

6-[2-Biotinylamidoethyl]-dithiopropionamido]-4,8-diaza-5,7-diketoundecanoic Acid Bis-N-sulfosuccinimidyl Ester-d4 Disodium Salt, CAS: /, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈D₄N₈Na₂O₁₉S₅.

6-[2-Biotinylamidoethyl]-dithiopropionamido]-5,9-diaza-6,8-diketotridecanoic Acid Bis-N-sulfosuccinimidyl Ester Disodium Salt, CAS: /, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₆N₈Na₂O₁₉S₅.

4-[(Propan-2-yl)amino]butanoic Acid Hydrochloride, CAS: 1094598-19-2, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂ • HCl.

6-[2-Biotinylamidoethyl]-dithiopropionamido]-5,9-diaza-6,8-diketotridecanoic Acid Bis-N-sulfosuccinimidyl Ester-d4 Disodium Salt, CAS: /, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₂D₄N₈Na₂O₁₉S₅.

6-[4’-N-(biotinylaminopropyl-NHCOCH2-PEG2-acetyl)-aminophenyl]-hexane-2,4-dione, CAS: 1522299-17-7, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₉N₅O₉S.

4-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid, CAS: 13182-87-1, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₆.

4-[2-Chloro-4-(chlorosulfonyl)phenoxy]butanoic Acid, CAS: 1016835-63-4, stock: 9.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₅SCl₂.

7,8-Diaminopelargonic Acid Dihydrochloride, CAS: 951786-35-9, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₂Cl₂N₂O₂.

8-Amino-7-oxopelargonic Acid Hydrochloride, CAS: 177408-65-0, stock: 3.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈ClNO₃.

4-[2-Nitro-4-(trifluoromethyl)anilino]butanoic Acid, CAS: 65783-35-9, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀F₃N₂O₄.

4-[3-(1-Azepanylcarbonyl)anilino]-4-oxobutanoic Acid, CAS: 1003688-34-3, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₄.

9-Methyl Biotin (mixture of diastereomers), CAS: 415725-35-8, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂O₃S.

4-[3-(2-Chlorophenyl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 827014-22-2, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₂O₃Cl.

4-[3-(2-Furyl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 878437-17-3, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂O₄.

4-[3-(3-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 883546-59-6, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₄.

4-[3-(4-Methoxyphenyl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 876721-15-2, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₄.

4-[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 851628-34-7, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₃.

4-[3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl]butanoic Acid, CAS: 1038356-92-1, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₃.

Biocytin, CAS: 576-19-2, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₄O₄S.

Biotin, CAS: 58-85-5, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₃S.

4-[3-Hydroxy-6-ethyl-2-propylphenoxy]butanoic Acid Ethyl Ester, CAS: /, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆O₄.

4-[4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy]butanoic Acid, CAS: 175281-76-2, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₇.

Biotin 5-Bromopentylamide, CAS: 1217605-72-5, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆BrN₃O₂S.

Biotin Alkyne, CAS: 1006592-45-5, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀N₄O₇S.

4-[4-(2-Methoxyethyl)phenoxy]butanoic Acid, CAS: 1094693-27-2, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₄.

4-[4-(2-Methylpropyl)phenyl]butanoic Acid, CAS: 1041514-31-1, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₂.

Biotin Diacid, CAS: 57671-79-1, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₅S.

Biotin HPDP, CAS: 129179-83-5, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇N₅O₃S₃.

4-[4-(Chlorosulfonyl)-2-fluorophenoxy]butanoic Acid, CAS: 1016838-81-5, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₅FSCl.

4-[4-(Methylsulfanyl)phenyl]butanoic Acid, CAS: 116174-33-5, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₂S.

Biotin Hydrazide, CAS: 66640-86-6, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₄O₂S.

4-[4-(morpholine-4-sulfonyl)phenyl]-4-oxobutanoic acid, CAS: 1432677-96-7, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₆S.

4-[4-(Trifluoromethyl)Phenyl]Butanoic Acid, CAS: 136295-01-7, stock: 5.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁O₂F₃.

Biotin Sulfone, CAS: 40720-05-6, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₅S.

Biotin-11-dCTP, CAS: 136632-30-9, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂Li₄N₇O₁₆P₃S.

4-[5-(2,4-Dichlorophenyl)-1,3,4-oxadiazol-2-yl]butanoic Acid, CAS: 1183417-92-6, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₃Cl₂.

4-[5-(2-Iodophenyl)-1,3,4-oxadiazol-2-yl]butanoic Acid, CAS: 1183048-13-6, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₂O₃I.

Biotin-11-dUTP, CAS: 1221498-88-9, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄Li₄N₇O₁₆P₃S.

4-[6-Acetyl-3-(3-bromopropoxy)-2-propylphenoxy]butanoic Acid Ethyl Ester, CAS: 167211-61-2, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉BrO₅.

Biotin-cysteine, CAS: 151009-85-7, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁N₃O₄S₂.

4-[6-Acetyl-3-(phenylmethoxy)-2-propylphenoxy]butanoic Acid Ethyl Ester, CAS: 122714-52-7, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₅.

4-[6-Acetyl-3-[3-[(4-acetyl-3-hydroxy-2-propylphenyl)thio]propoxy]-2-propylphenoxy]butanoic Acid Ethyl Ester, CAS: 813425-82-0, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₂O₇S.

Biotin-dPEG-Lipoamide, CAS: 1334172-74-5, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀N₄O₆S₃.

Biotin-Necrosulfonamide Propyl Amide, CAS: /, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆N₈O₈S₃.

4-[N-Methyl-1-(1-methyl-4-sulfamoyl-1H-pyrrol-2-yl)formamido]butanoic Acid, CAS: 1094740-40-5, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃O₅S.

4-[[2-(1H-Indol-3-yl)ethyl]amino]-4-oxobutanoic Acid, CAS: 92256-33-2, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₃.

Biotin-PEG 2-NHS Ester, CAS: 596820-83-6, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂N₄O₈S.

Biotin-PEG3-Maleimide, CAS: 1431618-70-0, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉N₅O₈S.

4-[[2-[2-[(6-Chlorohexyl)oxy]ethoxy]ethyl]amino]-4-oxo-butanoic Acid, CAS: 1488363-39-8, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆ClNO₅.

4-[[3-Carboxypropyl(dimethyl)silyl]oxy-dimethylsilyl]butanoic Acid, CAS: 3353-68-2, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₆O₅Si₂.

Biotin-PEG4-alkyne, CAS: 1458576-00-5, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₅N₃O₆S.

Biotin-PEG4-Azide, CAS: 1309649-57-7, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆N₆O₆S.

4-[[4-(1,2,5,6-Tetrahydro-1-methyl-3-pyridinyl)-1,2,5-thiadiazol-3-yl]oxy]butanoic Acid, CAS: 159058-46-5, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₃S.

4-[[4-(1,2,5,6-Tetrahydro-3-pyridinyl)-1,2,5-thiadiazol-3-yl]oxy]-butanoic Acid, CAS: 174656-57-6, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₃S.

Biotin-PEG4-O-Aflatoxin P2, CAS: /, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₃N₃O₁₁S.

Biotin-TEG Azide, CAS: 875770-34-6, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₆O₅S.

4-[[5-[(Carboxymethyl)thio]-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]amino]-4-oxo-butanoic Acid, CAS: 1533519-99-1, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀N₄O₅S.

4-{3-[(4-Methyl-1-piperazinyl)carbonyl]anilino}-4-oxobutanoic Acid, CAS: 1003151-98-1, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₄.

Biotin-[2-(2-pyridyldithio)ethylamide], CAS: 112247-65-1, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₄O₂S₃.

Biotinamido Poly(ethylene glycol)1000, CAS: /, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

4-{3a-Methyl-1,5-dioxo-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinazolin-4-yl}butanoic Acid, CAS: 1049872-98-1, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₄.

4-{5,6-Dimethyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-2-yl}butanoic Acid, CAS: 1038333-32-2, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₃S.

Biotinamidocaproate Tobramycin Amide, CAS: 419573-19-6, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₂N₈O₁₂S.

Biotinoyl Ouabain, CAS: /, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₈N₂O₁₄S.

4-{Methyl[(methylcarbamoyl)methyl]sulfamoyl}butanoic Acid, CAS: 1096896-15-9, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₅S.

4-{[(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)-methyl]amino}butanoic Acid, CAS: 1273578-10-1, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₆.

Biotinyl Cystamine, CAS: 128915-82-2, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₄O₂S₃.

Biotinyl Cystamine Hydrochloride, CAS: 1346597-28-1, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇ClN₄O₂S₃.

4-{[(2-Chloro-4-fluorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1172779-62-2, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂FCl • HCl.

4-{[(2-Chlorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1221723-20-1, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂Cl • HCl.

Biotinyl Cystamine-d4, CAS: 1322625-65-9, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂D₄N₄O₂S₃.

Biotinyl Poly(ethylene glycol)-3400-carboxyaminoethyl Methanethiosulfonate, CAS: /, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

4-{[(2-Methylphenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1181458-44-5, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂ • HCl.

4-{[(3-Chlorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1170550-19-2, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂Cl • HCl.

Biotinyl Tobramycin Amide, CAS: 419573-18-5, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₁N₇O₁₁S.

Biotinyl Tyramide, CAS: 41994-02-9, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₃S.

4-{[(3-Fluorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1181458-22-9, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂F  •  HCl.

4-{[(4-Chlorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1193389-52-4, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂Cl • HCl.

Biotinyl-NHSS Aspartyl-(2’,5’-dimethoxybenzhydryl)-4-(hydroxyacetyl)aminoglycine-NHSS Disodium Salt, CAS: /, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₁N₇Na₂O₂₁S₃.

Biotinylamidoethyl]-dithiomethylenemalonic Acid Bis(3-aminopropionic Acid), CAS: 1217630-39-1, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈N₆O₉S₃.

4-{[(4-Fluorophenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1181458-25-2, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₂F • HCl.

4-{[(4-Methylphenyl)sulfonyl]amino}butanoic Acid, CAS: 1213-42-9, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₄S.

Biotinylated 11α-Hydroxy Progesterone β-D-Glucuronide Sodium Salt, CAS: /, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₆N₄O₁₀S.

Bisnorbiotin, CAS: 16968-98-2, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O₃S.

4-{[(4-tert-Butylphenyl)methyl]amino}butanoic Acid Hydrochloride, CAS: 1193388-43-0, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₂ • HCl.

4-{[(tert-butoxy)carbonyl]amino}-3-methylbutanoic acid, CAS: 1387445-53-5, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

Boc-4-Amino-L-phenylalanine, CAS: 55533-24-9, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₄.

Bovine BTD (Biotinidase) ELISA Kit (96T), CAS: /, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-{[2-(4-Methylphenyl)-2-oxoethyl]amino}butanoic Acid Hydrochloride, CAS: 1193389-37-5, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃ • HCl.

4-{[2-(Pyrrolidin-1-yl)pyridin-3-yl]carbamoyl}butanoic Acid, CAS: 1183368-87-7, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₃.

cis-(-)-1,3-Dibenzylhexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-valeric Acid, CAS: 33607-60-2, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃S.

cis-1,3-Dibenzyl-2-imidazolidone-4,5-dicarboxylic Acid, CAS: 51591-75-4, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₅.

4-{[3-(Pyrrolidin-1-yl)phenyl]carbamoyl}butanoic Acid, CAS: 1178270-35-3, stock: 6.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₃.

4a,5-Dihydro Lovastatin, CAS: 77517-29-4, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈O₅.

cis-1,3-Dibenzyl-2-imidazolidone-4,5-dicarboxylic Acid Anhydride, CAS: 26339-42-4, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₄.

cis-1,3-Dibenzyl-tetrahydro-4-hydroxy-1H-furo[3,4-d]imidazol-2(3H)-one, CAS: /, stock: 6.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₂O₃.

4a,5-Dihydro Lovastatin-d3, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅D₃O₅.

4a,5-Epoxy Simvastatin, CAS: 149949-02-0, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₆.

cis-1,3-Dibenzylhexahydro-1H-thieno[3,4-d]imidazole-2,4-dione, CAS: 33607-57-7, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₂S.

cis-N,N-Dibenzyl-tetrahydro-selenolo[3,4-d]imidazol-2(3H)-one, CAS: 1346604-74-7, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₂OSe.

4a’,6’-Anhydro-4-tert-butyldimethylsilyl Simvastatin, CAS: 125175-64-6, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₂O₆Si.

4’-Acetyl Simvastatin, CAS: 145576-25-6, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₆.

D-(+)Biotin 2-Nitrophenyl Ester, CAS: 131303-71-4, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₅S.

D-Biotin 4-Ntrophenyl Ester, CAS: 33755-53-2, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₃O₅S.

5,5-Diphenylhydantoin-3-butyric Acid, CAS: 56976-66-0, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₂O₄.

5,5-Diphenylhydantoin-3-butyric Acid Ethyl Ester, CAS: 56976-65-9, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₄.

D-Biotin Dimer Acid, CAS: 1163708-46-0, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₄O₄S₂.

D-Desthiobiotin, CAS: 533-48-2, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₃.

5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-Pyrazole-1-butanoic Acid, CAS: 380560-89-4, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄BrN₃O₄.

5-(Hydroxymethyl)-3-(4-octylbenzyl)-5-(4-octylphenethyl)morpholin-2-one, CAS: /, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₅NO₃.

DBCO-PEG4-Biotin, CAS: 1255942-07-4, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₁N₅O₈S.

Desthiobiotin N-Hydroxysuccinimide Ester, CAS: 80750-24-9, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₅.

5-Amino-1-methyl-1H-benzimidazole-2-propanol, CAS: 924832-40-6, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O.

5-Amino-4-(4-nitro-1-oxoisoindolin-2-yl)-5-oxopentanoic Acid, CAS: 1198299-72-7, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₆.

(1-Methoxy-2-methylprop-1-enoxy)trimethylsilane, CAS: 31469-15-5, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈O₂Si.

Desthiobiotin-TEG Azide, CAS: 1306615-47-3, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄N₆O₅.

Dexamethasone-biotin, CAS: 85679-56-7, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₃FN₄O₆S.

5-Butanoic Acid 1,3-Benzodioxole, CAS: 41303-44-0, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

5-Hydroxyimino-5-(3-pyridyl)butanoic Acid Ethyl Ester, CAS: 60234-66-4, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

2,4-Xylenesulfonic Acid Hydrate, CAS: 58811-92-0, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄S.

Diamino Biotin, CAS: 22342-46-7, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₂S.

Diazo Biotin-PEG3-azide, CAS: 1339202-33-3, stock: 1.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅N₉O₇S.

5-Oxo-5-phenylvaleric Acid, CAS: 1501-05-9, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid 1-Methylethyl Ester, CAS: 1797008-41-3, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈ClN₃O₃.

Bismuth (III) Nitrate Oxide, CAS: 10361-46-3, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Bi₅H₉N₄O₂₂.

Diboc Biotin, CAS: /, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₂O₇S.

Diboc Biotin Methyl Ester, CAS: /, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄N₂O₇S.

5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester, CAS: 898224-95-8, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₃.

5-[(2-tert-Butyldimethylsilyloxyethyl)(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester, CAS: 1796927-48-4, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀ClN₃O₃Si.

Bismuth Citrate, CAS: 813-93-4, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BiO₇.

Bismuth Gallate Hydrate (Technical Grade), CAS: 312623-77-1, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BiO₆ (H₂O).

DIFO-Biotin, CAS: /, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈F₂N₄O₇S.

DOTA-Biotin-Sarcosine, CAS: 180978-54-5, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₄N₈O₁₁S.

5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Methyl Ester, CAS: 109882-25-9, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃Cl₂N₃O₂.

5’,6’-Epoxyeicosatrienoic acid, CAS: 87173-80-6, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O₃.

Bismuth Nitrate Pentahydrate, CAS: 10035-06-0, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiH₁₃N₃O₁₄.

Bismuth Oxychloride, CAS: 7787-59-9, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiClO.

erythro-ω-Amino Sphingosine Biotinamide, CAS: 752987-57-8, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₂N₄O₄S.

erythro-ω-Amino Sphingosine Biotinamide Phosphate, CAS: 799812-63-8, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₃N₄O₇PS.

5’-Chloro-6’-oxo Simvastatin, CAS: 134395-21-4, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇ClO₆.

6(R)-{2-[8(S)-2-Methyl-d3-butyryloxy-2(S),6(R)-dimethyl-1,2,6,7,8,8d(R)-hexahydro-1(S)-naphthyl]ethyl}-4(R)-tert-butyldimethylsilyloxy-3,4,5,6-tetrahydro-2H-pyran-2-one, CAS: 1217723-49-3, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇D₃O₅Si.

Bismuth Oxyiodide, CAS: 7787-63-5, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiIO.

Bismuth Potassium Iodide, CAS: 41944-01-8, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiI₇K₄.

erythro-ω-Amino Sphingosine Biotinamide-d4, CAS: /, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈D₄N₄O₄S.

EZ-Link NHS-PEG12-Biotin, CAS: 365441-71-0, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₇₂N₄O₁₈S.

6-Oxo Simvastatin, CAS: 130468-11-0, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₆.

6-Oxo Simvastatin-d6, CAS: /, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀D₆O₆.

Bismuth Sodium Ethylenediaminetetraacetate, CAS: 12558-49-5, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂BiN₂NaO₈.

Fmoc-D-lys(biotin)-OH, CAS: 110990-09-5, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₄O₆S.

6’-Exomethylene Lovastatin, CAS: 121624-17-7, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₅.

6’-Exomethylene Simvastatin, CAS: 121624-18-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₅.

Bismuth Sodium rac-Tartrate, CAS: 31586-77-3, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NaO₆ xBi.

Bismuth Subcarbonate, CAS: 04/10/5892, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CBi₂O₅.

Fmoc-L-Tyr(propargyl)-OH, CAS: 1204595-05-0, stock: 6.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₃NO₅.

Fmoc-N-amido-(PEG4-biotin)-acid, CAS: 1334172-63-2, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₇N₅O₁₁S.

6’-Hydroxymethyl Simvastatin, CAS: 114883-29-3, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₆.

6’-Ketopravastatin Lactone, CAS: 124773-83-7, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂O₆.

Bismuth Subnitrate, CAS: 1304-85-4, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Bi₅H₉N₄O₂₂.

Bismuth Subnitrate, CAS: 1304-85-4, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiN₃O₉.

Fmoc-N-Lys-(dPEG-biotin)-OH-(acid), CAS: 1334172-65-4, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₉₁N₅O₁₉S.

Fmoc-N-Lys-(dPEG-biotin)-OH-(acid), CAS: 1334172-64-3, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₉N₅O₁₁S.

7-Aminosuccinylbenzo[a]pyrene, CAS: 1076198-86-1, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇NO₃.

8-Butyryloxypyrene-1,3,6-trisulfonic Acid Trisodium Salt, CAS: 115787-82-1, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₁₁S₃.

Bismuth Subsalicylate, CAS: 14882-18-9, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅BiO₄.

Bismuth Tripotassium Dicitrate, CAS: 57644-54-9, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈Bi₀.₅K₁.₅O₇.

FP-Biotin(Mixture of Diastereomers), CAS: 259270-28-5, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₀FN₄O₅PS.

FP-Biotin-d4, CAS: 1219356-78-1, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆D₄FN₄O₅PS.

Bismuth(III) Chloride, CAS: 7787-60-2, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiCl₃.

Bismuth(III) Iodide, CAS: 7787-64-6, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiI₃.

Iminobiotin Hydrobromide, CAS: 76985-52-9, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈BrN₃O₂S.

9-(2,5-d|-Dioxo-L-3-amino-1-pyrrolidineacetic acid)-10-deglycine Daptomycin, CAS: 121869-35-0, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₂H₉₉N₁₇O₂₅.

9-[[(2,2,2-Trifluoroethyl)amino]carbonyl]-9H-fluorene-9-butanoic Acid, CAS: 182439-11-8, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈F₃NO₃.

Bismuth(III) Oxide, CAS: 1304-76-3, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  O₃Bi₂.

Bismuth(III) Trifluoromethanesulfonate (3:1), CAS: 88189-03-1, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃BiF₉O₉S₃.

ε-Caprolactam-d10, CAS: 169297-53-4, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₁₀NO.

Methyl Carbamate, CAS: 598-55-0, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅NO₂.

Lipoamide-PEG3-biotin, CAS: 1311963-67-3, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀N₄O₆S₃.

Lithium 2-(3-((4S)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)propyl)malonate, CAS: /, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄Li₂N₂O₅S.

Antimycin A1b, CAS: 116095-18-2, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀N₂O₉.

Sodium Bismuthate (>80%), CAS: 12232-99-4, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BiNaO₃.

Triphenylbismuth, CAS: 603-33-8, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅Bi.

m-Maleimidobenzoyl-L-thyroxine Methyl Ester, CAS: 69343-52-8, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₁₈I₄N₂O₇.

Methotrexate-Cadaverine-Biotin Conjugate, CAS: /, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₈N₁₂O₆S.

Antimycin A3, CAS: 522-70-3, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆N₂O₉.

Asterinin D, CAS: 163136-31-0, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃N₅O₇.

Tris(4-ethoxyphenyl)bismuthine, CAS: 90591-48-3, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇BiO₃.

Methotrexyl-N’-biotinylethylenediamine, CAS: /, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₁₂O₆S.

Methyl 4-(triphenylphosphonio)crotonate Bromide, CAS: 2181-98-8, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂BrO₂P.

Methyl N-Biotinyl-6-amino-2-naphthonate, CAS: 1041143-49-0, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅N₃O₄S.

MM-22, CAS: 956605-71-3, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₀N₄O₅S.

Atto 425-NHS ester, CAS: 892156-28-4, stock: 4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀N₂O₈.

Monoethyl (Benzyloxycarbonylamino)malonate, CAS: 7682-49-7, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₅.

Mouse Btd (Biotinidase) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Aztreonam Amide, CAS: 1219444-93-5, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₆O₈S₂.

Barium Chloride Dihydrate, CAS: 10326-27-9, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BaCl₂H₄O₂.

Mouse Hlcs (Biotin--protein ligase) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N,N-Bis(ethylmethanethiosulfonate) Biotinamide, CAS: 1217607-38-9, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉N₃O₆S₅.

Bendamustine, CAS: 16506-27-7, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁Cl₂N₃O₂.

N,N-Dibenzyl rac Selenobiotin, CAS: /, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃Se.

N-((6-((6-(Aminooxy)hexyl)disulfanyl)hexyl)oxy)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, CAS: 1946010-72-5, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₂N₄O₄S₃.

Bendamustine Bis-mercapturic Acid, CAS: 956344-34-6, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇N₅O₈S₂.

Bendamustine Bis-mercapturic Acid-d6, CAS: 1356930-62-5, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁D₆N₅O₈S₂.

N-(15,16-Dihydroxy-4,7,10,13-tetraoxahexadecyl-D-(+)-biotinamide, CAS: 869354-59-6, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₁N₃O₈S.

N-(16-(Dimethoxytrityl)oxy-15-hydroxy-4,7,10,13-tetraoxahexadecyl)-D-(+)-biotinamide, CAS: 869354-57-4, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₉N₃O₁₀S.

Bendamustine Dimer Deschloro 2’-Allyl Ester, CAS: /, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₆Cl₂N₆O₅.

Bendamustine Dimer Impurity, CAS: 1228551-91-4, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁Cl₃N₆O₄.

N-(2-Aminoethyl)-N’-(2-Sulfothioacetamid)biotinamide, Sodium Salt, CAS: 1330264-29-3, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃N₄NaO₆S₃.

N-(2-Aminoethyl)biotinamide, CAS: 111790-37-5, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂N₄O₂S.

Bendamustine Ethyl Ester, CAS: 87475-54-5, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅Cl₂N₃O₂.

Bendamustine Hydrochloride, CAS: 3543-75-7, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂Cl₃N₃O₂.

N-(3-Azidopropyl)biotinamide, CAS: 908007-17-0, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₆O₂S.

N-(5-Bromopentyl)phthalimide, CAS: 954-81-4, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄BrNO₂.

Bendamustine Isopropyl Ester, CAS: 1313020-25-5, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇Cl₂N₃O₂.

Bendamustine M3 Hydrochloride, CAS: 1258418-50-6, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁Cl₂N₃O₃ • HCl.

N-(6-Biotinamidohexanoyl)-N’-D-thiocitrullinyl-pentamethylenediamine, CAS: /, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₀N₈O₄S₂.

N-Acetyl-N-21-(biotinylamino)-4,7,10,13,16,19-hexaoxaheneicosanoyl-3,5-diaminophenol-α-glucoside, CAS: /, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₃N₅O₁₆S.

Bendamustine-d6 (major) Hydrochloride, CAS: /, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₆Cl₃N₃O₂.

Benzenebutanoic Acid Ethyl Ester, CAS: 10031-93-3, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

N-Acetyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-Tyrosine 2,5-Dioxo-1-pyrrolidinyl Ester, CAS: 75937-15-4, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆I₄N₂O₇.

N-Biotinyl D-erythro-Sphingosine, CAS: /, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₁N₃O₄S.

Benzyl (2,2-Dimethyl-5-(4-octylphenethyl)-1,3-dioxan-5-yl)carbamate, CAS: /, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₃NO₄.

Benzyl (2S,3R)-2,3-Dihydroxy-2-methylbutyrate, CAS: 442159-34-4, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₄.

N-Biotinyl D-erythro-Sphingosine-1-phosphate, CAS: 1093733-24-4, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₂N₃O₇PS.

Benzyl 2,4-Dibromobutyrate-d5, CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅Br₂O₂.

Benzyl 2-(3-Cyanopropyl)-3-methyl-7,8-dihydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazine-6(3H)-carboxylate, CAS: /, stock: 9.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₄O₂S.

N-Biotinyl Dopamine, CAS: 241142-94-9, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅N₃O₄S.

N-Biotinyl Glycine, CAS: 160390-90-9, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃O₄S.

Benzyl 2-(3-Hydroxypropyl)-3-methyl-7,8-dihydroimidazo[4’,5’:5,6]benzo[1,2-b][1,4]thiazine-6(3H)-carboxylate, CAS: /, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₃S.

Benzyl 2-Methylbutyrate-d3, CAS: 1215566-12-3, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₃O₂.

N-Biotinyl O,O’-[(1,1-Dimethylethyl)dimethylsilyl]-dopamine, CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₃N₃O₄SSi₂.

N-Biotinyl p-Aminophenyl Arsenic Acid, CAS: 212391-23-6, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂AsN₃O₄S.

Benzyl 2-Oxo-4-phenylbutyrate, CAS: 84688-29-9, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₃.

Benzyl 4-Phenylbutanoate, CAS: 77100-93-7, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈O₂.

N-Biotinyl Propionylaminoethyl Methanethiosulfate, CAS: 1330172-68-3, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈N₄O₅S₃.

N-Biotinyl trans-3’-Aminomethylnicotine(Mixture of Diastereomers), CAS: /, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₂S.

Benzyl Acetoacetate, CAS: 5396-89-4, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

N-Biotinyl-1,6-hexanediamine, CAS: 65953-56-2, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₀N₄O₂S.

N-Biotinyl-12-aminododecanoic Acid, CAS: 135447-73-3, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₉N₃O₄S.

N-Biotinyl-12-aminododecanoyltobramycin Amide, CAS: 419573-20-9, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₄N₈O₁₂S.

N-Biotinyl-3-aminopropyl Solketal, CAS: 131606-43-4, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃N₃O₅S.

N-Biotinyl-3-aminopropyl Solketal-d5, CAS: /, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈D₅N₃O₅S.

N-Biotinyl-6-amino-2-naphthoic Acid, CAS: 1217755-61-7, stock: 1.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₃O₄S.

N-Biotinyl-N’-(iodoacetyl)-1,6-hexanediamine, CAS: 93285-75-7, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₁IN₄O₃S.

N-Biotinyl-N’-(N-Boc-S-trityl)cysteinyl Ethylenediamine, CAS: 508234-94-4, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₉N₅O₅S₂.

BIO 5192, CAS: 327613-57-0, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₆Cl₂N₆O₈S.

BioA-IN-13, CAS: 1164475-61-9, stock: 1.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₄S.

N-Biotinyl-N’-Boc-1,6-hexanediamine, CAS: 153162-70-0, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₈N₄O₄S.

N-Biotinyl-N’-cysteinyl Ethylenediamine Trifluoroacetic Acid Salt, CAS: /, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈F₃N₅O₅S₂.

BMS 299897, CAS: 290315-45-6, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁ClF₃NO₄S.

Boc-(R)-3-amino-4-(3,4-dichloro-phenyl)-butyric Acid, CAS: 269396-56-7, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉Cl₂NO₄.

N-Biotinyl-N’-maleimido-ethylenediamine, CAS: 139554-72-6, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₄O₄S.

N-Biotinylaminoethyl Methanethiosulfonate, CAS: 162758-04-5, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃N₃O₄S₃.

Boc-(S)-3-Amino-4-(2,4,5-trifluorophenyl)butyric Acid, CAS: 922178-94-7, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈F₃NO₄.

Boc-(S)-3-amino-4-(3,4-dichloro-phenyl)-butyric Acid, CAS: 270063-51-9, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉Cl₂NO₄.

N-Biotinylcaproic Acid, CAS: 72040-64-3, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇N₃O₄S.

Boc-(S)-3-amino-4-(3-chloro-phenyl)-butyric Acid, CAS: 270596-39-9, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀ClNO₄.

Boc-(S)-3-amino-4-(4-bromophenyl)-butyric Acid, CAS: 270062-85-6, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀BrNO₄.

N-Biotinylcaproylaminocaproylaminocaproyl N-Hydroxysuccinimide, CAS: 1322625-23-9, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂N₆O₇S.

N-Biotinylcaproylaminocaproylaminocaproylaminoethyl Methanethiosulfonate, CAS: 1322625-00-2, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₆N₆O₇S₃.

Boc-(S)-3-amino-4-(4-chloro-phenyl)-butyric Acid, CAS: 270596-42-4, stock: 8.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀ClNO₄.

Boc-​(S)​-​3-​amino-​4-​(4-​cyanophenyl)​butanoic Acid, CAS: 270065-89-9, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₄.

N-Biotinylcaproylaminocaproylaminoethyl Methanethiosulfonate, CAS: 1038749-81-3, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₅N₅O₆S₃.

N-Biotinylcaproylaminoethyl Methanethiosulfonate, CAS: 353754-95-7, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₄N₄O₅S₃.

Boc-D-2-aminobutanoic Acid, CAS: 45121-22-0, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

Boc-d-dab(fmoc)-oh, CAS: 131570-57-5, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₆.

N-Boc-Biotinylethylenediamine, CAS: 225797-46-6, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₀N₄O₄S.

N-d-Biotinyl-7-amino-4-methylcoumarin, CAS: 191223-35-5, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N₃O₄S.

Boc-d-dab(z)-oh DCHA, CAS: 101854-42-6, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇N₃O₆.

Boc-D-β-homophenylalanine, CAS: 101555-61-7, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₄.

N-GlcNAc-Biotin, CAS: 1272755-69-7, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀N₄O₇S.

N-Methanethiosulfonylethylene-N6-(6-biotinamidocaproyl)lysineamido-N-α-ammonium Trifluoroacetic Acid Salt, CAS: /, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₇F₃N₆O₈S₃.

Boc-D-Thr(Bzl)-OH, CAS: 69355-99-3, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₅.

Boc-D-Thr(Bzl)-OH, CAS: 64905-10-8, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₅.

N-Succinimido (+)-Biotin, CAS: 35013-72-0, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₅S.

N-[2-[2-[2-[(N-Biotinyl-caproylamino)-ethoxy)ethoxyl]-4-[2-(trifluoromethyl)-3H-diazirin-3-yl]benzoyl]-1,3-bis(mannopyranosyl-4-yloxy)-2-propylamine, CAS: 207971-25-3, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₇₀F₃N₇O₁₉S.

Boc-dab(aloc)-oh, CAS: 171820-73-8, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₂O₆.

Boc-dab(fmoc)-oh, CAS: 117106-21-5, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₆.

N-[23-(9-Mercaptononyl)-3,6,9,12,15,18,21-Heptaoxatricosanyl]-N’-(biotinyl)ethylenediamine, CAS: /, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₈N₄O₁₀S₂.

N-[6-(Biotinamido)hexanoyl]-(R)-2-amino-2-carboxyethylmethanethiosulfonate, CAS: /, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄N₄O₇S₃.

Boc-dl-3-aminobutyric acid, CAS: 52815-19-7, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

Boc-α-Methylalanine, CAS: 30992-29-1, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

N1-(4-(t-Butyl)benzoyl)-D-(+)biotin 2-Nitrophenyl Ester, CAS: 869354-61-0, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁N₃O₆S.

N1-(D-(+)-Biotinyl)-1,19-diamino-4,7,10,13,16-pentaoxa-nonadecane, CAS: 869354-65-4, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₆N₄O₇S.

Boc-β-Homoala-OH, CAS: 158851-30-0, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

Boc-L-2,4-diaminobutyric Acid, CAS: 25691-37-6, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈N₂O₄.

N1-(Dimethoxytrityl)-D-(+)biotin 2-Nitrophenyl Ester, CAS: 869354-63-2, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₇N₃O₇S.

N2-t-Boc-N6-(biotinamido-6-N-caproylamido)lysine, CAS: 102910-26-9, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₇N₅O₇S.

Boc-l-beta-homotryptophan, CAS: 229639-48-9, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₄.

N2-t-Boc-N6-(biotinamido-6-N-caproylamido)lysine N-Hydroxysuccinimide Ester, CAS: 102910-27-0, stock: 6.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₀N₆O₉S.

N2-t-Boc-N6-(biotinamido-6-N-caproylamido)lysinylamidoethane Methanethiosulfonate, CAS: /, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₄N₆O₈S₃.

Boc-L-dab-otBu Hydrochloride, CAS: 250611-08-6, stock: 2.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₆N₂O₄ • HCl.

Boc-L-Val-OMe, CAS: 58561-04-9, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N’-(13-Chloroacetamido-4,7,10-trioxatridecanyl)-N-methyl-N-biotinylglycinamide, CAS: /, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₄ClN₅O₇S.

N’-(13-Iodoacetamido-4,7,10-trioxatridecanyl)-N-methyl-N-biotinylglycinamide, CAS: /, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₄IN₅O₇S.

Boc-L-Valine, CAS: 13734-41-3, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

Boc-o-benzyl-L-beta-homoserine, CAS: 218943-31-8, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₅.

N’-(13-Iodoacetamido-4,7,10-trioxatridecanyl-2,2’,3,3’,11,11’,12,12’-d8)-N-methyl-N-biotinylglycinamide, CAS: /, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆D₈IN₅O₇S.

NHS SS Biotin, CAS: 142439-92-7, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃N₅O₇S₃.

Boc-O-benzyl-L-threonine, CAS: 15260-10-3, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₅.

Nα-Fmoc-Nε-biotinyl-L-lysine, CAS: 146987-10-2, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₄O₆S.

O,O′-Bis(2-aminoethyl)hexaethylene Glycol, CAS: 332941-25-0, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₆N₂O₇.

Butanoic Acid, CAS: 107-92-6, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

O-(2-Aminoethyl)-O’-[2-(Boc-amino)ethyl]hexaethylene Glycol, CAS: 206265-98-7, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₄N₂O₉.

Oleic Acid Alkyne, CAS: 151333-45-8, stock: 8.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀O₂.

Butanoic-d7 Acid, CAS: 73607-83-7, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₇O₂.

Butyryl Chloride, CAS: 141-75-3, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClO.

Photobiotin Acetate Salt, CAS: 96087-38-6, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉N₉O₆S.

Pigment Red 149, CAS: 4948-15-6, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₂₆N₂O₄.

Butyryl Phosphate Dilithium Salt, CAS: /, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇Li₂O₅P.

Butyryl-d7 Chloride, CAS: 1219805-71-6, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄D₇ClO.

Pyrimethamine Biotin, CAS: 1219358-20-9, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉N₇O₃S.

rac Biotin-d4, CAS: 1217850-77-5, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₄N₂O₃S.

Calcium Butyrate (~90%), CAS: 5743-36-2, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈Ca₀.₅O₂.

Carbetocin, CAS: 37025-55-1, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₉N₁₁O₁₂S.

rac Selenobiotin, CAS: 57956-29-3, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆N₂O₃Se.

rac-Desthio Biotin, CAS: 636-20-4, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₃.

CATPB, CAS: 1322598-09-3, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇ClF₃NO₃.

CAY10695, CAS: /, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄O₃.

rac-Trimethaphan Bromide, CAS: 60209-10-1, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅BrN₂OS.

Rat Btd (Biotinidase) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chlorambucil, CAS: 305-03-3, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂NO₂.

Chlorambucil 2-Chloroethyl Ester, CAS: 94236-91-6, stock: 7.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂Cl₃NO₂.

S-(1-Pentyl-5-biotinylamido)glutathione, CAS: /, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂N₆O₈S₂.

Succinimidyl-6-(biotinamido) Hexanoate, CAS: 72040-63-2, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₄O₆S.

Chlorambucil Dimer Impurity, CAS: 1988791-13-4, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇Cl₃N₂O₄.

Chlorambucil Trimer Impurity, CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₅Cl₄N₃O₆.

Succinimidyl-6-[6-(biotinamido)caproyl]caproylate, CAS: 89889-52-1, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁N₅O₇S.

Sulfo-N-succinimidyl 6-(biotinamido) hexanoate Sodium Salt(~90%), CAS: 191671-46-2, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉N₄NaO₉S₂.

Chlorambucil-d8, CAS: /, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₈Cl₂NO₂.

Cholanoic Acid, CAS: 546-18-9, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₂.

Sulfo-NHS-(PEG4-bismannose)-SS-biotin (Technical Grade), CAS: /, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₅H₈₃N₈NaO₂₉S₄.

Sulfo-NHS-Biotin Sodium Salt, CAS: 119616-38-5, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NaN₃O₈S₂.

CI-988, CAS: 130332-27-3, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂N₄O₆.

Cinalukast, CAS: 128312-51-6, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈N₂O₃S.

Sulfosuccinimidyl 3-[[2-(Biotinamido)ethyl] dithio]propionate Sodium Salt, CAS: 325143-98-4, stock: 6.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇N₄NaO₉S₄.

tert-Butyl(3-(5-(4-Aminophenylsulfonamido)-6-methoxypyrazin-2-yl)propyl)carbamate, CAS: 1621083-43-9, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇N₅O₅S.

Cinalukast-d4, CAS: /, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₄N₂O₃S.

cis-Ethyl 2-Hydroxyimino-3-oxobutyrate, CAS: 66508-93-8, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₄.

tert-Butyl 5-Iodovalerate, CAS: 56198-37-9, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇IO₂.

Vitamin D2 3’-Biotinylaminopropyl Ether, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₅N₃O₃S.

Citric Acid 1,2-Diethyl Ester, CAS: 19958-02-2, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₇.

Clanobutin, CAS: 30544-61-7, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClNO₄.

[1-N-(4,4’-Dimethoxytrityl)biotinyl-6-aminohexyl]-2-(cyanoethyl-N,N-diisopropyl)phosphoramidite, CAS: 135137-87-0, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₄N₅O₆PS.

[3aS-(3aα,4β,6aα)]-Hexahydro-2-oxo-1,3-bis(phenylmethyl)-1H-Thieno[3,4-d]imidazole-4-pentanoic Acid Phenylmethyl Ester, CAS: 179532-60-6, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₃S.

Clanobutin Methyl Ester, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClNO₄.

Clanobutin Methyl Ester- d4, CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₄ClNO₄.

[Biotinylamidoethyl]-dithiomethylenemalonic Acid Bis(2-aminoethanoic Acid), CAS: 1217718-11-0, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₄N₆O₉S₃.

Clanobutin-d4, CAS: /, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₄ClNO₄.

Clinofibrate, CAS: 30299-08-2, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₆O₆.

[Biotinylamidoethyl]-dithiomethylenemalonic Acid Bis(4-aminobutyric Acid), CAS: 1322625-02-4, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂N₆O₉S₃.

Colistin B Sulfate Salt (~90%), CAS: 1338055-88-1, stock: 4.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₉₈N₁₆O₁₃ • x(H₂SO₄).

D(-)-2-Amino-4-phosphonobutanoic Acid (D-AP4), CAS: 78739-01-2, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₅P.

D,L-Buthionine Sulfoxide, CAS: 98487-33-3, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₃S.

D,L-Buthionine-(S,R)-sulfoximine, CAS: 5072-26-4, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O₃S.

D,L-Homotryptophan, CAS: 26988-87-4, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

D-(R)-Homophenylalanine Hydrochloride, CAS: 105382-08-9, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂ •HCl.

D-2,4-Diaminobutyric Acid Dihydrochloride, CAS: 127531-11-7, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₂O₂ • 2HCl.

D-allo-Threonine, CAS: 24830-94-2, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

D-Buthionine Sulfoxide, CAS: 98487-33-3, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₃S.

D-Buthionine-(S,R)-sulfoximine, CAS: 113158-69-3, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O₃S.

D-Glutamic Acid 5-Methyl Ester, CAS: 07/04/6461, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

D-Homocystine, CAS: 6027-15-2, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₄S₂.

D-Kynurenine, CAS: 13441-51-5, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

D-Methionine Sulfoxide, CAS: 21056-56-4, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₃S.

D-Penicillamine, CAS: 52-67-5, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂S.

D-Penicillamine N-Lactose Adduct, CAS: /, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁NO₁₂S.

D-Penicillamine-d6, CAS: /, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₆NO₂S.

D-Threonine, CAS: 632-20-2, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

D-Threonine-4,4,4-d3, CAS: /, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₃NO₃.

D-Threonine-4-13C-4,4,4-d3, CAS: /, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₆D₃NO₃.

D-Valine, CAS: 640-68-6, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

D-Valine Methyl Ester Hydrochloride, CAS: 7146-15-8, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂.

DBCO-Acid, CAS: 1353016-70-2, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅NO₃.

DBCO-NHS Ester, CAS: 1353016-71-3, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈N₂O₅.

DCPIB, CAS: 82749-70-0, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈Cl₂O₄.

Dehydro Lovastatin, CAS: 109273-98-5, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₄.

Dehydro Simvastatin, CAS: 210980-68-0, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₄.

Des(dimethylamino) Crotethamide Acid, CAS: /, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃.

Des(dimethylamino) Crotethamide Acid Ethyl Ester, CAS: /, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₃.

Des(ethylphenyl-3-methoxy)-2-formylsarpogrelate, CAS: 1659311-40-6, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₆.

Desamino Glufosinate-d3, CAS: 1794938-71-8, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃O₄P.

Desamino P-Ethoxy Glufosinate-d3 Ethyl Ester, CAS: 1346598-74-0, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆D₃O₄P.

Deschloroethyl Bendamustine Hydrochloride, CAS: 1797881-48-1, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂N₃O₂.

Desfluoro Idelalisib, CAS: 870281-74-6, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉N₇O.

Desmethyl Bendamustine Hydrochloride, CAS: 31349-38-9, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀Cl₃N₃O₂.

1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole Hydrochloride, CAS: /, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClN₃O.

Desmethyl Gabazine, CAS: 835870-49-0, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₃.

Dibenzyl Dipyridamole Tartaric Acid Ester, CAS: /, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₆N₈O₉.

1’-Hydroxy Bilastine, CAS: 1638785-23-5, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇N₃O₄.

1’-Hydroxy Bilastine Weinreb’s Amide, CAS: 1638785-25-7, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₄O₄.

Diethyl 2-Acetylsuccinate, CAS: 1115-30-6, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₅.

4-(2-Chloroacetyl)-N-methoxy-N,α,α-trimethyl-benzeneacetamide, CAS: 1638785-15-5, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClNO₃.

4-(2-Chloroethyl)-N-methoxy-N,α,α-trimethyl-benzeneacetamide, CAS: 1638785-17-7, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClNO₂.

Diethylphosphonobutanoic acid, CAS: 38694-48-3, stock: 1.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇O₅P.

Dihydroxy Bendamustine Sodium Salt, CAS: /, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₃NaO₄.

Bilastine N-Oxide, CAS: 2069238-47-5, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₇N₃O₄.

Bilastine-d6, CAS: 1215358-58-9, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₁D₆N₃O₃.

Dihydroxy Bendamustine-d3, CAS: 1794737-33-9, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀D₃N₃O₄.

N-Boc 1-(2-Ethyoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole, CAS: 1181267-36-6, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₃.

Dimethyl Glutaconate (~10% Cis), CAS: 5164-76-1, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₄.

DL-2-Amino-4-phosphonobutanoic acid (AP4), CAS: 6323-99-5, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₅P.

DL-2-Aminobutyric Acid Methyl Ester Hydrochloride, CAS: 7682-18-0, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.

DL-2-Hydroxy-4-(methylthio)butanoic Acid-13C4, CAS: 1215556-82-3, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₄H₁₀O₃S.

DL-2-Hydroxy-4-(methylthio)butanoic acid-d3, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₃S.

DL-2-Methylbutyric Acid, CAS: 116-53-0, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

DL-2-Methylbutyric Acid Methyl Ester, CAS: 868-57-5, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

DL-2-Methylbutyric Acid Methyl-d3 Ester, CAS: 1082582-07-7, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₃O₂.

DL-AP4, CAS: 6323-99-5, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₅P.

DL-Homocystine, CAS: 870-93-9, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₄S₂.

DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8, CAS: 108641-82-3, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₈N₂O₄S₂.

DL-Homophenylalanine, CAS: 1012-05-1, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

Elagolix Sodium, CAS: 832720-36-2, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉F₅N₃NaO₅.

Epi Lovastatin, CAS: 79952-44-6, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₅.

Epi Lovastatin-d3, CAS: 1330264-51-1, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃D₃O₅.

Eptaloprost, CAS: 90693-76-8, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₅.

Eritadenine, CAS: 23918-98-1, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄.

Erythro-2-methyl-3(Methoxy-d3)-4-phenylbutyric Acid, CAS: 224627-72-9, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₃O₃.

Esonarimod, CAS: 101973-77-7, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆O₄S.

Ethoxy Deschloro Bendamustine, CAS: /, stock: 3.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₃.

Ethoxy Deschloro Bendamustine, CAS: /, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₃.

Ethyl (2-Azidoethoxy)aceto-2-(2-chlorophenylmethlene)acetate, CAS: 837427-86-8, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆ClN₃O₄.

Ethyl (2-Azidoethoxy)aceto-2-(2-chlorophenylmethlene)acetate-d4, CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₄ClN₃O₄.

Ethyl (2-Azidoethoxy)acetoacetate, CAS: 88150-45-2, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃N₃O₄.

Ethyl (2-Azidoethoxy-d4)acetoacetate, CAS: 1189691-91-5, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₄N₃O₄.

Ethyl (R)-2-Hydroxy-4-phenylbutyrate Triflate, CAS: 88767-98-0, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅F₃O₅S.

Ethyl (R)-2-Hydroxy-4-phenylbutyrate-d5 Triflate, CAS: /, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀D₅F₃O₅S.

Ethyl (S)-3-Hydroxybutyrate, CAS: 56816-01-4, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

Ethyl 2-(2-((tert-butoxycarbonyl)amino)propanamido)-3-oxobutanoate, CAS: 1259022-54-2, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄N₂O₆.

Ethyl 2-Benzylacetoacetate, CAS: 620-79-1, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₃.

Ethyl 2-Bromobutyrate, CAS: 533-68-6, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

Ethyl 2-Bromoisobutyrate, CAS: 600-00-0, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

Ethyl 2-Bromoisovalerate, CAS: 609-12-1, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃BrO₂.

Ethyl 2-Chloracetoacetate, CAS: 609-15-4, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₃.

Ethyl 2-Ethylacetoacetate, CAS: 607-97-6, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

Ethyl 2-Isopropylacetoacetate, CAS: 1522-46-9, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₃.

Ethyl 2-Methylacetoacetate, CAS: 609-14-3, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

Ethyl 2-Methylbutyrate, CAS: 7452-79-1, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂.

Ethyl 2-Methylbutyrate-D3, CAS: 181878-39-7, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁D₃O₂.

Ethyl 2-oxo-4-phenylbutyrate (93%), CAS: 64920-29-2, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

Ethyl 2-Oxo-4-phenylbutyrate-d5, CAS: 1189911-53-2, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₅O₃.

Ethyl 3-(Butanoylamino)-2-oxobutanoate, CAS: 68282-26-8, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₄.

Ethyl 3-(Dimethylamino)butanoate, CAS: 85118-28-1, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂.

Ethyl 3-Amino-4-(2,4,5-trifluorophenyl)butanoate, CAS: 1151240-92-4, stock: 5.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄F₃NO₂.

Ethyl 3-Hydroxybutyrate, CAS: 5405-41-4, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₃.

Ethyl 3-Hydroxybutyrate-13C4, CAS: /, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₄H₁₂O₃.

Ethyl 3-Hydroxybutyrate-d5, CAS: 1206486-01-2, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₅O₃.

Ethyl 3-Nitrobenzylideneacetoacetate, CAS: 39562-16-8, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₅.

Ethyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate, CAS: 1151240-88-8, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁F₃O₃.

Ethyl 3-Oxo-4-(triphenylphosphoranylidene)butyrate, CAS: 13148-05-5, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃O₃P.

Ethyl 3-[(Tetrahydropyranyl)oxy]butanoate, CAS: 104372-23-8, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀O₄.

Ethyl 4,4-Difluoroacetoacetate, CAS: 352-24-9, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈F₂O₃.

Ethyl 4-(4-Fluorophenyl)-3-oxobutanoate, CAS: 221121-37-5, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃FO₃.

Ethyl 4-(5-Amino-1-methyl-4-thiocyanato-1H-benzo[d]imidazol-2-yl)butanoate, CAS: /, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₂S.

Ethyl 4-Acetoxy-3-oxobutanoate, CAS: 35594-15-1, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₅.

1-(4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)phenyl)ethanone, CAS: 1349659-53-5, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀O.

Ethyl 4-Acetoxybutanoate, CAS: 25560-91-2, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

Ethyl 4-​(6-​Acetyl-​3-​hydroxy-​2-​propylphenoxy)​butyrate, CAS: 122714-53-8, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₅.

2,2,5,5-Tetramethyloxolan-3-one, CAS: 5455-94-7, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₂.

Ethyl 4-benzyloxy-3-oxobutanoate, CAS: 67354-34-1, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₄.

Ethyl 4-Bromo-2-(methoxyimino)-3-oxobutyrate, CAS: 60845-87-6, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀BrNO₄.

Ethyl 4-Bromobutanoate, CAS: 2969-81-5, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO₂.

Ethyl 4-Chloroacetoacetate, CAS: 638-07-3, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₃.

Ethyl 4-Chloroacetoacetate-13C4, CAS: 1216736-40-1, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₄H₉ClO₃.

Ethyl 4-Chlorobutyrate, CAS: 3153-36-4, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO₂.

Ethyl 4-Chlorobutyrate-d4, CAS: /, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₄ClO₂.

Ethyl 4-Chlorobutyrate-d6, CAS: 927810-76-2, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₆ClO₂.

Ethyl 4-Oxo-4-(3-pyridyl)butanoate, CAS: 59086-27-0, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

Ethyl 4-Phenylacetoacetate, CAS: 718-08-1, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₃.

Bexarotene Acyl-β-D-glucuronide, CAS: 198700-33-3, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆O₈.

Bexarotene Dimer, CAS: /, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₅₆O₄.

Ethyl Acetoacetate, CAS: 141-97-9, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃.

Ethyl Acetoacetate-13C4, CAS: 84508-55-4, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₄H₁₀O₃.

Ethyl Acetolactate, CAS: 16508-89-7, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₄.

Ethyl Isovalerate(Isovaleric Acid Ethyl Ester), CAS: 108-64-5, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂.

Ethyl α-Bromoethylglyoxalate, CAS: 57332-84-0, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉BrO₃.

Ethyl S-(+)-4-Cyano-3-hydroxybutyrate, CAS: 312745-91-8, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁NO₃.

Ethyl Succinoyl Chloride, CAS: 14794-31-1, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₃.

Ethyl-d5 2-Methylbutyrate, CAS: 1082581-95-0, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉D₅O₂.

Methyl Bexarotenate, CAS: 153559-48-9, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀O₂.

Ethyl-d5 4-Oxo-4-(3-pyridyl)butanoate, CAS: /, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₅NO₃.

Ethyl-d5 Butyrate, CAS: 38447-86-8, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₅O₂.

Fenpipramide, CAS: 77-01-0, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O.

Fluoresceinyl Gabazine, Bromide, CAS: 1024389-03-4, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₇BrN₅O₇S.

Fluoxetine Succinamic Acid, CAS: 1026723-45-4, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂F₃NO₄.

Fmoc-(2S,3S)-2-amino-3-methoxybutanoic acid, CAS: 1279029-70-7, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₅.

Fmoc-(7-hydroxycoumarin-4-yl)-ethyl-gly-OH, CAS: 1187744-84-8, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃NO₇.

Fmoc-(R)-3-amino-4-(4-methylphenyl)butanoic acid, CAS: 269398-86-9, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₄.

Fmoc-4-aminobutanoic Acid, CAS: 116821-47-7, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₄.

Fmoc-4-nitro-L-β-homophenylalanine, CAS: 270062-88-9, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂N₂O₆.

Fmoc-asn(tmob)-oh, CAS: 120658-63-1, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₂O₈.

Fmoc-D-Abu-OH, CAS: 170642-27-0, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₄.

Fmoc-D-dab(boc)-OH, CAS: 114360-56-4, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₆.

Fmoc-Dab(Boc)-OH, CAS: 125238-99-5, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₆.

Fmoc-Thr(Bzl)-OH, CAS: 117872-75-0, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₅.

Fmoc-Tle-OH, CAS: 132684-60-7, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

Fmoc-valine, CAS: 68858-20-8, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

FTY720 Butanoic Acid Hydrochloride, CAS: 896472-93-8, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄ClNO₄.

Gabazine Ethyl Ester, CAS: 763886-63-1, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₃.

Gabazine Hydrobromide, CAS: 104104-50-9, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₃O₃Br.

GLPG 0974, CAS: 1391076-61-1, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅ClN₂O₄S.

Glufosinate Ammonium, CAS: 77182-82-2, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₅N₂O₄P.

Glufosinate P Ammonium Salt, CAS: 73777-50-1, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂NO₄P • NH  ₃.

Glufosinate-d3 Hydrochloride, CAS: 1323254-05-2, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀D₃ClNO₄P.

GSK 2018682, CAS: 1034688-30-6, stock: 10g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₄O₄.

HaloTag Succinimidyl Ester O2 Ligand, CAS: 1803085-03-1, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClN₂O₇.

Heliotrine, CAS: 303-33-3, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NO₅.

Heliotrine N-Oxide, CAS: 6209-65-0, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NO₆.

Heliotrine N-Oxide-D3, CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄D₃NO₆.

Heliotrine-D3, CAS: /, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄D₃NO₅.

Heptafluorobutyric Acid, CAS: 375-22-4, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HF₇O₂.

Heptafluorobutyric Acid (50ug/mL), CAS: 375-22-4, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HF₇O₂.

Homo-L-tyrosine Hydrobromide, CAS: 141899-12-9, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄BrNO₃.

Homocysteine-cysteine Disulfide, CAS: 4985-47-1, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₄S₂.

Hopantenate Calcium, CAS: 17097-76-6, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₆CaN₂O₁₀.

Hopantenate-d6 Calcium, CAS: /, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄D₁₂CaN₂O₁₀.

Hopantenate-d6 Calcium, CAS: /, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄D₁₂CaN₂O₁₀.

Hydrolyzed Pomalidomide M10, CAS: 918314-45-1, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₅.

Hydroxy Tipelukast-d6, CAS: /, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄D₆O₇S.

Ibrutinib M25, CAS: 1839090-60-6, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄N₆O₄.

Indicine, CAS: 480-82-0, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₅.

Indicine N-Oxide, CAS: 41708-76-3, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₆.

Indicine N-Oxide-D7, CAS: /, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₇NO₆.

Indicine-D7, CAS: /, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₇NO₅.

Indole-3-butyric Acid, CAS: 133-32-4, stock: 3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₂.

Indole-3-butyric Acid Methyl Ester, CAS: 15591-70-5, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₂.

Indole-3-butyric Acid Potassium Salt, CAS: 60096-23-3, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂KNO₂.

Indole-3-butyric Acid-d4, CAS: 1216408-71-7, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₄NO₂.

Intermedine, CAS: 10285-06-0, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₅.

Intermedine N-Oxide, CAS: 95462-14-9, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₆.

Intermedine N-Oxide-D7, CAS: /, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₇NO₆.

Intermedine-D7, CAS: /, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₇NO₅.

Iodopanoic Acid, CAS: 96-83-3, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂I₃NO₂.

Isobutyric Acid, CAS: 79-31-2, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

Isobutyric-d6 Acid, CAS: 29054-08-8, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₆O₂.

Isobutyric-d7 Acid, CAS: 223134-74-5, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₇O₂.

Isodecyl Daptomycin, CAS: /, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₂H₁₀₁N₁₇O₂₆.

Isopilocarpic Acid Sodium Salt, CAS: 101769-87-3, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₂NaO₃.

Isopilocarpic Acid-d3 Sodium Salt, CAS: /, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄D₃N₂NaO₃.

1,3-Benzodioxole-5-ethanamine Hydrochloride, CAS: 1653-64-1, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₂.

Isopropyl Acetoacetate, CAS: 542-08-5, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

Isopropyl Acetoacetate-d7, CAS: 1329502-96-6, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅D₇O₃.

Bifendate Dicarboxylic Acid, CAS: 105868-34-6, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄O₁₀.

Isopropyl Butyrate, CAS: 638-11-9, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂.

Isovaleric acid, CAS: 503-74-2, stock: 2.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

Isovaleric Acid Ethyl-d5 Ester, CAS: 1082581-99-4, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉D₅O₂.

Isovaleric Acid Methyl Ester, CAS: 556-24-1, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

Isovaleric Acid Methyl-d3 Ester, CAS: 1082582-09-9, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₃O₂.

Isovaleric Acid-d9, CAS: 344298-81-3, stock: 6.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HD₉O₂.

(R)-Betaxolol Hydrochloride, CAS: 91878-54-5, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀ClNO₃.

Itaconic Acid, CAS: 97-65-4, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₄.

Itaconic Acid-13C1, CAS: /, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₆O₄.

(R)-Betaxolol-d7 Hydrochloride, CAS: /, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃D₇ClNO₃.

(R)-[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]-oxirane, CAS: 108008-08-8, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₃.

Itaconic Acid-13C5, CAS: /, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₆O₄.

Itaconic Acid-13C5,d4, CAS: /, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₂D₄O₄.

1-(2-Cyclobutoxyethyl)-4-methoxybenzene, CAS: /, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₂.

1-(4-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)phenoxy)-3-(isopropylamino)propan-2-ol, CAS: /, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₁NO₃Si.

α-Acetohydroxybutyric Acid, CAS: 3142-65-2, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

α-Amino-2-(ethoxycarbonyl)-1-azetidinebutanoic Acid Ethyl Ester Hydrochloride, CAS: 1028192-80-4, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃ClN₂O₄.

α-Amino-4-octylbenzenebutanoic Acid, CAS: 596820-19-8, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₂.

1-[4-[[Tris(1-methylethyl)silyl]oxy]phenyl]ethanone, CAS: 935859-12-4, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈O₂Si.

2-(4-Benzyloxyphenyl)ethanol, CAS: 61439-59-6, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₂.

α-Amino-β-methyl-β-sulfino-1H-1,2,3-triazole-1-butanoic Acid, CAS: 118175-11-4, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₄O₄S.

α-​Cyano-​β-​(4-​methoxyphenyl)​-benzenebutanoic Acid Ethyl Ester, CAS: 1373401-98-9, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₃.

2-Bromo-1-(4-((tert-butyldimethylsilyl)oxy)phenyl)ethanol, CAS: /, stock: 8.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃BrO₂Si.

2-Bromo-1-(4-((triisopropylsilyl)oxy)phenyl)ethanol, CAS: /, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉BrO₂Si.

α-Keto Isovaleric Acid Sodium Salt, CAS: 3715-29-5, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NaO₃.

α-Keto Isovaleric Acid-13C Sodium Salt, CAS: 1173023-03-4, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₇NaO₃.

2-Bromo-1-(4-methoxyphenyl)ethanol, CAS: 19922-83-9, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrO₂.

2-Bromo-1-[4-[[tris(1-methylethyl)silyl]oxy]phenyl]ethanone, CAS: 935859-13-5, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇BrO₂Si.

α-Keto Isovaleric Acid-13C,d Sodium Salt, CAS: 1329835-35-9, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₆DNaO₃.

α-Keto Isovaleric Acid-13C5,d Sodium Salt, CAS: 420095-74-5, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₆DNaO₃.

2-Cyclobutoxy-1-(4-((triisopropylsilyl)oxy)phenyl)ethanol, CAS: /, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆O₃Si.

3-(1-Methylethyl)-2-phenyl-5-oxazolidinemethanol, CAS: 54126-58-8, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.

α-Keto Isovaleric Acid-3-d Sodium Salt, CAS: 360769-16-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆DNaO₃.

α-Ketobutyric Acid, CAS: 600-18-0, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₃.

3-(1-Methylethyl)-2-phenyl-5-oxazolidinemethanol 5-(4-Methylbenzenesulfonate), CAS: 86587-72-6, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄S.

4-(2-Cyclobutoxy-1-hydroxyethyl)phenol, CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

α-Ketobutyric Acid-13C,d2 Sodium Salt, CAS: 1189500-69-3, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₃D₂NaO₃.

α-Ketobutyric Acid-13C4,d2 Sodium Salt, CAS: 360769-17-1, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₃D₂NaO₃.

4-[2-(Cyclopropylmethoxy)ethyl]phenol, CAS: 63659-16-5, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

α-Ketobutyric Acid-d2 Sodium Salt, CAS: 1007476-82-5, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₂NaO₃.

4-[[(tert-Butyl)dimethylsilyl]oxy]phenacyl Bromide, CAS: 157610-58-7, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁BrO₂Si.

Betaxolol, CAS: 63659-18-7, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉NO₃.

β-(Trifluoromethyl)phenylalanine, CAS: 114829-12-8, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀F₃NO₂.

Betaxolol Hydrochloride, CAS: 63659-19-8, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₀ClNO₃.

Betaxolol-d5, CAS: 1189957-99-0, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₅NO₃.

β-​[[[4,​5-Dihydro-​5-​[2-​(1H-​imidazol-​2-​ylamino)​ethyl]​-​3-​isoxazolyl]​carbonyl]​amino]​-​3,​4-​dihydro-​γ-​oxo-2(1H)​-​Isoquinolinebutanoic Acid, CAS: 1230487-85-0, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₆O₅.

β-Butyrolactone, CAS: 3068-88-0, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O₂.

Des[4-(2-cyclopropylmethoxy)] Betaxolol Hydrochloride, CAS: 464877-45-0, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄ClNO₂.

Des[4-(2-cyclopropylmethoxy)] Betaxolol-d5 Hydrochloride, CAS: 1329488-43-8, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉D₅ClNO₂.

β-Caryophyllinic Acid, CAS: 957055-11-7, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂O₄.

β-Formylpropionic Acid, CAS: 692-29-5, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

α-[(Cyclobutyloxy)methyl]-4-methoxy-benzenemethanol, CAS: 1249472-88-5, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈O₃.

O-(2-Cyclobutoxy-1-(4-methoxyphenyl)ethyl) O-Phenyl Carbonothioate, CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₄S.

β-Hydroxyisovaleric Acid, CAS: 625-08-1, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

β-Hydroxyisovaleric Acid-d8, CAS: 123743-99-7, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₈O₃.

O-Des(cyclopropylmethyl)-O-butyl Betaxolol Hydrochloride, CAS: /, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂ClNO₃.

O-Desmethyl Metoprolol, CAS: 62572-94-5, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₃NO₃.

[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane, CAS: 63659-17-6, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀O₃.

[[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane-d5, CAS: 1185169-90-7, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₅O₃.

γ-Aminobutyric Acid, CAS: 56-12-2, stock: 8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

2-Pyridineethanol, CAS: 103-74-2, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO.

γ-Oxo-1-naphthalenebutanoic Acid, CAS: 4653-13-8, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

2-Vinylpyridine (stabilized with 0.1% 4-tert-butylcatechol), CAS: 100-69-6, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N.

Betahistine, CAS: 5638-76-6, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

γ-Oxo-3-pyridinebutyric Acid, CAS: 4192-31-8, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

Betahistine Adduct 1, CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₆.

Betahistine Dihydrochloride, CAS: 5579-84-0, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄Cl₂N₂.

γ-Oxo-3-pyridinebutyric Acid, N-Hydroxysuccinimide Ester, CAS: 1076199-29-5, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₅.

γ-Oxo-4-pyridinebutyric Acid, CAS: 5693-75-4, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

Betahistine Hydrochloride, CAS: 15430-48-5, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃ClN₂.

Betahistine Methanesulfonate, CAS: 54856-23-4, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.CH₄O₃S.

γ-Oxo-4-pyridinebutyric Acid Ethyl Ester, CAS: 25370-46-1, stock: 4.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

Betahistine-d3 Dihydrochloride, CAS: 244094-72-2, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₃Cl₂N₂.

β-Histine-d3, CAS: 244094-70-0, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₃N₂.

L(+)-2-Amino-4-phosphonobutanoic Acid (L-AP4), CAS: 23052-81-5, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₅P.

L-(+)-Cystathionine, CAS: 56-88-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₄S.

L-2,4-Diaminobutyric Acid, Dihydrochloride, CAS: 1883-09-6, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂Cl₂N₂O₂.

L-2,4-Diaminobutyric Acid-13C4 Dihydrochloride, CAS: /, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₁₂Cl₂N₂O₂.

L-2-Aminobutyric Acid 3,3,4,4,4-d5, CAS: /, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₅NO₂.

L-2-Aminobutyric Acid D4, CAS: /, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅D₄NO₂.

L-2-Aminobutyric Acid Methyl Ester Hydrochloride, CAS: 56545-22-3, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₂.

L-2-Aminobutyric Acid-d3 Ester Hydrochloride, CAS: /, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉D₃ClNO₂.

L-2-Aminobutyric Acid-d5 Methyl Ester Hydrochloride, CAS: 1346617-05-7, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₅ClNO₂.

L-2-Aminobutyric Acid-d6, CAS: 1276197-51-3, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₆NO₂.

L-allo-Threonine, CAS: 28954-12-3, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

L-allo-Threonine Methyl Ester Hydrochloride Hydrate, CAS: /, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₃ •HCl  •H₂O.

L-Aminobutyric Acid, CAS: 1492-24-6, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

L-Aminobutyric Acid-d3, CAS: 929202-07-3, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₃NO₂.

L-Buthionine Sulfone, CAS: 134859-31-7, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₄S.

L-Buthionine Sulfoxide, CAS: 199982-01-9, stock: 9.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₃S.

L-Buthionine-(S,R)-sulfoximine, CAS: 83730-53-4, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂O₃S.

L-Ethionine, CAS: 13073-35-3, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂S.

L-Fmoc-Aminobutyric Acid, CAS: 135112-27-5, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₄.

L-Fmoc-Aminobutyric Acid, CAS: 94744-50-0, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₄.

L-Glutamic Acid 5-Methyl Ester, CAS: 1499-55-4, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₄.

L-Homocysteine, CAS: 6027-13-0, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂S.

L-Homocysteinesulfinic Acid, CAS: 2686-70-6, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₄S.

(2R,3S,4S)-1-(2-Phenylhydrazono)-pentane-2,3,4-triacetate-d3, CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃N₂O₆.

L-Homocystine, CAS: 626-72-2, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂O₄S₂.

L-Homohistidine, CAS: 58501-47-6, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃O₂.

(6R)-5,6,7,8-Tetrahydrobiopterin Dihydrochloride, CAS: 69056-38-8, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₅O₃ • 2(HCl).

(6R)-Tetrahydro-L-biopterin Sulfate, CAS: 103130-44-5, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N₅O₇S.

L-Homophenylalanine, CAS: 943-73-7, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

L-Homophenylalanine hydrochloride, CAS: 105382-09-0, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂ •HCl.

(6R)-Tetrahydro-L-biopterin-15N3,13C1 Triflate, CAS: /, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₆F₃N₂¹⁵N₃O₆S.

(6R)-Tetrahydro-L-biopterin-d3 Sulfate(Mixture of Diastereomers), CAS: /, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄D₃N₅O₇S.

L-Homophenylalanine Methyl Ester, CAS: 106860-17-7, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

L-Homoserine, CAS: 672-15-1, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

(6S)-Tetrahydro-L-biopterin Disulfate, >80%, CAS: 103130-45-6, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉N₅O₁₁S₂.

(6S)-Tetrahydro-L-biopterin-d3 Disulfate(Mixture of Diastereomers), CAS: 1329499-33-3, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆D₃N₅O₁₁S₂.

L-Kynurenine-d4 Trifluoroacetic Acid Salt, CAS: /, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂O₃  •  x(C   ₂HF₃O₂).

L-Methionine, CAS: 63-68-3, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂S.

(6S)-Tetrahydrobiopterin, CAS: 62961-57-3, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅N₅O₃.

2,3-Dihydro-2-N-acetyl-1’,2’-di-O-acetyl-biopterin-d3, CAS: 1346597-41-8, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₃N₅O₆.

L-Methionine Methyl Ester Hydrochloride, CAS: 2491-18-1, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO₂S.

L-Methionine Sulfone, CAS: 7314-32-1, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₄S.

2-Amino-5,6,7,8-tetrahydro-6-methyl-4(1H)-pteridinone Dihydrochloride, CAS: 69113-63-9, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃Cl₂N₅O.

2-N-Acetyl-1’,2’-di-O-acetyl-6-biopterin, CAS: 81827-31-8, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₅O₆.

L-Methionine Sulfone-d3, CAS: /, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃NO₄S.

L-Methionine Sulfoxide, CAS: 3226-65-1, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₃S.

3,4-O-Cyclohexylidene-1-deoxy-D-allitol-d3, CAS: /, stock: 1.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉D₃O₅.

5,6-Dihydrodeoxysepiapterin Dihydrochloride, CAS: 69347-45-1, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₂ • 2(HCl).

L-Methionine [R,S]-Sulfoximine, CAS: 15985-39-4, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₃S.

L-Methionine [R,S]-Sulfoximine-13C5, CAS: /, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₂N₂O₃S.

5-Deoxy-D-ribose-d3, CAS: /, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₄.

5-Deoxy-D-ribose[cyclohexane]-d3, CAS: /, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅D₃O₄.

L-Methionine [R]-Sulfoximine, CAS: 21752-31-8, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₃S.

L-Methionine [S]-Sulfoximine, CAS: 21752-32-9, stock: 3.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₃S.

5-Deoxy-L-ribose Phenylhydrazone-d3, CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃N₂O₃.

7,8-Dihydro-L-biopterin, CAS: 6779-87-9, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₃.

L-Methionine-13C5, CAS: 202326-57-6, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₁NO₂S.

7,8-Dihydro-L-biopterin-d3, CAS: 1217782-44-9, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₃N₅O₃.

Anapterin, CAS: 13019-53-9, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₃.

L-Methionine-d3, CAS: 13010-53-2, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃NO₂S.

Biopterin, CAS: 22150-76-1, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₃.

Biopterin-d3, CAS: 1217838-71-5, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₃N₅O₃.

L-Norarginine, CAS: 14191-90-3, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₄O₂.

L-Norcarnitine, CAS: 2921-13-3, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

D-Arabinose-13C5 Phenylhydrazone, CAS: /, stock: 10g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₅H₁₀N₂O₄.

D-Neopterin, CAS: 2009-64-5, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄.

L-Norcarnitine-d6, CAS: 1795785-53-3, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₆NO₃.

L-Penicillamine Hydrochloride, CAS: 25526-04-9, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂S • (HCl).

D-Neopterin Hydrochloride, CAS: /, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄ • (HCl).

D-Neopterin-13C5, CAS: 1217632-04-6, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₅H₁₁N₅O₄.

L-Selenomethionine, CAS: 3211-76-5, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂Se.

L-tert-Leucine, CAS: 20859-02-3, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

Di-O-Acetylbiopterin, CAS: 62933-57-7, stock: 5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₅O₅.

Dihydroneopterin, CAS: 1218-98-0, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₅O₄.

L-Threonic Acid Calcium Salt, CAS: 70753-61-6, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇O₅•1/2Ca.

L-Threonine, CAS: 72-19-5, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃.

L-Primapterin, CAS: 2636-52-4, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₃.

Mouse Pts (6-pyruvoyl tetrahydrobiopterin synthase) ELISA Kit (96T), CAS: /, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Threonine Methyl Ester Hydrochloride, CAS: 39994-75-7, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO₃.

Pterin, CAS: 2236-60-4, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₅O.

Quinonoid-(6R)-dihydro-L-biopterin Hydrochloride, CAS: 102340-67-0, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClN₅O₃.

L-Threonine tert-Butyl Ester Hydrochloride, CAS: 69320-90-7, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClNO₃.

L-Threonine-13C, CAS: 81202-08-6, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³CH₉NO₃.

Rat Pts (6-pyruvoyl tetrahydrobiopterin synthase) ELISA Kit (96T), CAS: /, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Valine, CAS: 72-18-4, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

L-Valine-13C5,15N, CAS: 202407-30-5, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₅H₁₁¹⁵NO₂.

L-Valine-d8, CAS: 35045-72-8, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₈NO₂.

Lanifibranor, CAS: 927961-18-0, stock: 3.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅ClN₂O₄S₂.

Linear Daptomycin Hydrochloride Salt, CAS: /, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₂H₁₀₃N₁₇O₂₇ • xHCl.

Lisinopril (8R,S)-Diketopiperazine (Mixture of Diastereomers)Mps1-IN-1 dihydrochloride, CAS: 1092813-99-4, stock: 10g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₃O₄.

Lisinopril (S,S,R)-Diketopiperazine, CAS: 219677-82-4, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉N₃O₄.

Lithium Acetoacetate, CAS: 02/11/3483, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅LiO₃.

Lovastatin, CAS: 75330-75-5, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₅.

Lovastatin-d3, CAS: 1002345-93-8, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃D₃O₅.

LTA4 (Leukotriene A4 methyl ester), CAS: 73466-12-3, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O₃.

Lupersol 533-M75, CAS: 67567-23-1, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂O₆.

Magnesium Butyrate, CAS: 556-45-6, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₄H₇O₂)  •  Mg.

MDMB-FUBINACA Metabolite M1, CAS: /, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂FN₃O₃.

Mebeverine Acid, CAS: 475203-77-1, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₃.

Mebeverine Acid Methyl Ester, CAS: 1390154-39-8, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₃.

Mebeverine Acid-d5, CAS: /, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀D₅NO₃.

Menbutone, CAS: 3562-99-0, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₄.

meta-Chlorambucil, CAS: 134862-11-6, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂NO₂.

Methyl (2S)​-​2-​Aminobutanoate, CAS: 15399-22-1, stock: 2.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

Methyl (R)-3-Hydroxybutyrate, CAS: 3976-69-0, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

Methyl 2-(2,3-Dichlorobenzylidene)acetoacetate, CAS: 74073-22-6, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀Cl₂O₃.

Methyl 2-Bromo-4-(4-octylphenyl)butanoate, CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉BrO₂.

Methyl 2-Chloroacetoacetate, CAS: 4755-81-1, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇ClO₃.

Methyl 2-Hydroxybutanoate, CAS: 29674-47-3, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

Methyl 3-(1-Methyl-5-nitro-1H-benzo[d]imidazol-2-yl)propanoate, CAS: /, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃O₄.

Methyl 3-Methyl-3-(methylamino)butanoate, CAS: 89855-40-3, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

Methyl 3-Oxo-2-(hydroxyimino)butanoate, CAS: 73708-95-9, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NO₄.

Methyl 3-Oxo-4-(2,4,5-trifluorophenyl)butanoate, CAS: 769195-26-8, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃O₃.

Methyl 4-(4-Aminophenyl)butanoate, CAS: 20637-09-6, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

Methyl 4-(Chloroformyl)butyrate, CAS: 1501-26-4, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉ClO₃.

Methyl 4-Chloroacetoacetate, CAS: 32807-28-6, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇ClO₃.

Methyl 4-Methoxyacetoacetate, CAS: 41051-15-4, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

Methyl 4-[4-Benzyl-N-(2-methoxycarbonylethyl)]aminobutyrate, CAS: 109386-71-2, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₄.

Methyl Acetoacetate, CAS: 105-45-3, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₃.

Methyl butyrate, CAS: 623-42-7, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

Methyl-4,4-dimethoxy-2-(3-nitrobenzylidene)-acetoacetate, CAS: 67448-15-1, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₇.

Methyl-d3 butyrate, CAS: 38666-81-8, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₂.

Mevinolinic Acid, Monoammonium Salt, CAS: 77550-67-5, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₁NO₆.

Mitiglinide Benzyl Ester, CAS: 145324-19-2, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁NO₃.

Mono-tert-butyl Succinate, CAS: 15026-17-2, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₄.

Monomethyl Glutarate-1,5-13C2, CAS: 1189708-76-6, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₂H₁₀O₄.

Monomethyl Succinate, CAS: 3878-55-5, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₄.

Monophenyl Succinate, CAS: 6311-68-8, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₄.

Montelukast Gem-dimethylmethylene Analogue, CAS: 162489-70-5, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈ClNO₃S.

Mugineic Acid, CAS: 69199-37-7, stock: 5.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂O₈.

N,N-Dimethyl-L-valine, CAS: 2812-32-0, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₂.

N,N-Dimethyl-L-valine-d6, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉D₆NO₂.

N,N’-Bis(trifluoroacetyl)-L-homocystine Dimethyl Ester, CAS: 84355-09-9, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈F₆N₂O₆S₂.

N-(2-Hydroxyethyl) Chlorambucil, CAS: 27171-89-7, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀ClNO₃.

N-(3,3-Dimethylbutyl)-L-α-apartyl-L-phenylalanine, CAS: 190910-14-6, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₂O₅.

N-(3-tert-Butyldimethylsilyloxy-2,2-dimethylbutyryloxy)succinimide, CAS: 1076199-64-8, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₉NO₅Si.

N-(4-Pyridyl)-3,4-dihydroxybutyramide, CAS: 1246818-25-6, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₃.

N-(Benzyloxycarbonyl)glycyl-L-valine, CAS: 33912-87-7, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₅.

N-(Ethoxycarbonyl)-L-valine-d3, CAS: /, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₃NO₄.

N-Acetyl Glufosinate Sodium, CAS: 133659-60-6, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂NNa₂O₅P.

N-Acetyl Glufosinate-d3 Disodium Salt, CAS: 1356933-74-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉D₃NNa₂O₅P.

N-Acetyl-D,L-homotryptophan Ethyl Ester, CAS: 110504-55-7, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₃.

N-Acetyl-D-methionine, CAS: 1509-92-8, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃S.

N-Acetyl-DL-Valine, CAS: 3067-19-4, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₃.

N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine Disodium Salt (Mixture of Diastereomers), CAS: 1041285-62-4, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NNa₂O₅S.

N-Acetyl-S-(3-carboxy-2-propyl)-L-cysteine-d3 Disodium Salt, CAS: 1356933-73-7, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀D₃NNa₂O₅S.

N-Arachidonoyl-GABA (NA-GABA), CAS: 128201-89-8, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉NO₃.

N-​Boc-​4-​azido-​L-​homoalanine (Dicyclohexylammoniu​m) Salt, CAS: 1217459-14-7, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₄O₄ • C ₁₂H₂₃N.

N-Benzyl-2-ethyl-2-phenylglycine Ethyl Ester, CAS: 1330183-23-7, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₂.

N-Benzyloxycarbonyl-γ-aminobutyric Acid, CAS: 5105-78-2, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.

N-Boc-(+-)-2-amino-3-hydroxy-3-methylbutanoic Acid, CAS: 105504-72-1, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₅.

N-Boc-2-aminomethyl-3-hydroxy-3-methylbutanoic Acid, CAS: 1233513-26-2, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₅.

N-Boc-3-hydroxy-L-valine, CAS: 102507-13-1, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₅.

N-Boc-D-methionine, CAS: 5241-66-7, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄S.

N-Boc-D-tert-leucine, CAS: 124655-17-0, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-Boc-D-threonine, CAS: 55674-67-4, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₅.

N-Boc-gamma-aminobutyric Acid, CAS: 57294-38-9, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₄.

N-Boc-L-homophenylalanine, CAS: 100564-78-1, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₄.

N-Boc-L-Homoserine, CAS: 41088-86-2, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₅.

N-Boc-L-methionine, CAS: 2488-15-5, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄S.

N-Boc-L-threonine, CAS: 2592-18-9, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₅.

N-Boc-N-methyl-L-valine, CAS: 45170-31-8, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-boc-tert-Butylglycine, CAS: 169870-82-0, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-Cbz-D-valine, CAS: 1685-33-2, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

N-Cbz-L-threonine, CAS: 19728-63-3, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅.

N-Cbz-L-valine, CAS: 1149-26-4, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₄.

N-Des-(2-chloroethyl) Chlorambucil, CAS: 116505-53-4, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO₂.

N-Fmoc-L-methionine, CAS: 71989-28-1, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄S.

N-Hydroxysuccinimidyl Pyrenebutanoate, CAS: 114932-60-4, stock: 10g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉NO₄.

N-Methyl-4-aminobutyric Acid, CAS: 1119-48-8, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

N-Methyl-4-aminobutyric Acid-d3, CAS: 1215511-11-7, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃NO₂.

N-Nitroso-N-methyl-4-aminobutyric Acid, CAS: 61445-55-4, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₃.

N-Nitroso-N-methyl-4-aminobutyric Acid Methyl Ester, CAS: 51938-17-1, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₂O₃.

N-Nitroso-N-methyl-4-aminobutyric Acid-d3, CAS: 1184996-41-5, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃N₂O₃.

N-Nitroso-N-methyl-4-aminobutyric Acid-d3 Methyl Ester, CAS: 1246817-93-5, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₃N₂O₃.

N-tert-Butoxycarbonyl-L-tert-leucine, CAS: 62965-35-9, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₄.

N-tert-Butylcarbamoyl-L-tert-leucine, CAS: 101968-85-8, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₃.

N-tert-Butylcarbamoyl-L-tert-leucine Benzyl Ester, CAS: 1391068-03-3, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₃.

N-[1-(R)-Ethyloxycarbonyl-3-phenylpropyl]-L-alanine tert-Butyl Ester, CAS: 80828-28-0, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉NO₄.

N-[1-(S)-Benzyloxycarbonyl-3-phenylpropyl]-D-alanine tert-Butyl Ester, CAS: 1356022-42-8, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁NO₄.

N-[1-(S)-Benzyloxycarbonyl-3-phenylpropyl]-L-alanine, CAS: 89371-42-6, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

N-[1-(S)-Benzyloxycarbonyl-3-phenylpropyl]-L-alanine tert-Butyl Ester, CAS: 117560-14-2, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁NO₄.

N-[2(4-(-Octylphenyl))butanoic Acid] Fingolimod, CAS: /, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₉NO₄.

N-[2(4-(-Octylphenyl))butanoic Acid] Fingolimod-d4, CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₅D₄NO₄.

N-[2-Chloro-4-(trifluoromethyl)phenyl]-D-valine, CAS: 76769-07-8, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃ClF₃NO₂.

N-[3-(N-Alanyl)-amino-3-carboxypropyl]-histidine, CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₄O₆.

N-[3-(N-L-Alanyl)-amino-3-carboxypropyl]-D-histidine Trihydrochloride, CAS: /, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃Cl₃N₄O₆.

N-[3-(N-L-Alanyl)-amino-3-carboxypropyl]-D-histidine Trihydrochloride-13C3, CAS: /, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N2-(S)-1-Carboxy-3-phenylpropyl-L-lysine, CAS: 138247-43-5, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₄.

N2-(S)-1-Carboxy-3-phenylpropyl-L-lysine-d5, CAS: /, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₅N₂O₄.

N2-(S)-1-Ethoxycarbonyl-3-phenyl-d5-propyl-N8-trifluoroacetyl-L-lysine, CAS: /, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂D₅F₃N₂O₅.

N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine, CAS: 116169-90-5, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇F₃N₂O₅.

N3-(3-Dimethylamino,1-carboxyprop-2-yl) Afatinib, CAS: /, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆ClFN₆O₅.

N’-Formylkynurenine, CAS: 1022-31-7, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₄.

Nicotianamine, CAS: 34441-14-0, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₃O₆.

Nicotinoyl-γ-aminobutyric Acid, CAS: 34562-97-5, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

Nω-Hydroxy-nor-L-Arginine Dihydrochloride, CAS: 291758-32-2, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄Cl₂N₄O₃.

Nω-Methyl L-Norarginine, CAS: 186308-99-6, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₄O₂.

Nα-Boc-L-asparagine, CAS: 7536-55-2, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₅.

Nα-Cbz-L-asparagine, CAS: 2304-96-3, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₅.

Nor NOHA Monoacetate, CAS: 1140844-63-8, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₄O₅.

Norcarnitine tert-Butyl Ester, CAS: 104572-14-7, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁NO₃.

NSC 5137, CAS: 3984-34-7, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉ClO₃.

O-De-4-oxobutanoic Acid N-Demethly-N-4-oxobutanoic Acid Sarpogrelate, CAS: /, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₆.

O-Desmethyl Mebeverine Acid, CAS: 586357-02-0, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃NO₃.

O-Desmethyl Mebeverine Acid Acyl-β-D-Glucuronide Hexafluorophosphate (Mixture of Diastereomers), CAS: /, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂F₆NO₉P.

O-Desmethyl Mebeverine Acid Methyl Ester, CAS: /, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₃.

O-Desmethyl Mebeverine Acid O-β-D-Glucuronide Ammonium Salt, CAS: /, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁NO₉ xNH₃.

O-Desmethyl Mebeverine Acid-d5, CAS: 1329488-46-1, stock: 8.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₅NO₃.

ONO AE3 208, CAS: 402473-54-5, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁FN₂O₃.

ortho-Chlorambucil, CAS: 178481-89-5, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂NO₂.

PD 135158, CAS: 130285-87-9, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₄N₄O₆.

Pemafibrate, CAS: 848259-27-8, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₆.

Pentanoic-5,5,5-d3 Acid, CAS: 83741-76-8, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₃O₂.

Perfluoro-4-isopropoxybutanoic Acid, CAS: 801212-59-9, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇F₁₃O₃H.

Phenibut Hydrochloride, CAS: 3060-41-1, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.

Pilocarpic Acid Sodium Salt, CAS: 92598-79-3, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₂NaO₃.

Pilocarpic Acid-d3 Sodium Salt, CAS: 1346602-32-1, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄D₃N₂NaO₃.

Piperacillinpenicillenic Acid, CAS: /, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₅O₇S.

Plevitrexed, CAS: 153537-73-6, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅FN₈O₄.

Pravastatin Lactone, CAS: 85956-22-5, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₆.

Pravastatin Lactone Di-(tert-butyldimethylsilyl) Ether, CAS: 136980-32-0, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₂O₆Si₂.

Pravastatin Lactone Di-(tert-butyldimethylsilyl) Ether-d3, CAS: /, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₉D₃O₆Si₂.

Pravastatin Lactone-d3, CAS: 1217769-04-4, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁D₃O₆.

Pravastatin-D9 Lactone Di-(tert-butyldimethylsilyl) Ether, CAS: /, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₃D₉O₆Si₂.

Propyl Acetoacetate, CAS: 1779-60-8, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

rac 3-Aminobutyric Acid, CAS: 541-48-0, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₂.

rac 3-Hydroxy Kynurenine Hydrochloride Salt, CAS: /, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄ .   xHCl.

rac 3-Hydroxy Kynurenine-13C2,15N Hydrochloride Salt, CAS: /, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₂N¹⁵NO₄ .   xHCl.

rac 3-Hydroxybutyric Acid  Sodium Salt, CAS: 150-83-4, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₃.

rac 3-Hydroxybutyric Acid-13C4  Sodium Salt, CAS: 287111-43-7, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₇NaO₃.

rac 3-Hydroxybutyric Acid-d2  Sodium Salt, CAS: 352439-00-0, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅D₂NaO₃.

rac 3-Hydroxybutyric Acid-d4  Sodium Salt, CAS: 1219804-68-8, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₄NaO₃.

rac 4-Hydroxy-4-(3-pyridyl)butanoic Acid Dicyclohexylamine Salt, CAS: 1216491-66-5, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄N₂O₃.

rac 4-Hydroxy-4-(3-pyridyl)butanoic-d3 Acid Dicyclohexylamine Salt (d3 Major), CAS: /, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁D₃N₂O₃.

rac Kynurenine, CAS: 343-65-7, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

rac Kynurenine-13C2,15N, CAS: 1391051-69-6, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₂N¹⁵NO₃.

rac Kynurenine-d4 Trifluoroacetic Acid Salt (Major), CAS: /, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂O₃  • x(C ₂HF₃O₂).

rac-2,4-Diaminobutyric Acid-d5 Dihydrochloride, CAS: 1794713-67-9, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇D₅Cl₂N₂O₂.

rac-2-Aminobutyric Acid-d3 Hydrochloride, CAS: /, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₃NO₂•HCl.

rac-Pinobanksin 3-O-Butyrate, CAS: /, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈O₆.

rac-Viridifloric Acid, CAS: 466-18-2, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₄.

rac-Viridifloric Acid-d7, CAS: /, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₇O₄.

Resorufin Butyrate, CAS: 15585-42-9, stock: 9.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₄.

Rinderine, CAS: 6029-84-1, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅NO₅.

S-(3-Carboxypropyl)-L-cysteine, CAS: 30845-11-5, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO₄S.

Salinomycin Sodium Salt, CAS: 55721-31-8, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₉NaO₁₁.

Salinomycin Sodium Salt (12% min.), CAS: 55721-31-8, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₉NaO₁₁.

SarTATE, CAS: 1518779-60-6, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₉H₁₀₃N₁₇O₁₄S₂.

Seleno-D,L-ethionine, CAS: 2578-27-0, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂Se.

Simvastatin, CAS: 79902-63-9, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₅.

Simvastatin 4’-Methyl Ether, CAS: 864357-88-0, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₅.

Simvastatin-d6, CAS: 1002347-71-8, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂D₆O₅.

SM-21, CAS: 155058-71-2, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClNO₃.

SM-21 Maleate, CAS: 155059-42-0, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClNO₇.

Sodium 2-Hydroxybutyrate, CAS: 5094-24-6, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₃.

Sodium 4-(2-Amino-6-methyl-6H-imidazo[4’,5’:3,4]benzo[1,2-d]thiazol-7-yl)butanoate, CAS: /, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₄NaO₂S.

Sodium 4-Phenylbutyrate, CAS: 1716-12-7, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NaO₂.

Sodium Butyrate, CAS: 156-54-7, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₂.

Sodium Phenylbutyrate, CAS: 1716-12-7, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NaO₂.

Spirodiclofen, CAS: 148477-71-8, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄Cl₂O₄.

Spiromesifen, CAS: 283594-90-1, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀O₄.

t-Butyl (2S)-2-[(Benzyloxycarbonylamino)]-4-oxo-butyrate, CAS: 78553-60-3, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₅.

t-Butyl 4-Bromobutanoate, CAS: 110661-91-1, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅BrO₂.

t-Butyl 4-Bromobutyrate, CAS: 110661-91-1, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅BrO₂.

tert-Butoxycarbonyl-D-valine, CAS: 22838-58-0, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₄.

tert-Butoxycarbonyl-L-glutamine, CAS: 13726-85-7, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈N₂O₅.

tert-Butyl 2-(Trifluoromethyl)-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridine-5-carboxylate, CAS: 733758-27-5, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆F₃N₃O₂.

tert-Butyl 2-Methyl-3-oxobutanoate-D3, CAS: /, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₃O₃.

tert-Butyl 4-Aminobutanoate Hydrochloride, CAS: 58640-01-0, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂ • HCi.

tert-Butyl 4-Hydroxybutanoate, CAS: 59854-12-5, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₃.

tert-Butyl L-N-(3-Benzyloxycarbonylamino-3-(S)-tert-butylcarboxy-1-oxopropyl-azetidine-2-carboxylate, CAS: 201283-53-6, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₂O₇.

tert-Butyl Oxobutyrate, CAS: 1694-31-1, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄O₃.

Tipelukast, CAS: 125961-82-2, stock: 1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₈O₇S.

Tipelukast-d6, CAS: /, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂D₆O₇S.

Tolvaptan γ-Hydroxybutanoic Acid Impurity, CAS: 1346599-75-4, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅ClN₂O₅.

Tolvaptan γ-Oxobutanoic Acid Impurity, CAS: 1346599-56-1, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃ClN₂O₅.

Tosyl-D-valine, CAS: 68005-71-0, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₄S.

Tri(4-phenylbutyryl)glycerol, CAS: 611168-24-2, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈O₆.

Tri(4-phenylbutyryl)glycerol-d5, CAS: /, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₃D₅O₆.

Triacetic Acid, CAS: 2140-49-0, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₄.

Tropine 2-(phenylthio)butanoate Oxalate Salt, CAS: 155059-55-5, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₂S  • ( C₂H₂O₄).

Valtrate, CAS: 18296-44-1, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀O₈.

Vitamin B6 4-(N-(Butanoic Acid-d6))-N-hydroxysuccinimide, CAS: /, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₆N₃O₆.

Vitamin B6 4-(N-Butanoic Acid)-N-hydroxysuccinimide, CAS: /, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₆.

y-Oxo-1-pyrenebutanoic Acid-13C4, CAS: /, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₄O₃.

[1-Methyl-5-bis(2’-hydroxyethyl)aminobenzimidazolyl-2]butanoic Acid Ethyl EsterBendamustine Related Impurity 1, CAS: 3543-74-6, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₄.

[1-Methyl-5-bis(2’-hydroxyethyl)aminobenzimidazolyl-2]butanoic Acid Ethyl Ester-d3, CAS: 1286887-71-5, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₃N₃O₄.

[1-Methyl-5-bis(2’-hydroxyethyl)aminobenzimidazolyl-2]butanoic Acid Methyl Ester-d5, CAS: 1276499-54-7, stock: 2.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₅N₃O₄.

[R-(R*,R*)]-3,10-Dicarboxy-14,14-dimethyl-12-oxo-13-Oxa-6,7-dithia-2,11-diazapentadecanoic Acid 1-(1,1-Dimethylethyl) Ester, CAS: 113132-85-7, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂N₂O₈S₂.

[R-(R*,S*)]-α-[(1-Carboxyethyl)amino]-γ-oxo-benzenebutanoic Acid Monoethyl Ester, CAS: 105167-27-9, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₅.

[S-(R*,R*)]-α-Amino-β-methyl-β-sulfino-1H-1,2,3-triazole-1-butanoic Acid, CAS: 120701-87-3, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₄O₄S.

(3S)-Besifloxacin, CAS: 141388-77-4, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClFN₃O₃.

(R)-3-Amino-hexahydroazepine, CAS: 124932-43-0, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂.

(R)-7-(Azepan-3-ylamino)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O₃.

(S)-7-(3-((3-Carboxy-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)amino)azepan-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₈Cl₂F₂N₄O₆.

(S)-7-(3-((tert-Butoxycarbonyl)amino)azepan-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀FN₃O₅.

8-Chloro-1-cyclopropyl-6-fluoro-7-[[(3R)-hexahydro-1H-azepin-3-yl]amino]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid, CAS: /, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClFN₃O₃.

8-Dechloro Besifloxacin, CAS: 141388-69-4, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O₃.

Besifloxacin Hydrochloride, CAS: 405165-61-9, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂Cl₂FN₃O₃.

Besifloxacin-d4 Hydrochloride, CAS: /, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₄Cl₂FN₃O₃.

N-[(1,1-Dimethylethoxy)carbonyl]-6-hydroxy-L-norleucine-d2 Methyl Ester, CAS: /, stock: 4.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁D₂NO₅.

N-[(1,1-Dimethylethoxy)carbonyl]-6-methoxy-6-oxo-D-norleucine Methyl Ester, CAS: 1166394-55-3, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃NO₆.

[(1S)-5-Hydroxy-1-(hydroxymethyl)pentyl]carbamic Acid-d4 1,1-Dimethylethyl Ester, CAS: /, stock: 9.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉D₄NO₄.

3-Chloro-but-2-en-ol, CAS: 40605-42-3, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇ClO.

(R)-Bepotastine Besylate, CAS: 190730-42-8, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁ClN₂O₆S.

(R)-Bepotastine Besylate-d6, CAS: /, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅D₆ClN₂O₆S.

(S)-2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine, CAS: 201594-84-5, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O.

(S)-Bepotastine Besylate, CAS: 190786-44-8, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁ClN₂O₆S.

2-[(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine, CAS: 122368-54-1, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O.

2-[(S)-(4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine L-Tartrate, CAS: 210095-58-2, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₇.

4-(3-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid-d6, CAS: /, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₆ClN₂O₃.

4-Bromobutyryl Chloride, CAS: 927-58-2, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆BrClO.

4-Chlorophenyl-2-pyridinylmethanol, CAS: 27652-89-7, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀ClNO.

Bepostastine N-butyl ester, CAS: 1807606-59-2, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃ClN₂O₃.

Bepotastine, CAS: 125602-71-3, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₃.

Bepotastine Besylate (Racemate), CAS: 1415692-17-9, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₃ · C₆H₆O₃S.

Bepotastine Ethyl Ester, CAS: 190730-39-3, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClN₂O₃.

Bepotastine isopropyl ester, CAS: 1807607-93-7, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁ClN₂O₃.

Bepotastine-d6 Besylate, CAS: /, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₅D₆ClN₂O₆S.

Bepotastine-d6 Ethyl Ester, CAS: /, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₆ClN₂O₃.

(-)-Canadalisol, CAS: 123878-19-3, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₅.

(-)-Canadalisol-d3, CAS: /, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂D₃NO₅.

(R)-(+)-Canadine, CAS: 2086-96-6, stock: 7.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

(S)-(-)-Canadine, CAS: 5096-57-1, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

1-Hydroxy-N-methylcanadine, CAS: /, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀NO₅.

5-Fluoroindole-3-acetic Acid, CAS: 443-73-2, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈FNO₂.

8-​Oxopalmatine, CAS: 19716-59-7, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₅.

9-O-Benzenesulfonyl (±)-Tetrahydropalmatrubine, CAS: 1095271-88-7, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₇NO₆S.

Benzenesulfonyl Chloride, CAS: 98-09-9, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClO₂S.

Berberine Hydrochloride, CAS: 633-65-8, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈ClNO₄.

Berberine Hydrochloride-d6, CAS: /, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂D₆ClNO₄.

Berberine Sulfate, CAS: 633-66-9, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₈S.

Berberine Sulfate, CAS: 316-41-6, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₉H₁₆NO₄⁺)₂ • O ₄S²⁻.

Canadine, CAS: 522-97-4, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

Canadine-d3 Hydrochloride, CAS: /, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₃ClNO₄.

D,L-Stepholidine, CAS: 16562-14-4, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

Dehydro Berberrubine Bromide, CAS: 57721-67-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄BrNO₄.

Dihydroberberine, CAS: 483-15-8, stock: 1.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₄.

Epiberberine Chloride, CAS: 889665-86-5, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈NO₄ ⁺ •Cl⁻.

Jamaicin, CAS: 24211-36-7, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈O₆.

L-Stepholidine, CAS: 16562-13-3, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

N-(2,3-Dimethoxybenzyl)homopiperonylamine-d6, CAS: /, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₆NO₄.

Oxyberberin, CAS: 549-21-3, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₅.

Palmatine Chloride, CAS: 10605-02-4, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClNO₄.

[(2E)-4-Chloro-2-methylbut-2-ene-1-sulfonyl]benzene, CAS: 5829-79-8, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClO₂S.

Bepridil, CAS: 64706-54-3, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₂O.

Bepridil Hydrochloride, CAS: 68099-86-5, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄N₂O•HCl.

Bepridil-d5, CAS: /, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉D₅N₂O.

(o-Nitrophenyl)-p-benzoquinone, CAS: 105946-79-0, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇NO₄.

1,4,4a,8a-Tetrahydro-endo-1,4-methanonaphthalene-5,8-dione, CAS: 1200-89-1, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

1,4-Benzoquinone Monoguanylhydrazone, CAS: 7316-92-9, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄O.

1-(2-Phenylethyl)-4-(2-thienylcarbonyl)-2,6-piperazinedione, CAS: 697256-66-9, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₃S.

2,3-Dichloro-5,6-dicyanobenzoquinone, CAS: 84-58-2, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈Cl₂N₂O₂.

2,3-Diimethoxy-1,4-benzoquinone, CAS: 3117-02-0, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

2,3-Dimethoxy-5,6-dimethyl-p-benzoquinone, CAS: 483-54-5, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

2,3-Dimethoxy-5-methyl-p-benzoquinone, CAS: 605-94-7, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₄.

2,3-Dimethylbenzoquinone, CAS: 526-86-3, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

2,5-Di-tert-amylbenzoquinone, CAS: 4584-63-8, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄O₂.

2,5-Dibromo-1,4-benzoquinone, CAS: 1633-14-3, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Br₂O₂.

2,5-Dihydroxy-1,4-benzoquinone, CAS: 615-94-1, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄O₄.

2,5-Dimethoxy-1,4-benzoquinone, CAS: 01/03/3117, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

2,5-Diphenyl-1,4-benzoquinone, CAS: 844-51-9, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂O₂.

2,5-Xyloquinone, CAS: 137-18-8, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

2,6-Di-tert-butyl-p-benzoquinone, CAS: 719-22-2, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₂.

2,6-Dibromoquinone, CAS: 19643-45-9, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Br₂O₂.

2,6-Dibromoquinone-4-chloroimide, CAS: 537-45-1, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Br₂ClNO.

2,6-Dichloro-1,4-benzoquinone, CAS: 697-91-6, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₂O₂.

2,6-Dichloro-3-methyl-4-nitrophenol, CAS: 37693-15-5, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NO₃.

2,6-Dichloroquinone-4-chloroimide, CAS: 101-38-2, stock: 5.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₃NO.

2,6-Diisopropyl-1,4-benzoquinone, CAS: 1988-11-0, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

2,6-Dimethoxy-1,4-benzoquinone, CAS: 530-55-2, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₄.

2,6-Dimethylbenzoquinone, CAS: 527-61-7, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

2-​[(2,​6-Dichloro-​4-​oxo-​2,​5-​cyclohexadien-​1-​ylidene)​amino]​-benzeneacetic Acid, CAS: 928343-25-3, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl₂NO₃.

2-Chloro-1,4-Benzoquinone, CAS: 695-99-8, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClO₂.

2-Ethyl-1,4-benzoquinone, CAS: 4754-26-1, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

2-tert-Butyl-1,4-benzoquinone, CAS: 3602-55-9, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

3,5-Di-tert-butyl-o-benzoquinone, CAS: 3383-21-9, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₂.

3,5-Dichloro-2-methyl-benzoquinone, CAS: 40100-98-9, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₂O₂.

3,6-Di-tert-butyl-o-benzoquinone, CAS: 34105-76-5, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₂.

3,6-Di-tert-butylcatechol, CAS: 15512-06-8, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂O₂.

4-Amino-2,6-dichloro-3-methylphenol, CAS: 64981-11-9, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Cl₂NO.

4-Benzoquinone Monoxime, CAS: 637-62-7, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₂.

4-Hydroxy-3-methoxyphenylboronic Acid, CAS: 182344-21-4, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉BO₄.

5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine, CAS: 115794-55-3, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆F₃N₃O₆.

5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2’-deoxyuridine, CAS: 252337-58-9, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇F₃N₄O₇.

Benzoquinonium Dichloride, CAS: 311-09-1, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀Br₂N₄O₂.

Bromanil, CAS: 488-48-2, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆Br₄O₂.

Bromanilic Acid, CAS: 4370-59-6, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Br₂O₄.

Chloranilic Acid, CAS: 87-88-7, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₂O₄.

Chloroacetic Acid, CAS: 79-11-8, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃ClO₂.

Coenzyme Q1, CAS: 727-81-1, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₄.

Coenzyme Q2, CAS: 606-06-4, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₄.

Coenzyme Q7, CAS: 303-95-7, stock: 2.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₆O₄.

Coenzyme Q8, CAS: 2394-68-5, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₄O₄.

D-α-Tocopherol Quinone, CAS: 08/04/7559, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₃.

DL-α-Phenylglycine, CAS: 05/06/2835, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Embelin, CAS: 550-24-3, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆O₄.

Idebenone, CAS: 58186-27-9, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀O₅.

Idebenone Glucuronide, CAS: /, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₁₁.

Idebenone Glucuronide-13C,d3, CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₃₅D₃O₁₁.

Idebenone-13C,d3, CAS: 1189907-75-2, stock: 5.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₂₇D₃O₅.

Iodoethane-1,1-d2, CAS: 3652-82-2, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃D₂I.

Methoxybenzoquinone, CAS: 2880-58-2, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₃.

o-Chloranil, CAS: 2435-53-2, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆Cl₄O₂.

p-Benzoquinone, CAS: 106-51-4, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄O₂.

p-Benzoquinone-d4, CAS: 2237-14-1, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₄O₂.

p-Benzoquinonedioxime, CAS: 105-11-3, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

Tetrachloro-1,4-benzoquinone, CAS: 118-75-2, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆Cl₄O₂.

Tetrafluoro-1,4-benzoquinone, CAS: 527-21-9, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆O₂F₄.

Tetrahydroxyquinone Hydrate, CAS: 123334-16-7, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄O₆ • x(H ₂O).

Tetramethyl-1,4-benzoquinone, CAS: 527-17-3, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

Thymoquinone, CAS: 490-91-5, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

Aminobenztropine, CAS: 88097-86-3, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₂O.

Benzotropine Mesylate, CAS: 132-17-2, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₄S.

Pseudobenztropine, CAS: 802597-90-6, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO.

Benzoyl Peroxide, CAS: 94-36-0, stock: 10g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₄.

Sulfacetamide Sodium Salt, CAS: 127-56-0, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₂NaO₃S.

4-(2-(4-Chlorobenz-d4-amido)ethyl)phenyl 4-Chlorobenz-d4-oate, CAS: /, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₉D₈Cl₂NO₃.

Bezafibrate, CAS: 41859-67-0, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀ClNO₄.

Bezafibrate 1-O-β-Glucuronide, CAS: 72156-77-5, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈ClNO₁₀.

Bezafibrate Butyl Ester, CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClNO₄.

Bezafibrate Ethyl Ester, CAS: 41859-58-9, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClNO₄.

Bezafibrate-d4, CAS: 1189452-53-6, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₄ClNO₄.

Bezafibrate-d6, CAS: /, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₆ClNO₄.

Ethyl 2-(4-(2-(4-chlorobenz-d4-amido)ethyl)phenoxy)-2-methylpropanoate, CAS: /, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₄ClNO₄.

(7R,8S,9S)-Trihydroxy-10S(N2-deoxyguanosyl-3’-phosphate)-7,8,9,10-tetrahydrobenzo[a]pyrene Triethylamine, CAS: /, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₃N₆O₁₀P.

1,11,12,12a-Tetrahydro-benzopyren-3-one, CAS: 853925-19-6, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O.

1,2-Dihydro-5-methoxy-3H-benz[e]inden-3-one, CAS: 857552-15-9, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

1-(4-Methylphenyl)-3-(1-(4-methoxynaphthalenyl))-1-propanone, CAS: 1391054-19-5, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₂.

2,3-Dihydro-6-methoxy-phenalen-1-one, CAS: 100621-80-5, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

3-Hydroxy Benzopyrene, CAS: 13345-21-6, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O.

3-Hydroxy Benzopyrene O-β-D-glucuronide, CAS: 60262-81-9, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀O₇.

3-Hydroxy Benzopyrene-13C6, CAS: /, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₆H₁₂O.

3-Hydroxy Benzopyrene-d11, CAS: 1246819-35-1, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀HD₁₁O.

3-Methoxy Benzopyrene, CAS: 63059-68-7, stock: 4.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄O.

3-Methoxy Benzopyrene (Major)(Mixture of 3-Methoxy-11,12-dihydro-benzo[a]pyrene), CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₄O + C  ₂₁H₁₆O.

4-Mercapto-2,6-di-tert-butylphenol, CAS: 950-59-4, stock: 9.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂OS.

4-Methoxy-1-naphthaleneacrolein, CAS: 858461-16-2, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₂.

6-Acetyloxy-3-methoxy-11,12-dihydro-benzopyrene, CAS: 1797227-23-6, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈O₃.

7,8,9,10-Tetrahydro-benzo[a]pyren-7-ol, CAS: 6272-55-5, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O.

7,8,9,10-Tetrahydro-benzo[a]pyren-7-ol-13C4, CAS: /, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₆O.

7-Hydroxybenzo[a]pyrene, CAS: 37994-82-4, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O.

7-Hydroxybenzo[a]pyrene-13C4, CAS: /, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₂O.

7-Methoxy-2-naphthol, CAS: 5060-82-2, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

9,10-Dihydrobenzo[a]pyrene, CAS: 17573-15-8, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄.

9,10-Dihydrobenzo[a]pyrene-13C4, CAS: /, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₄.

9-Hydroxy Benzopyrene, CAS: 17573-21-6, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O.

9-Hydroxy Benzopyrene-d11, CAS: 1246818-35-8, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀HD₁₁O.

Benzopyrene, CAS: 50-32-8, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂.

Benzopyrene-13C4, CAS: /, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₂.

Benzo[a]​pyrene-​7,8-dione, CAS: 65199-11-3, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀O₂.

Benzo[a]​pyrene-​7,8-dione-d10, CAS: /, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀D₁₀O₂.

Benzo[a]​pyrene-​9,​10-​diol, CAS: 57303-98-7, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O₂.

Benzo[a]​pyrene-​9,​10-​diol-d10, CAS: /, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂D₁₀O₂.

Benzo[a]pyren-8-ol, CAS: 13345-26-1, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O.

Benzo[a]pyren-8-ol-d11, CAS: /, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀HD₁₁O.

Benzo[a]pyrene 7,8-Oxide, CAS: 36504-65-1, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂O.

Benzo[a]pyrene-1,6-quinone, CAS: 3067-13-8, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₀O₂.